Estimates of body composition as intermediate outcome variables: are DEXA and BIA ready for prime time?
Chertow, G. M. (1999). Estimates of body composition as intermediate outcome variables: are DEXA and BIA ready for prime time? Journal of Renal Nutrition , 9(3), 138–141.

The urea {clearance x dialysis time} product (Kt) as an outcome-based measure of hemodialysis dose
Lowrie, E. G., Chertow, G. M., Lew, N. L., Lazarus, J. M., & Owen, W. F. (1999). The urea {clearance x dialysis time} product (Kt) as an outcome-based measure of hemodialysis dose. KIDNEY INTERNATIONAL, 56(2), 729–737.

Exploring the reverse J-shaped curve between urea reduction ratio and mortality
Chertow, G. M., Owen, W. F., Lazarus, J. M., Lew, N. L., & Lowrie, E. G. (1999). Exploring the reverse J-shaped curve between urea reduction ratio and mortality. KIDNEY INTERNATIONAL, 56(5), 1872–1878.

Bioelectrical impedance methods in clinical research: A follow-up to the NIH technology assessment conference
Ellis, K. J., Bell, S. J., Chertow, G. M., Chumlea, W. C., Knox, T. A., Kotler, D. P., … Schoeller, D. A. (1999). Bioelectrical impedance methods in clinical research: A follow-up to the NIH technology assessment conference. NUTRITION, 15(11-12), 874–880.

Renal nutrition in the new millennium.
Chertow, G. M. (2000). Renal nutrition in the new millennium. Journal of Renal Nutrition , 10(1), 1-?

Acute renal failure with interstitial nephritis in a patient with AIDS
Mouratoff, J. G., Tokumoto, J., Olson, J. L., & Chertow, G. M. (2000). Acute renal failure with interstitial nephritis in a patient with AIDS. AMERICAN JOURNAL OF KIDNEY DISEASES, 35(3), 557–561.

Vintage, nutritional status, and survival in hemodialysis patients
Chertow, G. M., Johansen, K. L., Lew, N., Lazarus, J. M., & Lowrie, E. G. (2000). Vintage, nutritional status, and survival in hemodialysis patients. KIDNEY INTERNATIONAL, 57(3), 1176–1181.

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients
Chertow, Burke, Dillon, & Slatopolsky. (2000). Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 15(4), 559-?

Issues in renal nutrition for persons from the former Soviet Union.
Gorodetskaya, I., Matel, J., & Chertow, G. M. (2000). Issues in renal nutrition for persons from the former Soviet Union. Journal of Renal Nutrition , 10(2), 98–102.

Physical activity levels in patients on hemodialysis and healthy sedentary controls
Johansen, K. L., Chertow, G. M., Ng, A. V., Mulligan, K., Carey, S., Schoenfeld, P. Y., & Kent-Braun, J. A. (2000). Physical activity levels in patients on hemodialysis and healthy sedentary controls. KIDNEY INTERNATIONAL, 57(6), 2564–2570.

Predicting acute renal failure after coronary bypass surgery: Cross-validation of two risk-stratification algorithms
Fortescue, E. B., Bates, D. W., & Chertow, G. M. (2000). Predicting acute renal failure after coronary bypass surgery: Cross-validation of two risk-stratification algorithms. KIDNEY INTERNATIONAL, 57(6), 2594–2602.

Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the Cooperative Cardiovascular Project
Chertow, G. M., Normand, S. L. T., Silva, L. R., & McNeil, B. J. (2000). Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the Cooperative Cardiovascular Project. AMERICAN JOURNAL OF KIDNEY DISEASES, 35(6), 1044–1051.

Ochrobactrum anthropi bacteremia in a patient on hemodialysis
Chertow, G. M. (2000). Ochrobactrum anthropi bacteremia in a patient on hemodialysis. AMERICAN JOURNAL OF KIDNEY DISEASES, 35(6).

Leveling the "paying" field in end-stage renal disease
Chertow, G. M. (2000). Leveling the "paying" field in end-stage renal disease. AMERICAN JOURNAL OF MEDICINE, 108(8), 666–668.

Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial.
Chertow, G. M., DILLON, M. A., Amin, N., & Burke, S. K. (2000). Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial. Journal of Renal Nutrition , 10(3), 125–132.

Chronic renal confusion: Insufficiency, failure, dysfunction, or disease
Hsu, C., & Chertow, G. M. (2000). Chronic renal confusion: Insufficiency, failure, dysfunction, or disease. AMERICAN JOURNAL OF KIDNEY DISEASES, 36(2), 415–418.

Reply from the authors
Chertow, G. M. (2000). Reply from the authors. Kidney International, 58(3), 1358–9.

Crystalloids versus colloids for resuscitation in shock
Waikar, S. S., & Chertow, G. M. (2000). Crystalloids versus colloids for resuscitation in shock. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 9(5), 501–504.

Atrial natriuretic factor in oliguric acute renal failure
Lewis, J., Salem, M. M., Chertow, G. M., Weisberg, L. S., McGrew, F., Marbury, T. C., & Allgren, R. L. (2000). Atrial natriuretic factor in oliguric acute renal failure. AMERICAN JOURNAL OF KIDNEY DISEASES, 36(4), 767–774.

Hyperparathyroidism and dialysis vintage
Chertow, G. M., Plone, M., DILLON, M. A., Burke, S. K., & Slatopolsky, E. (2000). Hyperparathyroidism and dialysis vintage. CLINICAL NEPHROLOGY, 54(4), 295–300.

Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients
Chertow, G. M., Ackert, K., Lew, N. L., Lazarus, J. M., & Lowrie, E. G. (2000). Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients. KIDNEY INTERNATIONAL, 58(6), 2512–2517.

Gridlock on the road to kidney transplantation
Chertow, G. M., & Zenios, S. A. (2001). Gridlock on the road to kidney transplantation. AMERICAN JOURNAL OF KIDNEY DISEASES, 37(2), 435–37.

Mechanisms underlying renoprotection during renin-angiotensin system blockade
Taal, M. W., Chertow, G. M., Rennke, H. G., Gurnani, A., Jiang, T., Shahsafaei, A., … Mackenzie, H. S. (2001). Mechanisms underlying renoprotection during renin-angiotensin system blockade. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 280(2), F343–F355.

Mortality and costs of acute renal failure associated with amphotericin B therapy
Bates, D. W., Su, L., Yu, D. T., Chertow, G. M., Seger, D. L., Gomes, D. R. J., … Platt, R. (2001). Mortality and costs of acute renal failure associated with amphotericin B therapy. CLINICAL INFECTIOUS DISEASES, 32(5), 686–693.

beta(2)-microglobulin modified with advanced glycation end products delays monocyte apoptosis
Hou, F. F., Miyata, T., Boyce, J., Yuan, Q., Chertow, G. M., Kay, J., … Owen, W. F. (2001). beta(2)-microglobulin modified with advanced glycation end products delays monocyte apoptosis. KIDNEY INTERNATIONAL, 59(3), 990–1002.

Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease
Johansen, K. L., Painter, P., Kent-Braun, J. A., Ng, A. V., Carey, S., Da Silva, M., & Chertow, G. M. (2001). Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease. KIDNEY INTERNATIONAL, 59(3), 1121–1127.

Suspected iron dextran-related adverse drug events in hemodialysis patients
Fletes, R., Lazarus, J. M., Gage, J., & Chertow, G. M. (2001). Suspected iron dextran-related adverse drug events in hemodialysis patients. AMERICAN JOURNAL OF KIDNEY DISEASES, 37(4), 743–749.

Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients
Kaysen, G. A., Chertow, G. M., Adhikarla, R., Young, B., Ronco, C., & Levin, N. W. (2001). Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. KIDNEY INTERNATIONAL, 60(1), 333–340.

Cardiac arrest and sudden death in dialysis units
Karnik, J. A., Young, B. S., Lew, N. L., Herget, M., Dubinsky, C., Lazarus, J. M., & Chertow, G. M. (2001). Cardiac arrest and sudden death in dialysis units. KIDNEY INTERNATIONAL, 60(1), 350–357.

Correlates of acute renal failure in patients receiving parenteral amphotericin B
Bates, D. W., Su, L., Yu, D. T., Chertow, G. M., Seger, D. L., Gomes, D. R. J., & Platt, R. (2001). Correlates of acute renal failure in patients receiving parenteral amphotericin B. KIDNEY INTERNATIONAL, 60(4), 1452–1459.

Determinants of physical performance in ambulatory patients on hemodialysis
Johansen, K. L., Chertow, G. M., Da Silva, M., Carey, S., & Painter, P. (2001). Determinants of physical performance in ambulatory patients on hemodialysis. KIDNEY INTERNATIONAL, 60(4), 1586–1591.

"Wishing don't make it so" - Why we need a randomized clinical trial of high-intensity hemodialysis
Chertow, G. M. (2001). "Wishing don't make it so" - Why we need a randomized clinical trial of high-intensity hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 12(12), 2850–2853.

Guided medication dosing for inpatients with renal insufficiency
Chertow, G. M., Lee, J., Kuperman, G. J., Burdick, E., Horsky, J., Seger, D. L., … Bates, D. W. (2001). Guided medication dosing for inpatients with renal insufficiency. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 286(22), 2839–2844.

Renal insufficiency with monoclonal gammopathy and urticarial vasculitis
O''Hare, A., Olson, J. L., Connolly, M. K., Ward, J. W., Stein, P., Wisnieski, J. J., & Chertow, G. M. (2002). Renal insufficiency with monoclonal gammopathy and urticarial vasculitis. AMERICAN JOURNAL OF KIDNEY DISEASES, 39(1), 203–207.

Cardiac calcification in adult Hemodialysis patients - A link between end-stage renal disease and cardiovascular disease?
Raggi, P., Boulay, A., Chasan-Taber, S., Amin, N., Dillon, M., Burke, S. K., & Chertow, G. M. (2002). Cardiac calcification in adult Hemodialysis patients - A link between end-stage renal disease and cardiovascular disease? JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 39(4), 695–701.

With bioimpedance spectroscopy, the errors get fat when the patients get slim
Chertow, G. M. (2002). With bioimpedance spectroscopy, the errors get fat when the patients get slim. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 26(2), 128–129.

Refining predictive models in critically ill patients with acute renal failure
Mehta, R. L., Pascual, M. T., Gruta, C. G., Zhuang, S. P., & Chertow, G. M. (2002). Refining predictive models in critically ill patients with acute renal failure. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13(5).

Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency
Hsu, C. Y., Chertow, G. M., & Curhan, G. C. (2002). Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. KIDNEY INTERNATIONAL, 61(5), 1567–1576.

Bone mineral density is not diminished by mild to moderate chronic renal insufficiency
Hsu, C. Y., Cummings, S. R., McCulloch, C. E., & Chertow, G. A. (2002). Bone mineral density is not diminished by mild to moderate chronic renal insufficiency. KIDNEY INTERNATIONAL, 61(5), 1814–1820.

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
Chertow, G. M., Burke, S. K., & Raggi, P. (2002). Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. KIDNEY INTERNATIONAL, 62(1), 245–252.

Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis
Hung, A. M., Chertow, G. M., Young, B. S., Carey, S., & Johansen, K. L. (2002). Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis. JOURNAL OF RENAL NUTRITION, 12(3), 170–176.

Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency
Hsu, C. Y., & Chertow, G. M. (2002). Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. NEPHROLOGY DIALYSIS TRANSPLANTATION, 17(8), 1419–1425.

Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients
Shlipak, M. G., Heidenreich, P. A., Noguchi, H., Chertow, G. M., Browner, W. S., & McClellan, M. B. (2002). Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. ANNALS OF INTERNAL MEDICINE, 137(7), 555–62.

The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease
de Boer, I. H., Gorodetskaya, I., Young, B., Hsu, C. Y., & Chertow, G. M. (2002). The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13(11), 2762–2769.

Nephrology consultation in acute renal failure: Does timing matter?
Mehta, R. L., McDonald, B., Gabbai, F., Pahl, M., Farkas, A., Pascual, M. T. A., … Chertow, G. M. (2002). Nephrology consultation in acute renal failure: Does timing matter? AMERICAN JOURNAL OF MEDICINE, 113(6), 456–461.

Diuretics, mortality, and nonrecovery of renal function in acute renal
Mehta, R. L., Pascual, M. T., Soroko, S., & Chertow, G. M. (2002). Diuretics, mortality, and nonrecovery of renal function in acute renal. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 288(20), 2547–2553.

In critically ill patients with acute renal failure, outcomes, not dollars, should drive modality choice
Mehta, R. L., & Chertow, G. M. (2003). In critically ill patients with acute renal failure, outcomes, not dollars, should drive modality choice. CRITICAL CARE MEDICINE, 31(2), 644–646.

Beware the rising creatinine level
Shlipak, M. G., Chertow, G. C., & Massie, B. M. (2003). Beware the rising creatinine level. JOURNAL OF CARDIAC FAILURE, 9(1), 26–28.

Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients
Johansen, K. L., Kaysen, G. A., Young, B. S., Hung, A. M., Da Silva, M., & Chertow, G. M. (2003). Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients. AMERICAN JOURNAL OF CLINICAL NUTRITION, 77(4), 842–846.

The Chronic Renal Insufficiency Cohort (CRIC) study: Design and methods
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Cizman, B., Daugirdas, J., … Wright, J. T. (2003). The Chronic Renal Insufficiency Cohort (CRIC) study: Design and methods. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14(7), S148–S153.

Acute renal failure definitions and classification: Time for change?
Mehta, R. L., & Chertow, G. M. (2003). Acute renal failure definitions and classification: Time for change? JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14(8), 2178–2187.

Analgesia in patients with ESRD: A review of available evidence
Kurella, M., Bennett, W. M., & Chertow, G. M. (2003). Analgesia in patients with ESRD: A review of available evidence. AMERICAN JOURNAL OF KIDNEY DISEASES, 42(2), 217–228.

Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: Effects of age, race, and gender
Daugirdas, J. T., Greene, T., Depner, T. A., Chumlea, C., Rocco, M. J., & Chertow, G. M. (2003). Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: Effects of age, race, and gender. KIDNEY INTERNATIONAL, 64(3), 1108–1119.

The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients
Chertow, G. M., Raggi, P., McCarthy, J. T., Schulman, G., Silberzweig, J., Kuhlik, A., … Toto, R. D. (2003). The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients. AMERICAN JOURNAL OF NEPHROLOGY, 23(5), 307–314.

Slowing the progression of vascular calcification in hemodialysis
Chertow, G. M. (2003). Slowing the progression of vascular calcification in hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14(9), S310–S314.

Reasons for non-enrollment in a cohort study of ARF: The program to improve care in acute renal disease (PICARD) experience and implications for a clinical trials network
Chertow, G. M., Pascual, M. T., Soroko, S., Savage, B. R., Himmelfarb, J., Ikizler, T. A., … Mehta, R. L. (2003). Reasons for non-enrollment in a cohort study of ARF: The program to improve care in acute renal disease (PICARD) experience and implications for a clinical trials network. AMERICAN JOURNAL OF KIDNEY DISEASES, 42(3), 507–512.

Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis
Hung, A. M., Chertow, G. A., Young, B. S., Carey, S., & Johansen, K. L. (2003). Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis. ADVANCES IN RENAL REPLACEMENT THERAPY, 10(3), 232–240.

Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus, binders or sevelamer
Raggi, P., Bommer, J., & Chertow, G. M. (2004). Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus, binders or sevelamer. JOURNAL OF HEART VALVE DISEASE, 13(1), 134–141.

A 43-year-old woman with chronic renal insufficiency
Chertow, G. M. (2004). A 43-year-old woman with chronic renal insufficiency. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 291(10), 1252–1259.

The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis
Kaysen, G. A., Muller, H. G., Young, B. S., Leng, X. Y., & Chertow, G. M. (2004). The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis. JOURNAL OF RENAL NUTRITION, 14(2), 72–81.

Plasma cytokine levels predict mortality in patients with acute renal failure
Simmons, E. M., Himmelfarb, J., Sezer, M. T., Chertow, G. M., Mehta, R. L., Paganini, E. P., … Ikizler, T. A. (2004). Plasma cytokine levels predict mortality in patients with acute renal failure. KIDNEY INTERNATIONAL, 65(4), 1357–1365.

Determinants of progressive vascular calcification in haemodialysis patients
Chertow, G. M., Raggi, P., Chasan-Taber, S., Bommer, J., Holzer, H., & Burke, S. K. (2004). Determinants of progressive vascular calcification in haemodialysis patients. NEPHROLOGY DIALYSIS TRANSPLANTATION, 19(6), 1489–1496.

Physical and sexual function in women with chronic kidney disease
Kurella, M., Ireland, C., Hlatky, M. A., Shlipak, M. G., Yaffe, K., Hulley, S. B., & Chertow, G. M. (2004). Physical and sexual function in women with chronic kidney disease. AMERICAN JOURNAL OF KIDNEY DISEASES, 43(5), 868–76.

Screening to prevent coronary events or screening to detect obstruction?
Raggi, P., Budoff, M. J., & Chertow, G. M. (2004). Screening to prevent coronary events or screening to detect obstruction? AMERICAN JOURNAL OF KIDNEY DISEASES, 43(5), 940–940.

Prevention of radiocontrast nephropathy - Back to basics
Chertow, G. M. (2004). Prevention of radiocontrast nephropathy - Back to basics. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 291(19), 2376–2377.

On the relative safety of parenteral iron formulations
Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmen, J. (2004). On the relative safety of parenteral iron formulations. NEPHROLOGY DIALYSIS TRANSPLANTATION, 19(6), 1571–1575.

Incorporating recipient choice in kidney transplantation
Su, X. M., Zenios, S. A., & Chertow, G. M. (2004). Incorporating recipient choice in kidney transplantation. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 15(6), 1656–63.

Association of body size with outcomes among patients beginning dialysis
Johansen, K. L., Young, B., Kaysen, G. A., & Chertow, G. M. (2004). Association of body size with outcomes among patients beginning dialysis. AMERICAN JOURNAL OF CLINICAL NUTRITION, 80(2), 324–332.

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004). Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 15(8), 2208–2218.

Diminishing significance of HLA matching in kidney transplantation
Su, X. M., Zenios, S. A., Chakkera, H., Milford, E. L., & Chertow, G. M. (2004). Diminishing significance of HLA matching in kidney transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 4(9), 1501–8.

Vector length as a proxy for the adequacy of ultrafiltration in hemodialysis
Pillon, L., Piccoli, A., Lowrie, E. G., Lazarus, J. M., & Chertow, G. M. (2004). Vector length as a proxy for the adequacy of ultrafiltration in hemodialysis. KIDNEY INTERNATIONAL, 66(3), 1266–1271.

Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis
Ix, J. H., McCulloch, C. E., & Chertow, G. M. (2004). Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. NEPHROLOGY DIALYSIS TRANSPLANTATION, 19(11), 2747–2753.

"Renalism": Inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency
Chertow, G. M., Normand, S. L. T., & McNeil, B. J. (2004). "Renalism": Inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 15(9), 2462–2468.

Race/ethnicity and disease severity in IgA nephropathy.
Hall, Y. N., Fuentes, E. F., Chertow, G. M., & Olson, J. L. (2004). Race/ethnicity and disease severity in IgA nephropathy. BMC Nephrology, 5, 10-?

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D. J., McCulloch, C. E., & Hsu, C. Y. (2004). Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. NEW ENGLAND JOURNAL OF MEDICINE, 351(13), 1296–1305.

Spectrum of acute renal failure in the intensive care unit: The PICARD experience
Mehta, R. L., Pascual, M. T., Soroko, S., Savage, B. R., Himmelfarb, J., Ikizler, T. A., … Chertow, G. M. (2004). Spectrum of acute renal failure in the intensive care unit: The PICARD experience. KIDNEY INTERNATIONAL, 66(4), 1613–1621.

Cognitive impairment in chronic kidney disease
Kurella, M., Chertow, G. M., Luan, J., & Yaffe, K. (2004). Cognitive impairment in chronic kidney disease. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 52(11), 1863–1869.

Influence of race on kidney transplant outcomes within and outside the department of veterans affairs
Chakkera, H. A., O'Hare, A. M., Johansen, K. L., Hynes, D., Stroupe, K., Colin, P. M., & Chertow, G. M. (2005). Influence of race on kidney transplant outcomes within and outside the department of veterans affairs. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(1), 269–277.

Validation of the kidney disease quality of life (KDQOL) cognitive function subscale
Kurella, M., Luan, J., Yaffe, K., & Chertow, G. M. (2004). Validation of the kidney disease quality of life (KDQOL) cognitive function subscale. KIDNEY INTERNATIONAL, 66(6), 2361–2367.

Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction - The Survival and Ventricular Enlargement (SAVE) study
Tokmakova, M. P., Skali, H., Kenchaiah, S., Braunwald, E., Rouleau, J. L., Packer, M., … Solomon, S. D. (2004). Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction - The Survival and Ventricular Enlargement (SAVE) study. CIRCULATION, 110(24), 3667–3673.

Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis - A randomized clinical trial
Garg, J. P., Chasan-Taber, S., Blair, A., Plone, M., Bommer, J., Raggi, P., & Chertow, G. M. (2005). Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis - A randomized clinical trial. ARTHRITIS AND RHEUMATISM, 52(1), 290–295.

Calcification or classification?
Chertow, G. M., & Moe, S. M. (2005). Calcification or classification? JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(2), 293–295.

Suicide in the United States end-stage renal disease program
Kurella, M., Kimmel, P. L., Young, B. S., & Chertow, G. M. (2005). Suicide in the United States end-stage renal disease program. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(3), 774–781.

Achieving NKF-K/DOQI (TM) bone metabolism and disease treatment goals with cinacalcet HCl
Moe, S. M., Chertow, G. M., Coburn, J. W., Quarles, L. D., Goodman, W. G., Block, G. A., … Martin, K. J. (2005). Achieving NKF-K/DOQI (TM) bone metabolism and disease treatment goals with cinacalcet HCl. KIDNEY INTERNATIONAL, 67(2), 760–771.

Chronic kidney disease and cognitive impairment in menopausal women
Kurella, M., Yaffe, K., Shlipak, M. G., Wenger, N. K., & Chertow, G. M. (2005). Chronic kidney disease and cognitive impairment in menopausal women. AMERICAN JOURNAL OF KIDNEY DISEASES, 45(1), 66–76.

Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease
Lo, J. C., Chertow, G. M., Go, A. S., & Hsu, C. Y. (2005). Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. KIDNEY INTERNATIONAL, 67(3), 1047–1052.

Frequent hemodialysis and psychosocial function
Kurella, M., Suri, R. S., & Chertow, G. M. (2005). Frequent hemodialysis and psychosocial function. SEMINARS IN DIALYSIS, 18(2), 132–136.

Dialysis session length ("t") as a determinant of the adequacy of dialysis
Kurella, M., & Chertow, G. M. (2005). Dialysis session length ("t") as a determinant of the adequacy of dialysis. SEMINARS IN NEPHROLOGY, 25(2), 90–95.

Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis
Raggi, P., James, G., Burke, S. K., Bommer, J., Chasan-Taber, S., Holzer, H., … Chertow, G. M. (2005). Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis. JOURNAL OF BONE AND MINERAL RESEARCH, 20(5), 764–772.

Bone disease and bottle caps
Tichy, M., Garg, J. P., Cho, K. C., & Chertow, G. M. (2005). Bone disease and bottle caps. JOURNAL OF RENAL NUTRITION, 15(2), 257–259.

Medicare ESRD prospective payment system: Weighing the evidence
Himmelfarb, J., & Chertow, G. M. (2005). Medicare ESRD prospective payment system: Weighing the evidence. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(5), 1164–1165.

Insulin resistance in critically ill patients with acute renal failure
Basi, S., Pupim, L. B., Simmons, E. M., Sezer, M. T., Shyr, Y., Freedman, S., … Ikizler, T. A. (2005). Insulin resistance in critically ill patients with acute renal failure. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 289(2), F259–F264.

Control of hypertension in adults with chronic kidney disease in the United States
Peralta, C. A., Hicks, L. S., Chertow, G. M., Ayanian, J. Z., Vittinghoff, E., Lin, F., & Shlipak, M. G. (2005). Control of hypertension in adults with chronic kidney disease in the United States. HYPERTENSION, 45(6), 1119–1124.

Beyond Framingham: Cardiovascular risk profiling in ESRD
McClellan, W. M., & Chertow, G. M. (2005). Beyond Framingham: Cardiovascular risk profiling in ESRD. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(6), 1539–1541.

Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study
Kurella, M., Chertow, G. M., Fried, L. F., Cummings, S. R., Harris, T., Simonsick, E., … Yaffe, K. (2005). Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(7), 2127–2133.

Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients
Ferramosca, E., Burke, S., Chasan-Taber, S., Ratti, C., Chertow, G. M., & Raggi, P. (2005). Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. AMERICAN HEART JOURNAL, 149(5), 820–825.

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults
Kurella, M., Lo, J. C., & Chertow, G. M. (2005). Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(7), 2134–2140.

Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates
Kirtane, A. J., Leder, D. M., Waikar, S. S., Chertow, G. M., Ray, K. K., Pinto, D. S., … Gibson, C. M. (2005). Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 45(11), 1781–1786.

Angiotensin receptor blockade and arterial compliance in chronic kidney disease: A pilot study
Garg, J. P., Ellis, R., Elliott, W. J., Hasabou, N., Chua, D., Chertowa, G. M., & Bakris, G. L. (2005). Angiotensin receptor blockade and arterial compliance in chronic kidney disease: A pilot study. AMERICAN JOURNAL OF NEPHROLOGY, 25(4), 393–399.

Self-assessed sleep quality in chronic kidney disease.
Kurella, M., Luan, J., Lash, J. P., & Chertow, G. M. (2005). Self-assessed sleep quality in chronic kidney disease. International Urology and Nephrology, 37(1), 159–165.

End stage renal disease.
Hall, Y., & Chertow, G. (2005). End stage renal disease. Clinical Evidence, (13), 1048–1059.

Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study ?
Dwyer, J. T., Larive, B., Leung, J., Rocco, M. V., Greene, T., Burrowes, J., … Kusek, J. W. (2005). Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study ? KIDNEY INTERNATIONAL, 68(4), 1766–1776.

Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism
Cunningham, J., Danese, M., Olson, K., Klassen, P., & Chertow, G. M. (2005). Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. KIDNEY INTERNATIONAL, 68(4), 1793–1800.

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients
Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V., & Bates, D. W. (2005). Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(11), 3365–3370.

Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the hemodialysis (HEMO) study
Burrowes, J. D., Larive, B., Chertow, G. M., Cockram, D. B., Dwyer, J. T., Greene, T., … Rocco, M. V. (2005). Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the hemodialysis (HEMO) study. NEPHROLOGY DIALYSIS TRANSPLANTATION, 20(12), 2765–2774.

Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD
Hall, Y. N., Sugihara, J. G., Go, A. S., & Chertow, G. M. (2005). Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(12), 3711–3720.

Cystatin C and mortality risk in the elderly: The health, aging, and body composition study
Shlipak, M. G., Fyr, C. L. W., Chertow, G. M., Harris, T. B., Kritchevsky, S. B., Tylavsky, F. A., … Fried, L. F. (2006). Cystatin C and mortality risk in the elderly: The health, aging, and body composition study. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(1), 254–261.

Update on adverse drug events associated with parenteral iron
Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmen, J. (2006). Update on adverse drug events associated with parenteral iron. NEPHROLOGY DIALYSIS TRANSPLANTATION, 21(2), 378–382.

Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients
Chertow, G. M., Goldstein-Fuchs, D. J., Lazarus, J. M., & Kaysen, G. A. (2005). Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. KIDNEY INTERNATIONAL, 68(6), 2794–2800.

Health-related quality of life and estimates of utility in chronic kidney disease
Gorodetskaya, I., Zenios, S., McCulloch, C. E., Bostrom, A., Hsu, C. Y., Bindman, A. B., … Chertow, G. M. (2005). Health-related quality of life and estimates of utility in chronic kidney disease. KIDNEY INTERNATIONAL, 68(6), 2801–8.

PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis
Danese, M. D., Kim, J., Doan, Q. V., Dylan, M., Griffiths, R., & Chertow, G. M. (2006). PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. AMERICAN JOURNAL OF KIDNEY DISEASES, 47(1), 149–156.

Challenging the validity of the EPO index.
Kaysen, G. A., Müller, H. G., Ding, J., & Chertow, G. M. (2006). Challenging the validity of the EPO index. American Journal of Kidney Diseases , 47(1), 166-?

Declining mortality in patients with acute renal failure, 1988 to 2002
Waikar, S. S., Curhan, G. C., Wald, R., McCarthy, E. P., & Chertow, G. M. (2006). Declining mortality in patients with acute renal failure, 1988 to 2002. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(4), 1143–1150.

Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm
Wald, R., Waikar, S. S., Liangos, O., Pereira, B. J. G., Chertow, G. M., & Jaber, B. L. (2006). Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm. JOURNAL OF VASCULAR SURGERY, 43(3), 460–466.

Association of body size with health status in patients beginning dialysis
Johansen, K. L., Kutner, N. G., Young, B., & Chertow, G. M. (2006). Association of body size with health status in patients beginning dialysis. AMERICAN JOURNAL OF CLINICAL NUTRITION, 83(3), 543–549.

Validity of International Classification of Diseases, Ninth Revision, Clinical Modification codes for acute renal failure
Waikar, S. S., Wald, R., Chertow, G. M., Curhan, G. C., Winkelmayer, W. C., Liangos, O., … Jaber, B. L. (2006). Validity of International Classification of Diseases, Ninth Revision, Clinical Modification codes for acute renal failure. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(6), 1688–1694.

Fetuin-A and kidney function in persons with coronary artery disease-data from the heart and soul study
Ix, J. H., Chertow, G. M., Shlipak, M. G., Brandenburg, V. M., Ketteler, M., & Whooley, M. A. (2006). Fetuin-A and kidney function in persons with coronary artery disease-data from the heart and soul study. NEPHROLOGY DIALYSIS TRANSPLANTATION, 21(8), 2144–2151.

The enlarging body of evidence: Obesity and chronic kidney disease
Chertow, G. M., Hsu, C.-Y., & Johansen, K. L. (2006). The enlarging body of evidence: Obesity and chronic kidney disease. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(6), 1501–1502.

Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study
Kurella, M., Mapes, D. L., Port, F. K., & Chertow, G. M. (2006). Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study. NEPHROLOGY DIALYSIS TRANSPLANTATION, 21(9), 2543–2548.

The tortoise and hare on hemodialysis: Does slow and steady win the race?
Chertow, G. M., Kurella, M., & Lowrie, E. G. (2006). The tortoise and hare on hemodialysis: Does slow and steady win the race? KIDNEY INTERNATIONAL, 70(1), 24–25.

The metabolic syndrome and chronic kidney disease
Peralta, C. A., Kurella, M., Lo, J. C., & Chertow, G. M. (2006). The metabolic syndrome and chronic kidney disease. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 15(4), 361–365.

Lessons for Medicare Part D in the hemodialysis community.
Nayeem, A. I., & Chertow, G. M. (2006). Lessons for Medicare Part D in the hemodialysis community. BMC Nephrology, 7, 11-?

Renal function and heart failure risk in older black and white individuals - The health, aging, and body composition study
Bibbins-Domingo, K., Chertow, G. M., Fried, L. F., Odden, M. C., Newman, A. B., Kritchevsky, S. B., … Shlipak, M. G. (2006). Renal function and heart failure risk in older black and white individuals - The health, aging, and body composition study. ARCHIVES OF INTERNAL MEDICINE, 166(13), 1396–1402.

Mortality after acute renal failure: Models for prognostic stratification and risk adjustment
Chertow, G. M., Soroko, S. H., Paganini, E. P., Cho, K. C., Himmelfarb, J., Ikizler, T. A., & Mehta, R. L. (2006). Mortality after acute renal failure: Models for prognostic stratification and risk adjustment. KIDNEY INTERNATIONAL, 70(6), 1120–1126.

Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified
Ix, J. H., Quarles, L. D., & Chertow, G. M. (2006). Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified. NATURE CLINICAL PRACTICE NEPHROLOGY, 2(6), 337–339.

Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease
Peralta, C. A., Shlipak, M. G., Fan, D., Ordonez, J., Lash, J. P., Chertow, G. M., & Go, A. S. (2006). Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(10), 2892–2899.

End stage renal disease.
Hall, Y. N., & Chertow, G. M. (2006). End stage renal disease. Clinical Evidence, (15), 1171–1181.

Tesio catheter access for long-term maintenance hemodialysis
Wang, J., LaBerge, J. M., Chertow, G. M., Kerlan, R. K., Wilson, M. W., & Gordon, R. L. (2006). Tesio catheter access for long-term maintenance hemodialysis. RADIOLOGY, 241(1), 284–290.

A simulation model to estimate the cost and effectiveness of alternative dialysis initiation strategies
Lee, C. P., Chertow, G. M., & Zenios, S. A. (2006). A simulation model to estimate the cost and effectiveness of alternative dialysis initiation strategies. MEDICAL DECISION MAKING, 26(5), 535–49.

Survival by dialysis modality in critically ill patients with acute kidney injury
Cho, K. C., Himmelfarb, J., Paganini, E., Ikizler, T. A., Soroko, S. H., Mehta, R. L., & Chertow, G. M. (2006). Survival by dialysis modality in critically ill patients with acute kidney injury. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(11), 3132–3138.

Cystatin C and measures of physical function in elderly adults - The health, aging, and body composition (HABC) study
Odden, M. C., Chertow, G. M., Fried, L. F., Newman, A. B., Connelly, S., Angleman, S., … Shlipak, M. G. (2006). Cystatin C and measures of physical function in elderly adults - The health, aging, and body composition (HABC) study. AMERICAN JOURNAL OF EPIDEMIOLOGY, 164(12), 1180–89.

Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: Data from The Heart and Soul Study
Ix, J. H., Shlipak, M. G., Chertow, G. M., Ali, S., Schiller, N. B., & Whooley, M. A. (2006). Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: Data from The Heart and Soul Study. JOURNAL OF CARDIAC FAILURE, 12(8), 601–607.

Frequent Hemodialysis Network (FHN) randomized trials: Study design
Suri, R. S., Garg, A. X., Chertow, G. M., Levin, N. W., Rocco, M. V., Greene, T., … Kliger, A. S. (2007). Frequent Hemodialysis Network (FHN) randomized trials: Study design. KIDNEY INTERNATIONAL, 71(4), 349–359.

Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation
Triponez, F., Kebebew, E., Dosseh, D., Duh, Q.-Y., Hazzan, M., Noel, C., … Clark, O. H. (2006). Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. SURGERY, 140(6), 990–997.

Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease - Data from the Heart and Soul Study
Ix, J. H., Shlipak, M. G., Chertow, G. M., & Whooley, M. A. (2007). Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease - Data from the Heart and Soul Study. CIRCULATION, 115(2), 173–179.

Phosphorus balance and mineral metabolism with 3 h daily hemodialysis
Ayus, J. C., Achinger, S. G., Mizani, M. R., Chertow, G. M., Furmaga, W., Lee, S., & Rodriguez, F. (2007). Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. KIDNEY INTERNATIONAL, 71(4), 336–342.

Octogenarians and nonagenarians starting dialysis in the United States
Kurella, M., Covinsky, K. E., Collins, A. J., & Chertow, G. M. (2007). Octogenarians and nonagenarians starting dialysis in the United States. ANNALS OF INTERNAL MEDICINE, 146(3), 177–183.

The incidence and prognostic significance of acute kidney injury
Waikar, S. S., Liu, K. D., & Chertow, G. M. (2007). The incidence and prognostic significance of acute kidney injury. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 16(3), 227–236.

Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease - Data from the heart and soul study
Ix, J. H., Chertow, G. M., Shlipak, M. G., Brandenburg, V. M., Ketteler, M., & Whooley, M. A. (2007). Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease - Data from the heart and soul study. CIRCULATION, 115(19), 2533–2539.

Community-based incidence of acute renal failure
Hsu, C.-y, McCulloch, C. E., Fan, D., Ordonez, J. D., Chertow, G. M., & Go, A. S. (2007). Community-based incidence of acute renal failure. KIDNEY INTERNATIONAL, 72(2), 208–212.

Cinacalcet hydrochloride (sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate
Chertow, G. M., Blumenthal, S., Turner, S., Roppolo, M., Stern, L., Chi, E. M., & Reed, J. (2006). Cinacalcet hydrochloride (sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(2), 305–312.

Strategies for successful patient oriented research: Why did I (not) get funded?
Agarwal, R., Chertow, G. M., & Mehta, R. L. (2006). Strategies for successful patient oriented research: Why did I (not) get funded? CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(2), 340–343.

The case against calcium-based phosphate binders
Moe, S. M., & Chertow, G. M. (2006). The case against calcium-based phosphate binders. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(4), 697–703.

Evolving practices in critical care and potential implications for management of acute kidney injury
Liu, K. D., Matthay, M. A., & Chertow, G. M. (2006). Evolving practices in critical care and potential implications for management of acute kidney injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(4), 869–873.

Timing of initiation of dialysis in critically ill patients with acute kidney injury
Liu, K. D., Himmelfarb, J., Paganini, E., Ikizler, T. A., Soroko, S. H., Mehta, R. L., & Chertow, G. M. (2006). Timing of initiation of dialysis in critically ill patients with acute kidney injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(5), 915–919.

Studying the prevention of acute kidney injury: Lessons from an 18th-century mathematician
Chertow, G. M., Palevsky, P. M., & Greene, T. (2006). Studying the prevention of acute kidney injury: Lessons from an 18th-century mathematician. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(5), 1124–1127.

Evaluation of cinacalcet therapy to lower cardiovascular events (EVOLVE): Rationale and design overview
Chertow, G. M., Pupim, L. B., Block, G. A., Correa-Rotter, R., Drueke, T. B., Floege, J., … Parfrey, P. (2007). Evaluation of cinacalcet therapy to lower cardiovascular events (EVOLVE): Rationale and design overview. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2(5), 898–905.

Rise of pay for performance: Implications for care of people with chronic kidney disease
Desai, A. A., Garber, A. M., & Chertow, G. M. (2007). Rise of pay for performance: Implications for care of people with chronic kidney disease. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2(5), 1087–95.

Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients
Johansen, K. L., & Chertow, G. M. (2007). Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients. JOURNAL OF RENAL NUTRITION, 17(5), 305–313.

Race and mortality after acute renal failure
Waikar, S. S., Curhan, G. C., Ayanian, J. Z., & Chertow, G. M. (2007). Race and mortality after acute renal failure. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 18(10), 2740–2748.

Kidney function as a predictor of loss of lean mass in older adults: Health, aging and body composition study
Fried, L. F., Boudreau, R., Lee, J. S., Chertow, G., Kurella-Tamura, M., Shlipak, M. G., … Newman, A. B. (2007). Kidney function as a predictor of loss of lean mass in older adults: Health, aging and body composition study. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 55(10), 1578–1584.

Significance of frailty among dialysis patients
Johansen, K. L., Chertow, G. M., Jin, C., & Kutner, N. G. (2007). Significance of frailty among dialysis patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 18(11), 2960–2967.

Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury
Liu, K. D., Glidden, D. V., Eisner, M. D., Parsons, P. E., Ware, L. B., Wheeler, A., … Matthay, M. A. (2007). Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. CRITICAL CARE MEDICINE, 35(12), 2755–2761.

Kidney dysfunction and fatal cardiovascular disease - an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study
Deo, R., Fyr, C. L. W., Fried, L. F., Newman, A. B., Harris, T. B., Angleman, S., … Shlipak, M. G. (2008). Kidney dysfunction and fatal cardiovascular disease - an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study. AMERICAN HEART JOURNAL, 155(1), 62–68.

Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism
Block, G. A., Zeig, S., Sugihara, J., Chertow, G. M., Chi, E. M., Turner, S. A., & Bushinsky, D. A. (2008). Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism. NEPHROLOGY DIALYSIS TRANSPLANTATION, 23(7), 2311–2318.

Diagnosis, epidemiology and outcomes of acute kidney injury
Waikar, S. S., Liu, K. D., & Chertow, G. M. (2008). Diagnosis, epidemiology and outcomes of acute kidney injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 3(3), 844–61.

High-molecular weight iron dextran: A wolf in sheep's clothing?
Rodgers, G. M., Auerbach, M., Cella, D., Chertow, G. M., Coyne, D. W., Glaspy, J. A., & Henry, D. H. (2008). High-molecular weight iron dextran: A wolf in sheep's clothing? JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 19(5), 833–34.

Lessons for successful study enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study
Crowley, S. T., Chertow, G. M., Vitale, J., O'Connor, T., Zhang, J., Schein, R. M. H., … Palevsky, P. M. (2008). Lessons for successful study enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 3(4), 955–961.

Toward the promise of renal replacement therapy
Chertow, G. M., & Waikar, S. S. (2008). Toward the promise of renal replacement therapy. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 19(5), 839–40.

The risk of acute renal failure in patients with chronic kidney disease
Hsu, C. Y., Ordonez, J. D., Chertow, G. M., Fan, D., McCulloch, C. E., & Go, A. S. (2008). The risk of acute renal failure in patients with chronic kidney disease. KIDNEY INTERNATIONAL, 74(1), 101–107.

Higher serum creatinine concentrations in black patients with chronic kidney disease: Beyond nutritional status and body composition
Hsu, J., Johansen, K. L., Hsu, C.-Y., Kaysen, G. A., & Chertow, G. M. (2008). Higher serum creatinine concentrations in black patients with chronic kidney disease: Beyond nutritional status and body composition. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 3(4), 992–97.

Intensity of renal support in critically ill patients with acute kidney injury
Palevsky, P. M., Zhang, J. H., O'Connor, T. Z., Chertow, G. M., Crowley, S. T., Choudhury, D., … Peduzzi, P. (2008). Intensity of renal support in critically ill patients with acute kidney injury. NEW ENGLAND JOURNAL OF MEDICINE, 359(1), 7–20.

Trends and outcomes associated with serum albumin concentration among incident dialysis patients in the United States
Kaysen, G. A., Johansen, K. L., Cheng, S.-C., Jin, C., & Chertow, G. M. (2008). Trends and outcomes associated with serum albumin concentration among incident dialysis patients in the United States. JOURNAL OF RENAL NUTRITION, 18(4), 323–31.

Cost-effectiveness of frequent in-center hemodialysis
Lee, C. P., Zenios, S. A., & Chertow, G. M. (2008). Cost-effectiveness of frequent in-center hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 19(9), 1792–97.

A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease
Xie, D., Joffe, M. M., Brunelli, S. M., Beck, G., Chertow, G. M., Fink, J. C., … Feldman, H. I. (2008). A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 3(5), 1332–38.

Management of acute kidney injury in the intensive care unit - A cost-effectiveness analysis of daily vs alternate-day hemodialysis
Desai, A. A., Baras, J., Berk, B. B., Nakajima, A., Garber, A. M., Owens, D., & Chertow, G. M. (2008). Management of acute kidney injury in the intensive care unit - A cost-effectiveness analysis of daily vs alternate-day hemodialysis. ARCHIVES OF INTERNAL MEDICINE, 168(16), 1761–67.

Neighborhood poverty and kidney transplantation among US Asians and Pacific Islanders with end-stage renal disease
Halla, Y. N., O'Harea, A. M., Younga, B. A., Boyko, E. J., & Chertow, G. M. (2008). Neighborhood poverty and kidney transplantation among US Asians and Pacific Islanders with end-stage renal disease. AMERICAN JOURNAL OF TRANSPLANTATION, 8(11), 2402–9.

Regional Variation in Kidney Transplant Outcomes: Trends Over Time
Chakkera, H. A., Chertow, G. M., O'Hare, A. M., Amend, W. J., & Gonwa, T. A. (2009). Regional Variation in Kidney Transplant Outcomes: Trends Over Time. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 4(1), 152–59.

Comparison of Proposed Alternative Methods for Rescaling Dialysis Close: Resting Energy Expenditure, High Metabolic Rate Organ Mass, Liver Size, and Body Surface Area
Daugirdas, J. T., Levin, N. W., Kotanko, P., Depner, T. A., Kuhlmann, M. K., Chertow, G. M., & Rocco, M. V. (2008). Comparison of Proposed Alternative Methods for Rescaling Dialysis Close: Resting Energy Expenditure, High Metabolic Rate Organ Mass, Liver Size, and Body Surface Area. SEMINARS IN DIALYSIS, 21(5), 377–84.

Surface-Area-Normalized Kt/V: A Method of Rescaling Dialysis Dose to Body Surface Area-Implications for Different-Size Patients by Gender
Daugirdas, J. T., Depner, T. A., Greene, T., Kuhlmann, M. K., Levin, N. W., Chertow, G. M., & Rocco, M. V. (2008). Surface-Area-Normalized Kt/V: A Method of Rescaling Dialysis Dose to Body Surface Area-Implications for Different-Size Patients by Gender. SEMINARS IN DIALYSIS, 21(5), 415–21.

Cautious Optimism Concerning Long-Term Safety of Kidney Donation.
Tan, J. C., & Chertow, G. M. (2009). Cautious Optimism Concerning Long-Term Safety of Kidney Donation. NEW ENGLAND JOURNAL OF MEDICINE, 360(5), 522–23.

Melamine nephrotoxicity: an emerging epidemic in an era of globalization
Bhalla, V., Grimm, P. C., Chertow, G. M., & Pao, A. C. (2009). Melamine nephrotoxicity: an emerging epidemic in an era of globalization. KIDNEY INTERNATIONAL, 75(8), 774–79.

The decline in residual renal function in hemodialysis is slow and age dependent.
Hung, A. M., Young, B. S., & Chertow, G. M. (2003). The decline in residual renal function in hemodialysis is slow and age dependent. Hemodialysis International. International Symposium on Home Hemodialysis, 7(1), 17–22.

Coronary and aortic calcifications in patients new to dialysis.
Spiegel, D. M., Raggi, P., Mehta, R., Lindberg, J. S., Chonchol, M., Ehrlich, J., … Block, G. A. (2004). Coronary and aortic calcifications in patients new to dialysis. Hemodialysis International. International Symposium on Home Hemodialysis, 8(3), 265–272.

Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury
Bouchard, J., Soroko, S. B., Chertow, G. M., Himmelfarb, J., Ikizler, T. A., Paganini, E. P., & Mehta, R. L. (2009). Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. KIDNEY INTERNATIONAL, 76(4), 422–27.

End stage renal disease.
Hall, Y. N., & Chertow, G. M. (2007). End stage renal disease. Clinical Evidence, 2007.

Characteristics of Uninsured Americans with Chronic Kidney Disease
Hall, Y. N., Rodriguez, R. A., Boyko, E. J., Chertow, G. M., & O'Hare, A. M. (2009). Characteristics of Uninsured Americans with Chronic Kidney Disease. JOURNAL OF GENERAL INTERNAL MEDICINE, 24(8), 917–22.

Phosphorus binders and survival: need for randomized trials
Ix, J. H., & Chertow, G. M. (2009). Phosphorus binders and survival: need for randomized trials. NATURE REVIEWS NEPHROLOGY, 5(7), 368–70.

Frailty and Chronic Kidney Disease: The Third National Health and Nutrition Evaluation Survey
Wilhelm-Leen, E. R., Hall, Y. N., Tamura, M. K., & Chertow, G. M. (2009). Frailty and Chronic Kidney Disease: The Third National Health and Nutrition Evaluation Survey. AMERICAN JOURNAL OF MEDICINE, 122(7), 664–U86.

The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: A systematic review
Desai, A. A., Nissenson, A., Chertow, G. M., Farid, M., Singh, I., van Oijen, M. G. H., … Spiegel, B. M. R. (2009). The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: A systematic review. HEMODIALYSIS INTERNATIONAL, 13(3), 347–59.

A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: A new paradigm for clinical outcomes studies in nephrology
Block, G. A., Persky, M. S., Ketteler, M., Kestenbaum, B., Thadhani, R., Kooienga, L., … Wheeler, D. C. (2009). A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: A new paradigm for clinical outcomes studies in nephrology. HEMODIALYSIS INTERNATIONAL, 13(3), 360–62.

Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease
Lo, L. J., Go, A. S., Chertow, G. M., McCulloch, C. E., Fan, D., Ordonez, J. D., & Hsu, C.-yuan. (2009). Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. KIDNEY INTERNATIONAL, 76(8), 893–99.

Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study
Palevsky, P. M., O'Connor, T. Z., Chertow, G. M., Crowley, S. T., Zhang, J. H., & Kellum, J. A. (2009). Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study. CRITICAL CARE, 13(4).

Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury
Bouchard, J., Macedo, E., Soroko, S., Chertow, G. M., Himmelfarb, J., Ikizler, T. A., … Mehta, R. L. (2010). Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury. NEPHROLOGY DIALYSIS TRANSPLANTATION, 25(1), 102–7.

Fetuin-A and Change in Body Composition in Older Persons
Ix, J. H., Wassel, C. L., Chertow, G. M., Koster, A., Johnson, K. C., Tylavsky, F. A., … Shlipak, M. G. (2009). Fetuin-A and Change in Body Composition in Older Persons. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 94(11), 4492–98.

Increased fluid intake does not augment capacity to lay down new collagen in nursing home residents at risk for pressure ulcers: A randomized, controlled clinical trial
Stotts, N. A., Hopf, H. W., Kayser-Jones, J., Chertow, G. M., Cooper, B. A., & Wu, H.-S. (2009). Increased fluid intake does not augment capacity to lay down new collagen in nursing home residents at risk for pressure ulcers: A randomized, controlled clinical trial. WOUND REPAIR AND REGENERATION, 17(6), 780–88.

Functional Status of Elderly Adults before and after Initiation of Dialysis
Tamura, M. K., Covinsky, K. E., Chertow, G. M., Yaffe, K., Landefeld, C. S., & McCulloch, C. E. (2009). Functional Status of Elderly Adults before and after Initiation of Dialysis. NEW ENGLAND JOURNAL OF MEDICINE, 361(16), 1539–47.

Choroidopathy and kidney disease: a case report and review of the literature.
Kamdar, N. V., Erko, A., Ehrlich, J. S., Kim, J. W., Kambham, N., & Chertow, G. M. (2009). Choroidopathy and kidney disease: a case report and review of the literature. Cases Journal, 2, 7425-?

Medication errors in chronic kidney disease: one piece in the patient safety puzzle
Fink, J. C., & Chertow, G. M. (2009). Medication errors in chronic kidney disease: one piece in the patient safety puzzle. KIDNEY INTERNATIONAL, 76(11), 1123–25.

An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard
Lee, C. P., Chertow, G. M., & Zenios, S. A. (2009). An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard. VALUE IN HEALTH, 12(1), 80–87.

Preexisting Chronic Kidney Disease: A Potential for Improved Outcomes from Acute Kidney Injury
Khosla, N., Soroko, S. B., Chertow, G. M., Himmelfarb, J., Ikizler, T. A., Paganini, E., & Mehta, R. L. (2009). Preexisting Chronic Kidney Disease: A Potential for Improved Outcomes from Acute Kidney Injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 4(12), 1914–19.

Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease
Bibbins-Domingo, K., Chertow, G. M., Coxson, P. G., Moran, A., Lightwood, J. M., Pletcher, M. J., & Goldman, L. (2010). Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease. NEW ENGLAND JOURNAL OF MEDICINE, 362(7), 590–99.

Shorter dialysis times are associated with higher mortality among incident hemodialysis patients
Brunelli, S. M., Chertow, G. M., Ankers, E. D., Lowrie, E. G., & Thadhani, R. (2010). Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. KIDNEY INTERNATIONAL, 77(7), 630–36.

Standard Kt/V-urea: a method of calculation that includes effects of fluid removal and residual kidney clearance
Daugirdas, J. T., Depner, T. A., Greene, T., Levin, N. W., Chertow, G. M., & Rocco, M. V. (2010). Standard Kt/V-urea: a method of calculation that includes effects of fluid removal and residual kidney clearance. KIDNEY INTERNATIONAL, 77(7), 637–44.

Study design and subject baseline characteristics in the ADVANCE study: effects of cinacalcet on vascular calcification in haemodialysis patients
Floege, J., Raggi, P., Block, G. A., Torres, P. U., Csiky, B., Naso, A., … Chertow, G. M. (2010). Study design and subject baseline characteristics in the ADVANCE study: effects of cinacalcet on vascular calcification in haemodialysis patients. NEPHROLOGY DIALYSIS TRANSPLANTATION, 25(6), 1916–23.

Chronic Kidney Disease in the Urban Poor
Hall, Y. N., Choi, A. I., Chertow, G. M., & Bindman, A. B. (2010). Chronic Kidney Disease in the Urban Poor. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(5), 828–35.

Effects of Reduced Intradialytic Urea Generation Rate and Residual Renal Clearance on Modeled Urea Distribution Volume and Kt/V in Conventional, Daily, and Nocturnal Dialysis
Daugirdas, J. T., Depner, T. A., Greene, T., Levin, N. W., Chertow, G. M., Rocco, M. V., & Stokes, J. B. (2010). Effects of Reduced Intradialytic Urea Generation Rate and Residual Renal Clearance on Modeled Urea Distribution Volume and Kt/V in Conventional, Daily, and Nocturnal Dialysis. SEMINARS IN DIALYSIS, 23(1), 19–24.

Chronic Kidney Disease and Cognitive Function in Older Adults: Findings from the Chronic Renal Insufficiency Cohort Cognitive Study
Yaffe, K., Ackerson, L., Tamura, M. K., Le Blanc, P., Kusek, J. W., Sehgal, A. R., … Go, A. S. (2010). Chronic Kidney Disease and Cognitive Function in Older Adults: Findings from the Chronic Renal Insufficiency Cohort Cognitive Study. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 58(2), 338–45.

Weekend Hospital Admission, Acute Kidney Injury, and Mortality
James, M. T., Wald, R., Bell, C. M., Tonelli, M., Hemmelgarn, B. R., Waikar, S. S., & Chertow, G. M. (2010). Weekend Hospital Admission, Acute Kidney Injury, and Mortality. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 21(5), 845–51.

Reexploring Differences among For-Profit and Nonprofit Dialysis Providers
Lee, D. K. K., Chertow, G. M., & Zenios, S. A. (2010). Reexploring Differences among For-Profit and Nonprofit Dialysis Providers. HEALTH SERVICES RESEARCH, 45(3), 633–46.

Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study
Chang, T. I., Friedman, G. D., Cheung, A. K., Greene, T., Desai, M., & Chertow, G. M. (2011). Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study. JOURNAL OF HUMAN HYPERTENSION, 25(2), 98–105.

The elderly patients on hemodialysis.
Anand, S., Kurella Tamura, M., & Chertow, G. M. (2010). The elderly patients on hemodialysis. Minerva Urologica e Nefrologica = The Italian Journal of Urology and Nephrology, 62(1), 87–101.

GFR estimating equations, CKD prevalence and the public health
Chang, T. I., & Chertow, G. M. (2010). GFR estimating equations, CKD prevalence and the public health. JOURNAL OF INTERNAL MEDICINE, 267(4), 354–56.

Kidney Disease, Hospitalized Hypertension, and Cardiovascular Events: Cause or Consequence?
Chertow, G. M., & Chang, T. I. (2010). Kidney Disease, Hospitalized Hypertension, and Cardiovascular Events: Cause or Consequence? CIRCULATION, 121(20), 2160–61.

Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients
Macedo, E., Bouchard, J., Soroko, S. H., Chertow, G. M., Himmelfarb, J., Ikizler, T. A., … Mehta, R. L. (2010). Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. CRITICAL CARE, 14(3).

Vitamin D deficiency and frailty in older Americans
Wilhelm-Leen, E. R., Hall, Y. N., DEBOER, I. H., & Chertow, G. M. (2010). Vitamin D deficiency and frailty in older Americans. JOURNAL OF INTERNAL MEDICINE, 268(2), 171–80.

Prevalence and Correlates of Cognitive Impairment in Hemodialysis Patients: The Frequent Hemodialysis Network Trials
Tamura, M. K., Larive, B., Unruh, M. L., Stokes, J. B., Nissenson, A., Mehta, R. L., & Chertow, G. M. (2010). Prevalence and Correlates of Cognitive Impairment in Hemodialysis Patients: The Frequent Hemodialysis Network Trials. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(8), 1429–38.

Can Rescaling Dose of Dialysis to Body Surface Area in the HEMO Study Explain the Different Responses to Dose in Women versus Men?
Daugirdas, J. T., Greene, T., Chertow, G. M., & Depner, T. A. (2010). Can Rescaling Dose of Dialysis to Body Surface Area in the HEMO Study Explain the Different Responses to Dose in Women versus Men? CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(9), 1628–36.

Determinants of Cardiac Autonomic Dysfunction in ESRD
Chan, C. T., Levin, N. W., Chertow, G. M., Lariye, B., Schulman, G., & Kotanko, P. (2010). Determinants of Cardiac Autonomic Dysfunction in ESRD. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(10), 1821–27.

Infection-Related Hospitalizations in Older Patients With ESRD
Dalrymple, L. S., Johansen, K. L., Chertow, G. M., Cheng, S.-C., Grimes, B., Gold, E. B., & Kaysen, G. A. (2010). Infection-Related Hospitalizations in Older Patients With ESRD. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(3), 522–30.

On the relative safety of intravenous iron formulations: New answers, new questions
Chertow, G. M., & Winkelmayer, W. C. (2010). On the relative safety of intravenous iron formulations: New answers, new questions. AMERICAN JOURNAL OF HEMATOLOGY, 85(9), 643–44.

Low level of self-reported physical activity in ambulatory patients new to dialysis
Johansen, K. L., Chertow, G. M., Kutner, N. G., Dalrymple, L. S., Grimes, B. A., & Kaysen, G. A. (2010). Low level of self-reported physical activity in ambulatory patients new to dialysis. KIDNEY INTERNATIONAL, 78(11), 1164–70.

Blood Pressure Control in Type 2 Diabetes Mellitus
Chang, T. I., Cheung, A. K., & Chertow, G. M. (2010). Blood Pressure Control in Type 2 Diabetes Mellitus. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(6), 1029–31.

Vascular Risk Factors and Cognitive Impairment in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study
Tamura, M. K., Xie, D., Yaffe, K., Cohen, D. L., Teal, V., Kasner, S. E., … Go, A. S. (2011). Vascular Risk Factors and Cognitive Impairment in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(2), 248–56.

Updated comorbidity assessments and outcomes in prevalent hemodialysis patients
Chang, T. I., Paik, J., Greene, T., Miskulin, D. C., & Chertow, G. M. (2010). Updated comorbidity assessments and outcomes in prevalent hemodialysis patients. HEMODIALYSIS INTERNATIONAL, 14(4), 478–85.

Off-Label Use of Phosphate Binders in Non-Dialysis-Dependent CKD
Winkelmayer, W. C., & Chertow, G. M. (2010). Off-Label Use of Phosphate Binders in Non-Dialysis-Dependent CKD. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(5), 813–16.

Living donor evaluation and exclusion: the Stanford experience
Lapasia, J. B., Kong, S.-yee, Busque, S., Scandling, J. D., Chertow, G. M., & Tan, J. C. (2011). Living donor evaluation and exclusion: the Stanford experience. CLINICAL TRANSPLANTATION, 25(5), 697–704.

In-Center Hemodialysis Six Times per Week versus Three Times per Week
Chertow, G. M., Levin, N. W., Beck, G. J., Depner, T. A., Eggers, P. W., Gassman, J. J., … Kliger, A. S. (2010). In-Center Hemodialysis Six Times per Week versus Three Times per Week. NEW ENGLAND JOURNAL OF MEDICINE, 363(24), 2287–2300.

Curbing the Use of Ultrasonography in the Diagnosis of Acute Kidney Injury Penny Wise or Pound Foolish?
Liu, K. D., & Chertow, G. M. (2010). Curbing the Use of Ultrasonography in the Diagnosis of Acute Kidney Injury Penny Wise or Pound Foolish? ARCHIVES OF INTERNAL MEDICINE, 170(21), 1907–8.

Effluent Volume in Continuous Renal Replacement Therapy Overestimates the Delivered Dose of Dialysis
Claure-Del Gramdo, R., Macedo, E., Chertow, G. M., Soroko, S., Himmelfarb, J., Ikizler, T. A., … Mehta, R. L. (2011). Effluent Volume in Continuous Renal Replacement Therapy Overestimates the Delivered Dose of Dialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(3), 467–75.

Baseline Characteristics of Participants in the Frequent Hemodialysis Network (FHN) Daily and Nocturnal Trials
Rocco, M. V., Larive, B., Eggers, P. W., Beck, G. J., Chertow, G. M., Levin, N. W., & Kliger, A. S. (2011). Baseline Characteristics of Participants in the Frequent Hemodialysis Network (FHN) Daily and Nocturnal Trials. AMERICAN JOURNAL OF KIDNEY DISEASES, 57(1), 90–100.

The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis
Raggi, P., Chertow, G. M., Torres, P. U., Csiky, B., Naso, A., Nossuli, K., … Floege, J. (2011). The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. NEPHROLOGY DIALYSIS TRANSPLANTATION, 26(4), 1327–39.

Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease
Mehta, R. L., Bouchard, J., Soroko, S. B., Ikizler, T. A., Paganini, E. P., Chertow, G. M., & Himmelfarb, J. (2011). Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. INTENSIVE CARE MEDICINE, 37(2), 241–48.

End-stage Renal Disease.
Abbasi, M., Chertow, G., & Hall, Y. (2010). End-stage Renal Disease. American Family Physician, 82(12), 1512-?

Baseline Physical Performance, Health, and Functioning of Participants in the Frequent Hemodialysis Network (FHN) Trial
Kaysen, G. A., Larive, B., Painter, P., Craig, A., Lindsay, R. M., Rocco, M. V., … Chertow, G. M. (2011). Baseline Physical Performance, Health, and Functioning of Participants in the Frequent Hemodialysis Network (FHN) Trial. AMERICAN JOURNAL OF KIDNEY DISEASES, 57(1), 101–12.

Association of Self-reported Physical Activity With Laboratory Markers of Nutrition and Inflammation: The Comprehensive Dialysis Study
Anand, S., Chertow, G. M., Johansen, K. L., Grimes, B., Tamura, M. K., Dalrymple, L. S., & Kaysen, G. A. (2011). Association of Self-reported Physical Activity With Laboratory Markers of Nutrition and Inflammation: The Comprehensive Dialysis Study. JOURNAL OF RENAL NUTRITION, 21(6), 429–37.

Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?
Munoz Mendoza, J., Sun, S., Chertow, G. M., Moran, J., Doss, S., & Schiller, B. (2011). Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach? Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 26(4), 1281–87.

The 2011 ESRD Prospective Payment System: An Uncontrolled Experiment
Winkelmayer, W. C., & Chertow, G. M. (2011). The 2011 ESRD Prospective Payment System: An Uncontrolled Experiment. AMERICAN JOURNAL OF KIDNEY DISEASES, 57(4), 542–46.

The Phosphate Binder Equivalent Dose
Daugirdas, J. T., Finn, W. F., Emmett, M., & Chertow, G. M. (2011). The Phosphate Binder Equivalent Dose. SEMINARS IN DIALYSIS, 24(1), 41–49.

World Kidney Day 2011
Hostetter, T. H., Kochis, D. J., Shaffer, R. N., Chertow, G., Harmon, W. E., Klotman, P. E., … Winkelmayer, W. C. (2011). World Kidney Day 2011. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 22(3), 397–98.

Racial Ethnic Differences in Rates and Determinants of Deceased Donor Kidney Transplantation
Hall, Y. N., Choi, A. I., Xu, P., O'Hare, A. M., & Chertow, G. M. (2011). Racial Ethnic Differences in Rates and Determinants of Deceased Donor Kidney Transplantation. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 22(4), 743–51.

Aspirin and Arteriovenous Graft Thrombosis in Hemodialysis: Just What the Doctor Ordered?
Bech, F. R., & Chertow, G. M. (2011). Aspirin and Arteriovenous Graft Thrombosis in Hemodialysis: Just What the Doctor Ordered? JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 22(4), 595–97.

End-stage renal disease.
Abbasi, M. A., Chertow, G. M., & Hall, Y. N. (2010). End-stage renal disease. Clinical Evidence, 2010.

Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials
Suri, R. S., Larive, B., Garg, A. X., Hall, Y. N., Pierratos, A., Chertow, G. M., … Kliger, A. S. (2011). Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials. NEPHROLOGY DIALYSIS TRANSPLANTATION, 26(7), 2316–22.

Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study
Anand, S., Kaysen, G. A., Chertow, G. M., Johansen, K. L., Grimes, B., Dalrymple, L. S., & Tamura, M. K. (2011). Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study. NEPHROLOGY DIALYSIS TRANSPLANTATION, 26(11), 3683–88.

RELATIONSHIP OF BODY SIZE AND MORTALITY AMONG US ASIANS AND PACIFIC ISLANDERS ON DIALYSIS
Hall, Y. N., Xu, P., & Chertow, G. M. (2011). RELATIONSHIP OF BODY SIZE AND MORTALITY AMONG US ASIANS AND PACIFIC ISLANDERS ON DIALYSIS. ETHNICITY & DISEASE, 21(1), 40–46.

Update in Nephrology: Evidence Published in 2010
Arora, N., & Chertow, G. M. (2011). Update in Nephrology: Evidence Published in 2010. ANNALS OF INTERNAL MEDICINE, 154(12), 824–U79.

Modeled Urea Distribution Volume and Mortality in the HEMO Study
Daugirdas, J. T., Greene, T., Depner, T. A., Levin, N. W., & Chertow, G. M. (2011). Modeled Urea Distribution Volume and Mortality in the HEMO Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(5), 1129–38.

Risk of Cardiovascular Events after Infection-Related Hospitalizations in Older Patients on Dialysis
Dalrymple, L. S., Mohammed, S. M., Mu, Y., Johansen, K. L., Chertow, G. M., Grimes, B., … Nguyen, D. V. (2011). Risk of Cardiovascular Events after Infection-Related Hospitalizations in Older Patients on Dialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(7), 1708–13.

Incidence, Correlates, and Consequences of Acute Kidney Injury in Patients With Pulmonary Arterial Hypertension Hospitalized With Acute Right-Side Heart Failure
Haddad, F., Fuh, E., Peterson, T., Skhiri, M., Kudelko, K. T., Perez, V. D. J., … Zamanian, R. T. (2011). Incidence, Correlates, and Consequences of Acute Kidney Injury in Patients With Pulmonary Arterial Hypertension Hospitalized With Acute Right-Side Heart Failure. JOURNAL OF CARDIAC FAILURE, 17(7), 533–39.

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial
Rocco, M. V., Lockridge, R. S., Beck, G. J., Eggers, P. W., Gassman, J. J., Greene, T., … Kliger, A. S. (2011). The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. KIDNEY INTERNATIONAL, 80(10), 1080–91.

Assessment and management of vascular disease risk in patients with chronic kidney disease
Brown, W. V., Bakris, G., Lerma, E., & Chertow, G. (2011). Assessment and management of vascular disease risk in patients with chronic kidney disease. JOURNAL OF CLINICAL LIPIDOLOGY, 5(4), 251–60.

Intradialytic Hypotension and Vascular Access Thrombosis
Chang, T. I., Paik, J., Greene, T., Desai, M., Bech, F., Cheung, A. K., & Chertow, G. M. (2011). Intradialytic Hypotension and Vascular Access Thrombosis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 22(8), 1526–33.

Predialysis Nephrology Care of Older Patients Approaching End-stage Renal Disease
Winkelmayer, W. C., Liu, J., Chertow, G. M., & Tamura, M. K. (2011). Predialysis Nephrology Care of Older Patients Approaching End-stage Renal Disease. ARCHIVES OF INTERNAL MEDICINE, 171(15), 1371–78.

Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis
Chang, T. I., Shilane, D., Brunelli, S. M., Cheung, A. K., Chertow, G. M., & Winkelmayer, W. C. (2011). Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis. AMERICAN HEART JOURNAL, 162(2), 324–30.

Chronic Kidney Disease and Cardiovascular Therapeutics Time to Close the Evidence Gaps
Chang, T. I., & Chertow, G. M. (2011). Chronic Kidney Disease and Cardiovascular Therapeutics Time to Close the Evidence Gaps. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 58(11), 1162–64.

Model to Predict Mortality in Critically Ill Adults with Acute Kidney Injury
Demirjian, S., Chertow, G. M., Zhang, J. H., O'Connor, T. Z., Vitale, J., Paganini, E. P., & Palevsky, P. M. (2011). Model to Predict Mortality in Critically Ill Adults with Acute Kidney Injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(9), 2114–20.

Validity of Surrogate Measures for Functional Nephron Mass
Tan, J. C., Paik, J., Chertow, G. M., Grumet, F. C., Busque, S., Lapasia, J., & Desai, M. (2011). Validity of Surrogate Measures for Functional Nephron Mass. TRANSPLANTATION, 92(12), 1335–41.

Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols
Chertow, G. M., Lu, Z. J., Xu, X., Knight, T. G., Goodman, W. G., Bushinsky, D. A., & Block, G. A. (2012). Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols. HEMODIALYSIS INTERNATIONAL, 16(2), 188–97.

Trends in Acute Nonvariceal Upper Gastrointestinal Bleeding in Dialysis Patients
Yang, J.-Y., Lee, T.-C., Montez-Rath, M. E., Paik, J., Chertow, G. M., Desai, M., & Winkelmayer, W. C. (2012). Trends in Acute Nonvariceal Upper Gastrointestinal Bleeding in Dialysis Patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(3), 495–506.

Determinants of Left Ventricular Mass in Patients on Hemodialysis Frequent Hemodialysis Network (FHN) Trials
Chan, C. T., Greene, T., Chertow, G. M., Kliger, A. S., Stokes, J. B., Beck, G. J., … Rajagopalan, S. (2012). Determinants of Left Ventricular Mass in Patients on Hemodialysis Frequent Hemodialysis Network (FHN) Trials. CIRCULATION-CARDIOVASCULAR IMAGING, 5(2), 251–61.

Effects of Frequent Hemodialysis on Measures of CKD Mineral and Bone Disorder
Daugirdas, J. T., Chertow, G. M., Larive, B., Pierratos, A., Greene, T., Ayus, J. C., … Kliger, A. S. (2012). Effects of Frequent Hemodialysis on Measures of CKD Mineral and Bone Disorder. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(4), 727–38.

Effects of Six versus Three Times per Week Hemodialysis on Physical Performance, Health, and Functioning: Frequent Hemodialysis Network (FHN) Randomized Trials
Hall, Y. N., Larive, B., Painter, P., Kaysen, G. A., Lindsay, R. M., Nissenson, A. R., … Chertow, G. M. (2012). Effects of Six versus Three Times per Week Hemodialysis on Physical Performance, Health, and Functioning: Frequent Hemodialysis Network (FHN) Randomized Trials. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 782–794.

Design of Clinical Trials in Acute Kidney Injury: Report from an NIDDK Workshop on Trial Methodology
Palevsky, P. M., Molitoris, B. A., Okusa, M. D., Levin, A., Waikar, S. S., Wald, R., … Star, R. A. (2012). Design of Clinical Trials in Acute Kidney Injury: Report from an NIDDK Workshop on Trial Methodology. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 844–850.

Ongoing Clinical Trials in AKI
Faubel, S., Chawla, L. S., Chertow, G. M., Goldstein, S. L., Jaber, B. L., & Liu, K. D. (2012). Ongoing Clinical Trials in AKI. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 861–73.

Design of Clinical Trials in AKI: A Report from an NIDDK Workshop. Trials of Patients with Sepsis and in Selected Hospital Settings
Molitoris, B. A., Okusa, M. D., Palevsky, P. M., Chawla, L. S., Kaufman, J. S., Devarajan, P., … Star, R. A. (2012). Design of Clinical Trials in AKI: A Report from an NIDDK Workshop. Trials of Patients with Sepsis and in Selected Hospital Settings. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 856–860.

Design of Clinical Trials in Acute Kidney Injury: A Report from an NIDDK Workshop-Prevention Trials
Okusa, M. D., Molitoris, B. A., Palevsky, P. M., Chinchilli, V. M., Liu, K. D., Cheung, A. K., … Star, R. A. (2012). Design of Clinical Trials in Acute Kidney Injury: A Report from an NIDDK Workshop-Prevention Trials. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 851–855.

The effect of frequent hemodialysis on nutrition and body composition: Frequent Hemodialysis Network Trial
Kaysen, G. A., Greene, T., Larive, B., Mehta, R. L., Lindsay, R. M., Depner, T. A., … Chertow, G. M. (2012). The effect of frequent hemodialysis on nutrition and body composition: Frequent Hemodialysis Network Trial. KIDNEY INTERNATIONAL, 82(1), 90–99.

Toward the optimal dose metric in continuous renal replacement therapy
Claure-Del Granado, R., Macedo, E., Chertow, G. M., Soroko, S., Himmelfarb, J., Ikizler, T. A., … Mehta, R. L. (2012). Toward the optimal dose metric in continuous renal replacement therapy. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 35(6), 413–24.

Acute Kidney Injury and Mortality in Hospitalized Patients
Wang, H. E., Muntner, P., Chertow, G. M., & Warnock, D. G. (2012). Acute Kidney Injury and Mortality in Hospitalized Patients. AMERICAN JOURNAL OF NEPHROLOGY, 35(4), 349–55.

Challenges to enrollment and randomization of the frequent hemodialysis network (FHN) daily trial
Sergeyeva, O., Gorodetskaya, I., Ramos, R., Schiller, B. M., Larive, B., Raimann, J. G., … Levin, N. W. (2012). Challenges to enrollment and randomization of the frequent hemodialysis network (FHN) daily trial. JOURNAL OF NEPHROLOGY, 25(3), 302–9.

Validation of Reported Predialysis Nephrology Care of Older Patients Initiating Dialysis
Kim, J. P., Desai, M., Chertow, G. M., & Winkelmayer, W. C. (2012). Validation of Reported Predialysis Nephrology Care of Older Patients Initiating Dialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(6), 1078–85.

Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial
Chertow, G. M., Correa-Rotter, R., Block, G. A., Drueke, T. B., Floege, J., Goodman, W. G., … Parfrey, P. S. (2012). Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. NEPHROLOGY DIALYSIS TRANSPLANTATION, 27(7), 2872–79.

Individualized reduction in dialysate sodium in conventional in-center hemodialysis
Arramreddy, R., Sun, S. J., Mendoza, J. M., Chertow, G. M., & Schiller, B. (2012). Individualized reduction in dialysate sodium in conventional in-center hemodialysis. HEMODIALYSIS INTERNATIONAL, 16(4), 473–80.

Longitudinal Measures of Serum Albumin and Prealbumin Concentrations in Incident Dialysis Patients: The Comprehensive Dialysis Study
Dalrymple, L. S., Johansen, K. L., Chertow, G. M., Grimes, B., Anand, S., McCulloch, C. E., & Kaysen, G. A. (2013). Longitudinal Measures of Serum Albumin and Prealbumin Concentrations in Incident Dialysis Patients: The Comprehensive Dialysis Study. JOURNAL OF RENAL NUTRITION, 23(2), 91–97.

Prospective Safety Study of Bardoxolone Methyl in Patients with Type 2 Diabetes Mellitus, End-Stage Renal Disease and Peritoneal Dialysis
Warnock, D. G., Hebbar, S., Bargman, J., Burkart, J., Davies, S., Finkelstein, F. O., … Chertow, G. M. (2012). Prospective Safety Study of Bardoxolone Methyl in Patients with Type 2 Diabetes Mellitus, End-Stage Renal Disease and Peritoneal Dialysis. Presented at the International Vicenza Course on Peritoneal Dialysis, VICENZA,ITALY,ITALY,ITALY,ITALY,ITALY,ITALY,ITALY,ITALY,ITALY: KARGER.

Homelessness and CKD: A Cohort Study
Hall, Y. N., Choi, A. I., Himmelfarb, J., Chertow, G. M., & Bindman, A. B. (2012). Homelessness and CKD: A Cohort Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(7), 1094–1102.

Frailty, Dialysis Initiation, and Mortality in End-Stage Renal Disease
Bao, Y., Dalrymple, L., Chertow, G. M., Kaysen, G. A., & Johansen, K. L. (2012). Frailty, Dialysis Initiation, and Mortality in End-Stage Renal Disease. ARCHIVES OF INTERNAL MEDICINE, 172(14), 1071–77.

Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: The comprehensive dialysis study
Anand, S., Johansen, K. L., Grimes, B., Kaysen, G. A., Dalrymple, L. S., Kutner, N. G., & Chertow, G. M. (2013). Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: The comprehensive dialysis study. HEMODIALYSIS INTERNATIONAL, 17(1), 50–58.

Effects of Phosphate Binders in Moderate CKD
Block, G. A., Wheeler, D. C., Persky, M. S., Kestenbaum, B., Ketteler, M., Spiegel, D. M., … Chertow, G. M. (2012). Effects of Phosphate Binders in Moderate CKD. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(8), 1407–15.

Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney
Reisman, S. A., Chertow, G. M., Hebbar, S., Vaziri, N. D., Ward, K. W., & Meyer, C. J. (2012). Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(10), 1663–73.

Donor Recipient Sex Mismatch in Kidney Transplantation
Tan, J. C., Kim, J. P., Chertow, G. M., Grumet, F. C., & Desai, M. (2012). Donor Recipient Sex Mismatch in Kidney Transplantation. GENDER MEDICINE, 9(5), 335–47.

Venous Thromboembolism Yet Another Cardiovascular Complication of Chronic Kidney Disease?
Chertow, G. M., & Mahaffey, K. W. (2012). Venous Thromboembolism Yet Another Cardiovascular Complication of Chronic Kidney Disease? CIRCULATION, 126(16), 1937–38.

Association of Physical Activity with Survival among Ambulatory Patients on Dialysis: The Comprehensive Dialysis Study
Johansen, K. L., Kaysen, G. A., Dalrymple, L. S., Grimes, B. A., Glidden, D. V., Anand, S., & Chertow, G. M. (2013). Association of Physical Activity with Survival among Ambulatory Patients on Dialysis: The Comprehensive Dialysis Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(2), 248–53.

A transcriptional blueprint for human and murine diabetic kidney disease.
Bhalla, V., Velez, M.-G., & Chertow, G. M. (2013). A transcriptional blueprint for human and murine diabetic kidney disease. Diabetes, 62(1), 31–33.

Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008.
Lenihan, C. R., Montez-Rath, M. E., Mora Mangano, C. T., Chertow, G. M., & Winkelmayer, W. C. (2013). Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008. Annals of Thoracic Surgery, 95(1), 20–28.

Effects of 6-Times-Weekly Versus 3-Times-Weekly Hemodialysis on Depressive Symptoms and Self-reported Mental Health: Frequent Hemodialysis Network (FHN) Trials
Unruh, M. L., Larive, B., Chertow, G. M., Eggers, P. W., Garg, A. X., Gassman, J., … Kimmel, P. L. (2013). Effects of 6-Times-Weekly Versus 3-Times-Weekly Hemodialysis on Depressive Symptoms and Self-reported Mental Health: Frequent Hemodialysis Network (FHN) Trials. AMERICAN JOURNAL OF KIDNEY DISEASES, 61(5), 748–58.

Effect of frequent hemodialysis on residual kidney function.
Daugirdas, J. T., Greene, T., Rocco, M. V., Kaysen, G. A., Depner, T. A., Levin, N. W., … Kliger, A. S. (2013). Effect of frequent hemodialysis on residual kidney function. Kidney International, 83(5), 949–58.

Variation in Nephrologist Visits to Patients on Hemodialysis across Dialysis Facilities and Geographic Locations.
Erickson, K. F., Tan, K. B., Winkelmayer, W. C., Chertow, G. M., & Bhattacharya, J. (2013). Variation in Nephrologist Visits to Patients on Hemodialysis across Dialysis Facilities and Geographic Locations. Clinical Journal of the American Society of Nephrology , 8(6), 987–94.

Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).
de Zeeuw, D., Akizawa, T., Agarwal, R., Audhya, P., Bakris, G. L., Chin, M., … Chertow, G. M. (2013). Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON). American Journal of Nephrology, 37(3), 212–222.

Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease
Erickson, K. F., Japa, S., Owens, D. K., Chertow, G. M., Garber, A. M., & Goldhaber-Fiebert, J. D. (2013). Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 61(12), 1250–58.

Diabetic Severity and Risk of Kidney Stone Disease
Weinberg, A. E., Patel, C. J., Chertow, G. M., & Leppert, J. T. (2014). Diabetic Severity and Risk of Kidney Stone Disease. EUROPEAN UROLOGY, 65(1), 242–47.

Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study.
Yang, J.-Y., Lee, T.-C., Montez-Rath, M. E., Chertow, G. M., & Winkelmayer, W. C. (2013). Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. BMC Nephrology, 14, 97-?

Cinacalcet for cardiovascular disease in patients undergoing dialysis.
Chertow, G. M., & Parfrey, P. S. (2013). Cinacalcet for cardiovascular disease in patients undergoing dialysis. New England Journal of Medicine, 368(19), 1844–1845.

Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.
Weisbord, S. D., Gallagher, M., Kaufman, J., Cass, A., Parikh, C. R., Chertow, G. M., … Palevsky, P. M. (2013). Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial. Clinical Journal of the American Society of Nephrology , 8(9), 1618–1631.

Temporal Trends in the Incidence, Treatment, and Outcomes of Hip Fracture in Older Patients Initiating Dialysis in the United States
Nair, S. S., Mitani, A. A., Goldstein, B. A., Chertow, G. M., Lowenberg, D. W., & Winkelmayer, W. C. (2013). Temporal Trends in the Incidence, Treatment, and Outcomes of Hip Fracture in Older Patients Initiating Dialysis in the United States. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(8), 1336–42.

Oh! What a tangled web we weave.
Arora, N., & Chertow, G. M. (2013). Oh! What a tangled web we weave. Clinical Journal of the American Society of Nephrology , 8(7), 1066–67.

Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure?
Chertow, G. M., Sayegh, M. H., Allgren, R. L., & Lazarus, J. M. (1996). Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? AMERICAN JOURNAL OF MEDICINE, 101(1), 49–53.

Restless legs syndrome in end-stage renal disease
Winkelman, J. W., Chertow, G. M., & Lazarus, J. M. (1996). Restless legs syndrome in end-stage renal disease. AMERICAN JOURNAL OF KIDNEY DISEASES, 28(3), 372–378.

''Renal-dose'' dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials
Denton, M. D., Chertow, G. M., & Brady, H. R. (1996). ''Renal-dose'' dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials. KIDNEY INTERNATIONAL, 50(1), 4–14.

Birth weight and adult hypertension and obesity in women
Curhan, G. C., Chertow, G. M., Willett, W. C., Spiegelman, D., Colditz, G. A., Manson, J. E., … Stampfer, M. J. (1996). Birth weight and adult hypertension and obesity in women. CIRCULATION, 94(6), 1310–1315.

Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion
Lo, J. C., Chertow, G. M., Rennke, H., & Seifter, J. L. (1996). Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion. AMERICAN JOURNAL OF KIDNEY DISEASES, 28(4), 614–617.

Grafts vs fistulas for hemodialysis patients - Equal access for all?
Chertow, G. M. (1996). Grafts vs fistulas for hemodialysis patients - Equal access for all? JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 276(16), 1343–1344.

Performance characteristics of a dialysis-related amyloidosis questionnaire
Chertow, G. M., TRIMBUR, T., Karlson, E. W., Lazarus, J. M., & Kay, J. (1996). Performance characteristics of a dialysis-related amyloidosis questionnaire. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(8), 1235–1240.

Trimethoprim-sulfamethoxazole and hypouricemia
Chertow, G. M., Seifter, J. L., Christiansen, C. L., & ODONNELL, W. J. (1996). Trimethoprim-sulfamethoxazole and hypouricemia. CLINICAL NEPHROLOGY, 46(3), 193–198.

Antigen-independent determinants of cadaveric kidney transplant failure
Chertow, G. M., Milford, E. L., Mackenzie, H. S., & BRENNER, B. M. (1996). Antigen-independent determinants of cadaveric kidney transplant failure. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 276(21), 1732–1736.

Poorer graft survival in African-American transplant recipients cannot be explained by HLA mismatching.
Chertow, G. M., & Milford, E. L. (1997). Poorer graft survival in African-American transplant recipients cannot be explained by HLA mismatching. Advances in Renal Replacement Therapy, 4(1), 40–45.

Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure
Chertow, G. M., Burke, S. K., Lazarus, J. M., Stenzel, K. H., Wombolt, D., Goldberg, D., … Slatopolsky, E. (1997). Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. AMERICAN JOURNAL OF KIDNEY DISEASES, 29(1), 66–71.

Preoperative renal risk stratification
Chertow, G. M., Lazarus, J. M., Christiansen, C. L., Cook, E. F., Hammermeister, K. E., Grover, F., & Daley, J. (1997). Preoperative renal risk stratification. CIRCULATION, 95(4), 878–884.

Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related amyloidosis
Hou, F. F., Chertow, G. M., Kay, J., Boyce, J., Lazarus, J. M., Braatz, J. A., & Owen, W. F. (1997). Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related amyloidosis. KIDNEY INTERNATIONAL, 51(5), 1514–1519.

Development of a population-specific regression equation to estimate total body water in hemodialysis patients
Chertow, G. M., Lazarus, J. M., Lew, N. L., Ma, L. H., & Lowrie, E. G. (1997). Development of a population-specific regression equation to estimate total body water in hemodialysis patients. KIDNEY INTERNATIONAL, 51(5), 1578–1582.

A practical approach to acute renal failure
Mindell, J. A., & Chertow, G. M. (1997). A practical approach to acute renal failure. MEDICAL CLINICS OF NORTH AMERICA, 81(3), 731-?

Nephrology
Chertow, G. M. (1997). Nephrology. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 277(23), 1872–1873.

Renal vasculitis with HIV seropositivity: Potential manifestation of cytomegalovirus infection
Chertow, G. M., Rennke, H. G., Curhan, G. C., & Brady, H. R. (1997). Renal vasculitis with HIV seropositivity: Potential manifestation of cytomegalovirus infection. AMERICAN JOURNAL OF KIDNEY DISEASES, 30(3), 428–432.

The rise and fall of atrial natriuretic peptide for acute renal failure
Brenner, R. M., & Chertow, G. M. (1997). The rise and fall of atrial natriuretic peptide for acute renal failure. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 6(5), 474–476.

On the design and analysis of multicenter trials in acute renal failure
Chertow, G. M. (1997). On the design and analysis of multicenter trials in acute renal failure. AMERICAN JOURNAL OF KIDNEY DISEASES, 30(5), S96–S101.

Antigen-independent determinants of graft survival in living-related kidney transplantation
Chertow, G. M., BRENNER, B. M., Mori, M., Mackenzie, H. S., & Milford, E. L. (1997). Antigen-independent determinants of graft survival in living-related kidney transplantation. Presented at the Symposium on Progression of Renal Disease - Clinical Patterns, Therapeutic Options and What We Have Learned from Clinical Trials, COOLUM,AUSTRALIA: NATURE PUBLISHING GROUP.

Bioimpedance norms for the hemodialysis population
Chertow, G. M., Lazarus, J. M., Lew, N. L., Ma, L. H., & Lowrie, E. G. (1997). Bioimpedance norms for the hemodialysis population. KIDNEY INTERNATIONAL, 52(6), 1617–1621.

Dialysis: Cost-effective "SUPPORT" for patients with acute renal failure
Chertow, G. M. (1998). Dialysis: Cost-effective "SUPPORT" for patients with acute renal failure. AMERICAN JOURNAL OF KIDNEY DISEASES, 31(3), 545–548.

Olecranon bursitis caused by infection with Candida lusitaniae
Behar, S. M., & Chertow, G. H. (1998). Olecranon bursitis caused by infection with Candida lusitaniae. JOURNAL OF RHEUMATOLOGY, 25(3), 598–600.

Aminoguanidine inhibits advanced glycation end products formation on beta 2-microglobulin
Hou, F. F., Boyce, J., Chertow, G. M., Kay, J., & Owen, W. F. (1998). Aminoguanidine inhibits advanced glycation end products formation on beta 2-microglobulin. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(2), 277–283.

Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis
Chertow, G. M., Lazarus, J. M., Paganini, E. P., Allgren, R. L., Lafayette, R. A., & Sayegh, M. H. (1998). Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(4), 692–98.

beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts
Owen, W. F., Hou, F. F., Stuart, R. O., Kay, J., Boyce, J., Chertow, G. M., & Schimidt, A. M. (1998). beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts. KIDNEY INTERNATIONAL, 53(5), 1365–1373.

Independent association between acute renal failure and mortality following cardiac surgery
Chertow, G. M., Levy, E. M., Hammermeister, K. E., Grover, F., & Daley, J. (1998). Independent association between acute renal failure and mortality following cardiac surgery. AMERICAN JOURNAL OF MEDICINE, 104(4), 343–348.

Haemobilia mimicking acute cholecystitis following percutaneous renal biopsy
Lee, M. C., Jacobs, D. O., & Chertow, G. M. (1998). Haemobilia mimicking acute cholecystitis following percutaneous renal biopsy. NEPHROLOGY DIALYSIS TRANSPLANTATION, 13(8), 2118–2120.

Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD
Ginsburg, E. S., Walsh, B., Greenberg, L., Price, D., Chertow, G. M., & Owen, W. F. (1998). Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD. KIDNEY INTERNATIONAL, 54(4), 1344–1350.

Clearance of Pneumocystis carinii cysts in acute P carinii pneumonia - Assessment by serial sputum induction
O'Donnell, W. J., Pieciak, W., Chertow, G. M., Sanabria, J., & Lahive, K. C. (1998). Clearance of Pneumocystis carinii cysts in acute P carinii pneumonia - Assessment by serial sputum induction. CHEST, 114(5), 1264–1268.

Cancer screening and detection in patients with end-stage renal disease
Gornik, H. L., Lazarus, J. M., & Chertow, G. M. (1998). Cancer screening and detection in patients with end-stage renal disease. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 21(9), 495–500.

Dose of hemodialysis and survival - Differences by race and sex
Owen, W. F., Chertow, G. M., Lazarus, J. M., & Lowrie, E. G. (1998). Dose of hemodialysis and survival - Differences by race and sex. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 280(20), 1764–1768.

Modality-specific nutrition support in ESRD: Weighing the evidence
Chertow, G. M. (1999). Modality-specific nutrition support in ESRD: Weighing the evidence. AMERICAN JOURNAL OF KIDNEY DISEASES, 33(1), 193–197.

A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium - Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients
Chertow, G. M., Dillon, M., Burke, S. K., Steg, M., Bleyer, A. J., Garrett, B. N., … Slatopolsky, E. (1999). A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium - Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients. CLINICAL NEPHROLOGY, 51(1), 18–26.

Factors Associated With Depressive Symptoms and Use of Antidepressant Medications Among Participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Studies
Fischer, M. J., Xie, D., Jordan, N., Kop, W. J., Krousel-Wood, M., Tamura, M. K., … Lash, J. P. (2012). Factors Associated With Depressive Symptoms and Use of Antidepressant Medications Among Participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Studies. AMERICAN JOURNAL OF KIDNEY DISEASES, 60(1), 27–38.

Dynamic allocation of kidneys to candidates on the transplant waiting list
Zenios, S. A. A., Chertow, G. M., & Wein, L. M. (2000). Dynamic allocation of kidneys to candidates on the transplant waiting list. OPERATIONS RESEARCH, 48(4), 549–69.

Multi-attribute utility and health-related quality of life in persons with CKD stages IV-V.
Gorodetskaya, I., Young, B. S., Hsu, C. Y., Zenios, S. A., & Chertow, G. M. (2003). Multi-attribute utility and health-related quality of life in persons with CKD stages IV-V. Presented at the 36th Annual Meeting of the American-Society-of-Nephrology, SAN DIEGO,CA,CA,CA,CA,CA,CA,CA,CA: AMER SOC NEPHROLOGY.

Allocation of kidneys to patients on the transplant waiting list. Assessing the trade-off between equity and efficiency.
Zenios, S. A., Chertow, G. M., & Wein, L. M. (1997). Allocation of kidneys to patients on the transplant waiting list. Assessing the trade-off between equity and efficiency. AMER SOC NEPHROLOGY.

Optimal Initiation and Management of Dialysis Therapy
Lee, C. P., Chertow, G. M., & Zenios, S. A. (2008). Optimal Initiation and Management of Dialysis Therapy. OPERATIONS RESEARCH, 56(6), 1428–49.

Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
Chertow, G. M., Block, G. A., Correa-Rotter, R., Drueeke, T. B., Floege, J., Goodman, W. G., … Parfrey, P. S. (2012). Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis. NEW ENGLAND JOURNAL OF MEDICINE, 367(26), 2482–94.

Allocation of kidneys to patients on the transplant waiting list: a simulation-based policy model
Zenios, S. A., Chertow, G. M., & Wein, L. M. (1998). Allocation of kidneys to patients on the transplant waiting list: a simulation-based policy model. Presented at the 30th Conference on Transplantation and Clinical Immunology - Organ Allocation, FRANCE: KLUWER ACADEMIC PUBL.

TEMPORAL TRENDS IN THE INCIDENCE, TREATMENT, AND OUTCOMES OF HIP FRACTURE IN OLDER PATIENTS INITIATING DIALYSIS IN THE UNITED STATES.
Nair, S. S., Mitani, A. A., Goldstein, B. A., Chertow, G. M., Lowenberg, D. W., & Winkelmayer, W. C. (2013). TEMPORAL TRENDS IN THE INCIDENCE, TREATMENT, AND OUTCOMES OF HIP FRACTURE IN OLDER PATIENTS INITIATING DIALYSIS IN THE UNITED STATES. AMERICAN JOURNAL OF KIDNEY DISEASES, 61(4), A93–A93.

IMPACT OF CINACALCET THERAPY ON PATIENT-REPORTED SYMPTOMS IN PATIENTS WITH MODERATE TO SEVERE SECONDARY HYPERPARATHYROIDISM
Block, G. A., Xu, X., Lu, Z. J., Bushinsky, D. A., Goodman, W., Knight, T., & Chertow, G. M. (2009). IMPACT OF CINACALCET THERAPY ON PATIENT-REPORTED SYMPTOMS IN PATIENTS WITH MODERATE TO SEVERE SECONDARY HYPERPARATHYROIDISM. AMERICAN JOURNAL OF KIDNEY DISEASES, 53(4), A29–A29.

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
Chertow, G. M., Block, G. A., Correa-Rotter, R., Drüeke, T. B., Floege, J., Goodman, W. G., … Parfrey, P. S. (2012). Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. New England Journal of Medicine, 367(26), 2482–2494.

Angiotensin Converting Enzyme Inhibitors in Hemodialysis
Chang, T. I., Shilane, D., Brunelli, S. M., Cheung, A. K., Chertow, G. M., & Winkelmayer, W. C. (2011). Angiotensin Converting Enzyme Inhibitors in Hemodialysis. WILEY PERIODICALS, INC.

Use of Standard Kt/V for Comparison of Efficiency Between Continuous Renal Replacement Therapies and Intermittent Hemodialysis in Acute Kidney Injury
Claure-Del Granado, R., Macedo, E., Soroko, S., Chertow, G. M., Himmelfarb, J., Ikizler, A., … Mehta, R. L. (2010). Use of Standard Kt/V for Comparison of Efficiency Between Continuous Renal Replacement Therapies and Intermittent Hemodialysis in Acute Kidney Injury. BLOOD PURIFICATION, 30(3), 229–30.

Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis
Chang, T. I., Flythe, J. E., Brunelli, S. M., Muntner, P., Greene, T., Cheung, A. K., & Chertow, G. M. (2014). Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis. JOURNAL OF HUMAN HYPERTENSION, 28(1), 18–24.

Piecewise analysis of patient survival after onset of AKI.
Zhang, J. H., Palevsky, P. M., Chertow, G. M., Hartigan, J., O'Connor, T. Z., Guarino, P., & Zhou, B. (2013). Piecewise analysis of patient survival after onset of AKI. Clinical Journal of the American Society of Nephrology , 8(10), 1679–1684.

Vitamin d deficiency and mortality in patients receiving dialysis: the comprehensive dialysis study.
Anand, S., Chertow, G. M., Johansen, K. L., Grimes, B., Dalrymple, L. S., Kaysen, G. A., & Kurella Tamura, M. (2013). Vitamin d deficiency and mortality in patients receiving dialysis: the comprehensive dialysis study. Journal of Renal Nutrition , 23(6), 422–27.

Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease.
Erickson, K. F., Chertow, G. M., & Goldhaber-Fiebert, J. D. (2013). Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Annals of Internal Medicine, 159(6), 382–389.

Sensitization from transfusion in patients awaiting primary kidney transplant.
Yabu, J. M., Anderson, M. W., Kim, D., Bradbury, B. D., Lou, C. D., Petersen, J., … Tyan, D. B. (2013). Sensitization from transfusion in patients awaiting primary kidney transplant. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 28(11), 2908–18.

Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial.
Lambers Heerspink, H. J., Chertow, G. M., Akizawa, T., Audhya, P., Bakris, G. L., Goldsberry, A., … de Zeeuw, D. (2013). Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 28(11), 2841–50.

Pre-ESRD Changes in Body Weight and Survival in Nursing Home Residents Starting Dialysis
Stack, S., Chertow, G. M., Johansen, K. L., Si, Y., & Tamura, M. K. (2013). Pre-ESRD Changes in Body Weight and Survival in Nursing Home Residents Starting Dialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(10), 1734–40.

Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era.
Conti, S. L., Thomas, I.-C., Hagedorn, J. C., Chung, B. I., Chertow, G. M., Wagner, T. H., … Leppert, J. T. (2014). Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era. International Journal of Cancer. Journal International Du Cancer, 134(9), 2245–52.

Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States National Health and Nutrition Examination Survey.
Patel, C. J., Rehkopf, D. H., Leppert, J. T., Bortz, W. M., Cullen, M. R., Chertow, G. M., & Ioannidis, J. P. A. (2013). Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States National Health and Nutrition Examination Survey. International Journal of Epidemiology, 42(6), 1795–1810.

Utilization of renal mass biopsy in patients with renal cell carcinoma.
Leppert, J. T., Hanley, J., Wagner, T. H., Chung, B. I., Srinivas, S., Chertow, G. M., … Saigal, C. S. (2014). Utilization of renal mass biopsy in patients with renal cell carcinoma. Urology, 83(4), 774–80.

Reply.
Leppert, J. T., Hanley, J., Wagner, T. H., Chung, B. I., Brooks, J. D., Srinivas, S., … Saigal, C. S. (2014). Reply. Urology, 83(4), 779–80.

Effects of Frequent Hemodialysis on Ventricular Volumes and Left Ventricular Remodeling
Chan, C. T., Greene, T., Chertow, G. M., Kliger, A. S., Stokes, J. B., Beck, G. J., … Rajagopalan, S. (2013). Effects of Frequent Hemodialysis on Ventricular Volumes and Left Ventricular Remodeling. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(12), 2106–16.

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M., Christ-Schmidt, H., … Chertow, G. M. (2013). Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease. NEW ENGLAND JOURNAL OF MEDICINE, 369(26), 2492–2503.

Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial.
Chan, C. T., Chertow, G. M., Daugirdas, J. T., Greene, T. H., Kotanko, P., Larive, B., … Stokes, J. B. (2014). Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 29(1), 168–178.

The Clinical Course of Treated Hyperparathyroidism Among Patients Receiving Hemodialysis and the Effect of Cinacalcet: The EVOLVE Trial
Parfrey, P. S., Chertow, G. M., Block, G. A., Correa-Rotter, R., Drueeke, T. B., Floege, J., … Goodman, W. G. (2013). The Clinical Course of Treated Hyperparathyroidism Among Patients Receiving Hemodialysis and the Effect of Cinacalcet: The EVOLVE Trial. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 98(12), 4834–44.

Diabetes Severity, Metabolic Syndrome, and the Risk of Erectile Dysfunction
Weinberg, A. E., Eisenberg, M., Patel, C. J., Chertow, G. M., & Leppert, J. T. (2013). Diabetes Severity, Metabolic Syndrome, and the Risk of Erectile Dysfunction. JOURNAL OF SEXUAL MEDICINE, 10(12), 3102–9.

High prevalence of type 2 diabetes among the urban middle class in Bangladesh.
Saquib, N., Khanam, M. A., Saquib, J., Anand, S., Chertow, G. M., Barry, M., … Cullen, M. R. (2013). High prevalence of type 2 diabetes among the urban middle class in Bangladesh. BMC Public Health, 13, 1032-?

Phase Angle, Frailty and Mortality in Older Adults
Wilhelm-Leen, E. R., Hall, Y. N., Horwitz, R. I., & Chertow, G. M. (2014). Phase Angle, Frailty and Mortality in Older Adults. JOURNAL OF GENERAL INTERNAL MEDICINE, 29(1), 147–54.

Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010).
Winkelmayer, W. C., Mitani, A. A., Goldstein, B. A., Brookhart, M. A., & Chertow, G. M. (2014). Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). JAMA Internal Medicine, 174(5), 699–707.

Prognostic stratification in older adults commencing dialysis.
Cheung, K. L., Montez-Rath, M. E., Chertow, G. M., Winkelmayer, W. C., Periyakoil, V. S., & Kurella Tamura, M. (2014). Prognostic stratification in older adults commencing dialysis. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 69(8), 1033–39.

High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: a cross-sectional study.
Anand, S., Khanam, M. A., Saquib, J., Saquib, N., Ahmed, T., Alam, D. S., … Chertow, G. M. (2014). High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: a cross-sectional study. Globalization and Health, 10, 9-?

Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States.
Sukumaran Nair, S., Lenihan, C. R., Montez-Rath, M. E., Lowenberg, D. W., Chertow, G. M., & Winkelmayer, W. C. (2014). Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States. American Journal of Transplantation , 14(4), 943–51.

KRAS mutation confers resistance to antibody-dependent cellular cytotoxicity of cetuximab against human colorectal cancer cells
Conti, S. L., Thomas, I.-C., Hagedorn, J. C., Chung, B. I., Chertow, G. M., Wagner, T. H., … Leppert, J. T. (2014). KRAS mutation confers resistance to antibody-dependent cellular cytotoxicity of cetuximab against human colorectal cancer cells. INTERNATIONAL JOURNAL OF CANCER, 134(9), 2245–52.

Effects of Frequent Hemodialysis on Perceived Caregiver Burden in the Frequent Hemodialysis Network Trials
Suri, R. S., Larive, B., Hall, Y., Kimmel, P. L., Kliger, A. S., Levin, N., … Chertow, G. M. (2014). Effects of Frequent Hemodialysis on Perceived Caregiver Burden in the Frequent Hemodialysis Network Trials. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(5), 936–942.

Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis
Kaysen, G. A., Dalrymple, L. S., Grimes, B., Chertow, G. M., Kornak, J., & Johansen, K. L. (2014). Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis. NEPHROLOGY DIALYSIS TRANSPLANTATION, 29(2), 430–37.

Piecewise Analysis of Patient Survival after Onset of AKI
Zhang, J. H., Palevsky, P. M., Chertow, G. M., Hartigan, J., O'Connor, T. Z., Guarino, P., & Zhou, B. (2013). Piecewise Analysis of Patient Survival after Onset of AKI. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(10), 1679–84.

Prevention of Contrast-Induced AKI: A Review of Published Trials and the Design of the Prevention of Serious Adverse Events following Angiography (PRESERVE) Trial
Weisbord, S. D., Gallagher, M., Kaufman, J., Cass, A., Parikh, C. R., Chertow, G. M., … Palevsky, P. M. (2013). Prevention of Contrast-Induced AKI: A Review of Published Trials and the Design of the Prevention of Serious Adverse Events following Angiography (PRESERVE) Trial. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(9), 1618–31.

Characteristics and Performance of Minority-Serving Dialysis Facilities
Hall, Y. N., Xu, P., Chertow, G. M., & Himmelfarb, J. (2014). Characteristics and Performance of Minority-Serving Dialysis Facilities. HEALTH SERVICES RESEARCH, 49(3), 971–91.

Comparison of Hospitalization Rates among For-Profit and Nonprofit Dialysis Facilities
Dalrymple, L. S., Johansen, K. L., Romano, P. S., Chertow, G. M., Mu, Y., Ishida, J. H., … Nguyen, D. V. (2014). Comparison of Hospitalization Rates among For-Profit and Nonprofit Dialysis Facilities. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(1), 73–81.

Association between Body Composition and Frailty among Prevalent Hemodialysis Patients: A US Renal Data System Special Study
Johansen, K. L., Dalrymple, L. S., Delgado, C., Kaysen, G. A., Kornak, J., Grimes, B., & Chertow, G. M. (2014). Association between Body Composition and Frailty among Prevalent Hemodialysis Patients: A US Renal Data System Special Study. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 25(2), 381–89.

Estimation of 24-Hour Urine Phosphate Excretion From Spot Urine Collection: Development of a Predictive Equation
Robinson-Cohen, C., Ix, J. H., Smits, G., Persky, M., Chertow, G. M., Block, G. A., & Kestenbaum, B. R. (2014). Estimation of 24-Hour Urine Phosphate Excretion From Spot Urine Collection: Development of a Predictive Equation. JOURNAL OF RENAL NUTRITION, 24(3), 194–99.

Calibration of the Brief Food Frequency Questionnaire Among Patients on Dialysis
Delgado, C., Ward, P., Chertow, G. M., Storer, L., Dalrymple, L., Block, T., … Johansen, K. L. (2014). Calibration of the Brief Food Frequency Questionnaire Among Patients on Dialysis. JOURNAL OF RENAL NUTRITION, 24(3), 151–U30.

Challenging the validity of the EPO index
Kaysen, G. A., Muller, H. G., Ding, J., & Chertow, G. M. (2006). Challenging the validity of the EPO index. AMERICAN JOURNAL OF KIDNEY DISEASES, 47(1), 157–166.

Intensity of dialysis in established acute renal failure
Chertow, G. M., & Lazarus, J. M. (1996). Intensity of dialysis in established acute renal failure. SEMINARS IN DIALYSIS, 9(6), 476–480.

Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease.
Erickson, K. F., Chertow, G. M., & Goldhaber-Fiebert, J. D. (2013). Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Annals of Internal Medicine, 159(6), 382–89.

High prevalence of type 2 diabetes among the urban middle class in Bangladesh
Saquib, N., Khanam, M. A., Saquib, J., Anand, S., Chertow, G. M., Barry, M., … Cullen, M. R. (2013). High prevalence of type 2 diabetes among the urban middle class in Bangladesh. BMC PUBLIC HEALTH, 13.

High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: a cross-sectional study.
Anand, S., Khanam, M. A., Saquib, J., Saquib, N., Ahmed, T., Alam, D. S., … Chertow, G. M. (2014). High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: a cross-sectional study. Globalization and Health, 10(1), 9-?

Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study.
Yang, J.-Y., Lee, T.-C., Montez-Rath, M. E., Chertow, G. M., & Winkelmayer, W. C. (2013). Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. BMC Nephrology, 14, 97-?

PROGNOSTIC STRATIFICATION IN CRITICALLY ILL PATIENTS WITH ACUTE-RENAL-FAILURE REQUIRING DIALYSIS
Chertow, G. M., Christiansen, C. L., Cleary, P. D., Munro, C., & Lazarus, J. M. (1995). PROGNOSTIC STRATIFICATION IN CRITICALLY ILL PATIENTS WITH ACUTE-RENAL-FAILURE REQUIRING DIALYSIS. ARCHIVES OF INTERNAL MEDICINE, 155(14), 1505–1511.

MULTIFREQUENCY BIOELECTRICAL-IMPEDANCE ESTIMATES THE DISTRIBUTION OF BODY-WATER
Cha, K. C., Chertow, G. M., Gonzalez, J., Lazarus, J. M., & Wilmore, D. W. (1995). MULTIFREQUENCY BIOELECTRICAL-IMPEDANCE ESTIMATES THE DISTRIBUTION OF BODY-WATER. JOURNAL OF APPLIED PHYSIOLOGY, 79(4), 1316–1319.

Non-immunologic predictors of chronic renal allograft failure: data from the United Network of Organ Sharing.
Chertow, G. M., BRENNER, B. M., Mackenzie, H. S., & Milford, E. L. (1995). Non-immunologic predictors of chronic renal allograft failure: data from the United Network of Organ Sharing. Kidney International. Supplement, 52, S48–51.

NUTRITIONAL ASSESSMENT WITH BIOELECTRICAL-IMPEDANCE ANALYSIS IN MAINTENANCE HEMODIALYSIS-PATIENTS
Chertow, G. M., Lowrie, E. G., Wilmore, D. W., Gonzalez, J., Lew, N. L., Ling, J., … Lazarus, J. M. (1995). NUTRITIONAL ASSESSMENT WITH BIOELECTRICAL-IMPEDANCE ANALYSIS IN MAINTENANCE HEMODIALYSIS-PATIENTS. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(1), 75–81.

Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease.
Erickson, K. F., Chertow, G. M., & Goldhaber-Fiebert, J. D. (2014). Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Annals of Internal Medicine, 160(2), 143-?

Congenital oligonephropathy: an inborn cause of adult hypertension and progressive renal injury?
BRENNER, B. M., & Chertow, G. M. (1993). Congenital oligonephropathy: an inborn cause of adult hypertension and progressive renal injury? Current Opinion in Nephrology and Hypertension, 2(5), 691–695.

THE ASSOCIATION OF INTRADIALYTIC PARENTERAL-NUTRITION ADMINISTRATION WITH SURVIVAL IN HEMODIALYSIS-PATIENTS
Chertow, G. M., Ling, J., Lew, N. L., Lazarus, J. M., & Lowrie, E. G. (1994). THE ASSOCIATION OF INTRADIALYTIC PARENTERAL-NUTRITION ADMINISTRATION WITH SURVIVAL IN HEMODIALYSIS-PATIENTS. AMERICAN JOURNAL OF KIDNEY DISEASES, 24(6), 912–920.

Cost-effectiveness of cancer screening in end-stage renal disease
Chertow, G. M., Paltiel, A. D., Owen, W. F., & Lazarus, J. M. (1996). Cost-effectiveness of cancer screening in end-stage renal disease. ARCHIVES OF INTERNAL MEDICINE, 156(12), 1345–1350.

Estimation of 24-hour urine phosphate excretion from spot urine collection: development of a predictive equation.
Robinson-Cohen, C., Ix, J. H., Smits, G., Persky, M., Chertow, G. M., Block, G. A., & Kestenbaum, B. R. (2014). Estimation of 24-hour urine phosphate excretion from spot urine collection: development of a predictive equation. Journal of Renal Nutrition , 24(3), 194–99.

Nutrition and the dialysis prescription
Chertow, G. M., Bullard, A., & Lazarus, J. M. (1996). Nutrition and the dialysis prescription. AMERICAN JOURNAL OF NEPHROLOGY, 16(1), 79–89.

Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis.
Kaysen, G. A., Dalrymple, L. S., Grimes, B., Chertow, G. M., Kornak, J., & Johansen, K. L. (2014). Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 29(2), 430–437.

Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study.
Johansen, K. L., Dalrymple, L. S., Delgado, C., Kaysen, G. A., Kornak, J., Grimes, B., & Chertow, G. M. (2014). Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study. Journal of the American Society of Nephrology , 25(2), 381–389.

Calibration of the brief food frequency questionnaire among patients on dialysis.
Delgado, C., Ward, P., Chertow, G. M., Storer, L., Dalrymple, L., Block, T., … Johansen, K. L. (2014). Calibration of the brief food frequency questionnaire among patients on dialysis. Journal of Renal Nutrition , 24(3), 151–56 e1.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Chertow, G. M., & de Zeeuw, D. (2014). Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease. New England Journal of Medicine, 370(18), 1768-?

Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD).
Claure-Del Granado, R., Macedo, E., Soroko, S., Kim, Y., Chertow, G. M., Himmelfarb, J., … Mehta, R. L. (2014). Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD). Hemodialysis International. International Symposium on Home Hemodialysis, 18(3), 641–49.

Characteristics and performance of minority-serving dialysis facilities.
Hall, Y. N., Xu, P., Chertow, G. M., & Himmelfarb, J. (2014). Characteristics and performance of minority-serving dialysis facilities. Health Services Research, 49(3), 971–991.

Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities.
Dalrymple, L. S., Johansen, K. L., Romano, P. S., Chertow, G. M., Mu, Y., Ishida, J. H., … Nguyen, D. V. (2014). Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities. Clinical Journal of the American Society of Nephrology , 9(1), 73–81.

NONIMMUNOLOGICAL PREDICTORS OF CHRONIC RENAL-ALLOGRAFT FAILURE - DATA FROM THE UNITED-NETWORK-OF-ORGAN-SHARING
Chertow, G. M., BRENNER, B. M., Mackenzie, H. S., & Milford, E. L. (1995). NONIMMUNOLOGICAL PREDICTORS OF CHRONIC RENAL-ALLOGRAFT FAILURE - DATA FROM THE UNITED-NETWORK-OF-ORGAN-SHARING. Kidney international. Supplement. CUENCA,SPAIN,SPAIN: BLACKWELL SCIENCE PUBL INC CAMBRIDGE.

CONGENITAL OLIGONEPHROPATHY AND THE ETIOLOGY OF ADULT HYPERTENSION AND PROGRESSIVE RENAL INJURY
BRENNER, B. M., & Chertow, G. M. (1994). CONGENITAL OLIGONEPHROPATHY AND THE ETIOLOGY OF ADULT HYPERTENSION AND PROGRESSIVE RENAL INJURY. AMERICAN JOURNAL OF KIDNEY DISEASES, 23(2), 171–175.

POTENTIAL IDENTIFIABILITY AND PREVENTABILITY OF ADVERSE EVENTS USING INFORMATION-SYSTEMS
Bates, D. W., ONEIL, A. C., Boyle, D., Teich, J., Chertow, G. M., Komaroff, A. L., & Brennan, T. A. (1994). POTENTIAL IDENTIFIABILITY AND PREVENTABILITY OF ADVERSE EVENTS USING INFORMATION-SYSTEMS. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 1(5), 404–411.

Physician visits and 30-day hospital readmissions in patients receiving hemodialysis.
Erickson, K. F., Winkelmayer, W. C., Chertow, G. M., & Bhattacharya, J. (2014). Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. Journal of the American Society of Nephrology , 25(9), 2079–87.

Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.
Wheeler, D. C., London, G. M., Parfrey, P. S., Block, G. A., Correa-Rotter, R., Dehmel, B., … Herzog, C. A. (2014). Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial. Journal of the American Heart Association, 3(6).

Comparison of Self-report-Based and Physical Performance-Based Frailty Definitions Among Patients Receiving Maintenance Hemodialysis
Johansen, K. L., Dalrymple, L. S., Delgado, C., Kaysen, G. A., Kornak, J., Grimes, B., & Chertow, G. M. (2014). Comparison of Self-report-Based and Physical Performance-Based Frailty Definitions Among Patients Receiving Maintenance Hemodialysis. AMERICAN JOURNAL OF KIDNEY DISEASES, 64(4), 600–607.

Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial
Wheeler, D. C., London, G. M., Parfrey, P. S., Block, G. A., Correa-Rotter, R., Dehmel, B., … Herzog, C. A. (2014). Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 3(6).

Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl
Chin, M. P., Wrolstad, D., Bakris, G. L., Chertow, G. M., de Zeeuw, D., Goldsberry, A., … Meyer, C. J. (2014). Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl. JOURNAL OF CARDIAC FAILURE, 20(12), 953–58.

Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis.
Chang, T. I., Montez-Rath, M. E., Shen, J. I., Solomon, M. D., Chertow, G. M., & Winkelmayer, W. C. (2014). Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. Journal of the American Heart Association, 3(5).

Provider visit frequency and vascular access interventions in hemodialysis.
Erickson, K. F., Mell, M. W., Winkelmayer, W. C., Chertow, G. M., & Bhattacharya, J. (2015). Provider visit frequency and vascular access interventions in hemodialysis. Clinical Journal of the American Society of Nephrology , 10(2), 269–77.

Utilization of Renal Mass Biopsy in Patients With Renal Cell Carcinoma Reply
Leppert, J. T., Hanley, J., Wagner, T. H., Chung, B. I., Brooks, J. D., Srinivas, S., … Saigal, C. S. (2014). Utilization of Renal Mass Biopsy in Patients With Renal Cell Carcinoma Reply. UROLOGY, 83(4), 779–80.

Utilization of renal mass biopsy in patients with renal cell carcinoma
Leppert, J. T., Hanley, J., Wagner, T. H., Chung, B. I., Srinivas, S., Chertow, G. M., … Saigal, C. S. (2013). Utilization of renal mass biopsy in patients with renal cell carcinoma. Presented at the 12th International Kidney Cancer Symposium, CHICAGO,IL,IL,IL,IL,IL,IL,IL,IL,IL: WILEY-BLACKWELL.

Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era
Conti, S. L., Thomas, I.-C., Hagedorn, J. C., Chung, B. I., Chertow, G. M., Wagner, T. H., … Leppert, J. T. (2013). Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era. Presented at the 12th International Kidney Cancer Symposium, CHICAGO,IL,IL,IL,IL,IL,IL,IL,IL,IL: WILEY-BLACKWELL.

Navigating toward research success in times of uncertainty: funding opportunities for early career investigators in nephrology.
Ikizler, T. A., Lovett, D. H., Chertow, G. M., Mitch, W. E., & Schiller, B. (2015). Navigating toward research success in times of uncertainty: funding opportunities for early career investigators in nephrology. American Journal of Kidney Diseases , 65(3), 381–83.

Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial
Wheeler, D. C., London, G. M., Parfrey, P. S., Block, G. A., Correa-Rotter, R., Dehmel, B., … Herzog, C. A. (2015). Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 4(1).

Design of a Phase 2 Clinical Trial of an ASK1 Inhibitor, GS-4997, in Patients with Diabetic Kidney Disease
Lin, J. H., Zhang, J. J., Lin, S.-L., & Chertow, G. M. (2015). Design of a Phase 2 Clinical Trial of an ASK1 Inhibitor, GS-4997, in Patients with Diabetic Kidney Disease. NEPHRON, 129(1), 29–33.

Time-Updated Systolic Blood Pressure and the Progression of Chronic Kidney Disease A Cohort Study
Anderson, A. H., Yang, W., Townsend, R. R., Pan, Q., Chertow, G. M., Kusek, J. W., … Feldman, H. I. (2015). Time-Updated Systolic Blood Pressure and the Progression of Chronic Kidney Disease A Cohort Study. ANNALS OF INTERNAL MEDICINE, 162(4), 258-?

Longer-term Outcomes of Darbepoetin Alfa Versus Epoetin Alfa in Patients With ESRD Initiating Hemodialysis: A Quasi-experimental Cohort Study
Winkelmayer, W. C., Chang, T. I., Mitani, A. A., Wilhelm-Leen, E. R., Ding, V., Chertow, G. M., … Goldstein, B. A. (2015). Longer-term Outcomes of Darbepoetin Alfa Versus Epoetin Alfa in Patients With ESRD Initiating Hemodialysis: A Quasi-experimental Cohort Study. AMERICAN JOURNAL OF KIDNEY DISEASES, 66(1), 106–13.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial
Parfrey, P. S., Drueeke, T. B., Block, G. A., Correa-Rotter, R., Floege, J., Herzog, C. A., … Chertow, G. M. (2015). The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 10(5), 791–99.

Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
Moe, S. M., Abdalla, S., Chertow, G. M., Parfrey, P. S., Block, G. A., Correa-Rotter, R., … Drüeke, T. B. (2015). Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial. Journal of the American Society of Nephrology , 26(6), 1466–75.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
Parfrey, P. S., Drüeke, T. B., Block, G. A., Correa-Rotter, R., Floege, J., Herzog, C. A., … Chertow, G. M. (2015). The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Clinical Journal of the American Society of Nephrology , 10(5), 791–99.

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial
Moe, S. M., Chertow, G. M., Parfrey, P. S., Kubo, Y., Block, G. A., Correa-Rotter, R., … Floege, J. (2015). Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. CIRCULATION, 132(1), 27–39.

Hyperparathyroidism with hypercalcaemia in chronic kidney disease: primary or tertiary?
Lunn, M. R., Muñoz Mendoza, J., Pasche, L. J., Norton, J. A., Ayco, A. L., & Chertow, G. M. (2010). Hyperparathyroidism with hypercalcaemia in chronic kidney disease: primary or tertiary? NDT Plus, 3(4), 366–71.

Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease
Gill, K., Fink, J. C., Gilbertson, D. T., Monda, K. L., Muntner, P., Lafayette, R. A., … Bradbury, B. D. (2015). Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 24(6), 654–62.

Evaluating Risk of ESRD in the Urban Poor
Maziarz, M., Black, R. A., Fong, C. T., Himmelfarb, J., Chertow, G. M., & Hall, Y. N. (2015). Evaluating Risk of ESRD in the Urban Poor. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 26(6), 1434–42.

Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial
Kubo, Y., Sterling, L. R., Parfrey, P. S., Gill, K., Mahaffey, K. W., Gioni, I., … Chertow, G. M. (2015). Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial. PHARMACEUTICAL STATISTICS, 14(3), 242–51.

The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial
Floege, J., Kubo, Y., Floege, A., Chertow, G. M., & Parfrey, P. S. (2015). The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 10(5), 800–807.

A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5
Block, G. A., Fishbane, S., Rodriguez, M., Smits, G., Shemesh, S., Pergola, P. E., … Chertow, G. M. (2015). A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5. AMERICAN JOURNAL OF KIDNEY DISEASES, 65(5), 728–36.

Outcomes of Infection-Related Hospitalization in Medicare Beneficiaries Receiving In-Center Hemodialysis
Dalrymple, L. S., Mu, Y., Romano, P. S., Nguyen, D. V., Chertow, G. M., Delgado, C., … Johansen, K. L. (2015). Outcomes of Infection-Related Hospitalization in Medicare Beneficiaries Receiving In-Center Hemodialysis. AMERICAN JOURNAL OF KIDNEY DISEASES, 65(5), 754–62.

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
Moe, S. M., Chertow, G. M., Parfrey, P. S., Kubo, Y., Block, G. A., Correa-Rotter, R., … Floege, J. (2015). Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Circulation, 132(1), 27–39.

Prevalence of chronic kidney disease in two major Indian cities and projections for associated cardiovascular disease
Anand, S., Shivashankar, R., Ali, M. K., Kondal, D., Binukumar, B., Montez-Rath, M. E., … Prabhakaran, D. (2015). Prevalence of chronic kidney disease in two major Indian cities and projections for associated cardiovascular disease. KIDNEY INTERNATIONAL, 88(1), 178–85.

Homelessness and Risk of End-stage Renal Disease
Maziarz, M., Chertow, G. M., Himmeffarb, J., & Hall, Y. N. (2014). Homelessness and Risk of End-stage Renal Disease. JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 25(3), 1231–44.

Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
Kubo, Y., Sterling, L. R., Parfrey, P. S., Gill, K., Mahaffey, K. W., Gioni, I., … Chertow, G. M. (2015). Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial. Pharmaceutical Statistics, 14(4), 368-?

Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis
Erickson, K. F., Mell, M., Winkelmayer, W. C., Chertow, G. M., & Bhattacharya, J. (2015). Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 26(8), 1990–97.

Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial
Rocco, M. V., Daugirdas, J. T., Greene, T., Lockridge, R. S., Chan, C., Pierratos, A., … Kliger, A. S. (2015). Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial. AMERICAN JOURNAL OF KIDNEY DISEASES, 66(3), 459–68.

Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis
Kaysen, G. A., Johansen, K. L., Chertow, G. M., Dalrymple, L. S., Kornak, J., Grimes, B., … Fiehn, O. (2015). Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis. JOURNAL OF RENAL NUTRITION, 25(4), 351–56.

Risk prediction models for contrast induced nephropathy: systematic review
Silver, S. A., Shah, P. M., Chertow, G. M., Harel, S., Wald, R., & Harel, Z. (2015). Risk prediction models for contrast induced nephropathy: systematic review. BMJ-BRITISH MEDICAL JOURNAL, 351.

Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis.
Chang, T. I., Montez-Rath, M. E., Shen, J. I., Solomon, M. D., Chertow, G. M., & Winkelmayer, W. C. (2014). Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. Journal of the American Heart Association, 3(5).

Menopausal symptoms in women with chronic kidney disease.
Cheung, K. L., Stefanick, M. L., Allison, M. A., LeBlanc, E. S., Vitolins, M. Z., Shara, N., … Kurella Tamura, M. (2015). Menopausal symptoms in women with chronic kidney disease. Menopause (New York, N.Y.), 22(9), 1006–11.

Dialysis plus do not resuscitate--not a contradiction.
Wilhelm-Leen, E. R., & Chertow, G. M. (2015). Dialysis plus do not resuscitate--not a contradiction. JAMA Internal Medicine, 175(6), 1035–36.

Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial.
Rocco, M. V., Daugirdas, J. T., Greene, T., Lockridge, R. S., Chan, C., Pierratos, A., … Kliger, A. S. (2015). Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial. American Journal of Kidney Diseases , 66(3), 459–68.

Comparison of self-report-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis.
Johansen, K. L., Dalrymple, L. S., Delgado, C., Kaysen, G. A., Kornak, J., Grimes, B., & Chertow, G. M. (2014). Comparison of self-report-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis. American Journal of Kidney Diseases , 64(4), 600–607.

Urine electrolyte composition and diuretic therapy in heart failure: back to the future?
Pao, A. C., & Chertow, G. M. (2014). Urine electrolyte composition and diuretic therapy in heart failure: back to the future? Circulation. Heart Failure, 7(5), 697–98.

Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
Kaysen, G. A., Johansen, K. L., Chertow, G. M., Dalrymple, L. S., Kornak, J., Grimes, B., … Fiehn, O. (2015). Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis. Journal of Renal Nutrition , 25(4), 351–56.

Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial
Chan, C. T., Chertow, G. M., Daugirdasl, J. T., Greene', T. H., Kotanko, P., Larive, B., … Stokes, J. B. (2015). Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 282(1816).

Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT
Chertow, G. M., Beddhu, S., Lewis, J. B., Toto, R. D., & Cheung, A. K. (2016). Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 27(1), 40–43.

Risk Factors for Infection-Related Hospitalization in In-Center Hemodialysis
Dalrymple, L. S., Mu, Y., Nguyen, D. V., Romano, P. S., Chertow, G. M., Grimes, B., … Johansen, K. L. (2015). Risk Factors for Infection-Related Hospitalization in In-Center Hemodialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 10(12), 2170–80.

Association of Self-Reported Frailty with Falls and Fractures among Patients New to Dialysis
Delgado, C., Shieh, S., Grimes, B., Chertow, G. M., Dalrymple, L. S., Kaysen, G. A., … Johansen, K. L. (2015). Association of Self-Reported Frailty with Falls and Fractures among Patients New to Dialysis. AMERICAN JOURNAL OF NEPHROLOGY, 42(2), 134–40.

Association of bioimpedance spectroscopy-based volume estimation with postdialysis hypotension in patients receiving hemodialysis
Abreo, A. P., Chertow, G. M., Dalrymple, L. S., Kaysen, G. A., & Johansen, K. L. (2015). Association of bioimpedance spectroscopy-based volume estimation with postdialysis hypotension in patients receiving hemodialysis. HEMODIALYSIS INTERNATIONAL, 19(4), 536–42.

Cardiovascular and Renal Outcomes Trials-Is There a Difference?
Raggi, P., Boer, R., Goodman, W. G., Kalantar-Zadeh, K., Chertow, G. M., & Belozeroff, V. (2015). Cardiovascular and Renal Outcomes Trials-Is There a Difference? AMERICAN JOURNAL OF CARDIOLOGY, 116(6), 982–88.

Improving Care after Acute Kidney Injury: A Prospective Time Series Study
Silver, S. A., Harel, Z., Harvey, A., Adhikari, N. K., Slack, A., Acedillo, R., … Wald, R. (2015). Improving Care after Acute Kidney Injury: A Prospective Time Series Study. NEPHRON, 131(1), 43–50.

Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
Macdougall, I. C., Bircher, A. J., Eckardt, K.-U., Obrador, G. T., Pollock, C. A., Stenvinkel, P., … Chertow, G. M. (2016). Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. KIDNEY INTERNATIONAL, 89(1), 28–39.

Rehospitalizations and Emergency Department Visits after Hospital Discharge in Patients Receiving Maintenance Hemodialysis.
Harel, Z., Wald, R., McArthur, E., Chertow, G. M., Harel, S., Gruneir, A., … Bell, C. M. (2015). Rehospitalizations and Emergency Department Visits after Hospital Discharge in Patients Receiving Maintenance Hemodialysis. Journal of the American Society of Nephrology , 26(12), 3141–50.

Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial
Chang, T. I., Evans, G., Cheung, A. K., Cushman, W. C., Diamond, M. J., Dwyer, J. P., … Chertow, G. M. (2016). Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial. HYPERTENSION, 67(3), 550–55.

Overall Survival in Patients with Localized Prostate Cancer in the US Veterans Health Administration: Is PIVOT Generalizable?
Barbosa, P. V., Thomas, I.-C., Srinivas, S., Buyyounouski, M. K., Chung, B. I., Chertow, G. M., … Leppert, J. T. (2016). Overall Survival in Patients with Localized Prostate Cancer in the US Veterans Health Administration: Is PIVOT Generalizable? EUROPEAN UROLOGY, 70(2), 227–30.

Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults
Tamura, M. K., Pajewski, N. M., Bryan, R. N., Weiner, D. E., Diamond, M., Van Buren, P., … Zaharchuk, G. (2016). Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults. NEUROLOGY, 86(13), 1208–16.

Economic Evaluation of Cinacalcet in the United States: The EVOLVE Trial
Belozeroff, V., Chertow, G. M., Graham, C. N., Dehmel, B., Parfrey, P. S., & Briggs, A. H. (2015). Economic Evaluation of Cinacalcet in the United States: The EVOLVE Trial. VALUE IN HEALTH, 18(8), 1079–87.

Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis
Parfrey, P. S., Block, G. A., Correa-Rotter, R., Drueeke, T. B., Floege, J., Herzog, C. A., … Chertow, G. M. (2016). Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 11(3), 539–546.

Validating Appetite Assessment Tools Among Patients Receiving Hemodialysis
Molfino, A., Kaysen, G. A., Chertow, G. M., Doyle, J., Delgado, C., Dwyer, T., … Johansen, K. L. (2016). Validating Appetite Assessment Tools Among Patients Receiving Hemodialysis. JOURNAL OF RENAL NUTRITION, 26(2), 103–10.

The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial
Chang, T. I., AbdAlla, S., London, G. M., Block, G. A., Correa-Rotter, R., Drueeke, T. B., … Chertow, G. M. (2016). The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial. JOURNAL OF HUMAN HYPERTENSION, 30(3), 204–9.

Understanding barriers to home-based and self-care in-center hemodialysis.
Yau, M., Carver, M., Alvarez, L., Block, G. A., & Chertow, G. M. (2016). Understanding barriers to home-based and self-care in-center hemodialysis. Hemodialysis International. International Symposium on Home Hemodialysis, 20(2), 235–41.

Reforming Medicare's Dialysis Payment Policies: Implications for Patients with Secondary Hyperparathyroidism
Gupta, C., Chertow, G. M., Linthicum, M. T., Van Nuys, K., Belozeroff, V., Quarles, D., & Lakdawalla, D. N. (2014). Reforming Medicare's Dialysis Payment Policies: Implications for Patients with Secondary Hyperparathyroidism. HEALTH SERVICES RESEARCH, 49(6), 1925–43.

Association of Performance-Based and Self-Reported Function-Based Definitions of Frailty with Mortality among Patients Receiving Hemodialysis
Johansen, K. L., Dalrymple, L. S., Glidden, D., Delgado, C., Kaysen, G. A., Grimes, B., & Chertow, G. M. (2016). Association of Performance-Based and Self-Reported Function-Based Definitions of Frailty with Mortality among Patients Receiving Hemodialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 11(4), 626–32.

The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials.
Raimann, J. G., Chan, C. T., Daugirdas, J. T., Depner, T., Gotch, F. A., Greene, T., … Levin, N. W. (2016). The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials. Blood Purification, 41(4), 277–86.

Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States
Kim, S. M., Long, J., Montez-Rath, M. E., Leonard, M. B., Norton, J. A., & Chertow, G. M. (2016). Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 11(7), 1260–67.

Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial
Pun, P. H., Abdalla, S., Block, G. A., Chertow, G. M., Correa-Rotter, R., Dehmel, B., … Middleton, J. P. (2016). Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial. HEMODIALYSIS INTERNATIONAL, 20(3), 421–31.

Risk prediction to inform surveillance of chronic kidney disease in the US Healthcare Safety Net: a cohort study
Xie, Y., Maziarz, M., Tuot, D. S., Chertow, G. M., Himmelfarb, J., & Hall, Y. N. (2016). Risk prediction to inform surveillance of chronic kidney disease in the US Healthcare Safety Net: a cohort study. BMC NEPHROLOGY, 17.

Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged >= 75 Years A Randomized Clinical Trial
Williamson, J. D., Supiano, M. A., Applegate, W. B., Berlowitz, D. R., Campbell, R. C., Chertow, G. M., … Pajewski, N. M. (2016). Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged >= 75 Years A Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 315(24), 2673–82.

Long-Term Effects of Frequent In-Center Hemodialysis
Chertow, G. M., Levin, N. W., Beck, G. J., Daugirdas, J. T., Eggers, P. W., Kliger, A. S., … Greene, T. (2016). Long-Term Effects of Frequent In-Center Hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 27(6), 1830–36.

The win ratio approach to analyzing composite outcomes: An application to the EVOLVE trial
Abdalla, S., Montez-Rath, M. E., Parfrey, P. S., & Chertow, G. M. (2016). The win ratio approach to analyzing composite outcomes: An application to the EVOLVE trial. CONTEMPORARY CLINICAL TRIALS, 48, 119–24.

Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT)
Thomas, H. N., Evans, G. W., Berlowitz, D. R., Chertow, G. M., Conroy, M. B., Foy, C. G., … Hess, R. (2016). Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT). JOURNAL OF HYPERTENSION, 34(6), 1224–31.

How to Diagnose Solutions to a Quality of Care Problem
Harel, Z., Silver, S. A., McQuillan, R. F., Weizman, A. V., Thomas, A., Chertow, G. M., … Bell, C. M. (2016). How to Diagnose Solutions to a Quality of Care Problem. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 11(5), 901–7.

Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial
Pajewski, N. M., Williamson, J. D., Applegate, W. B., Berlowitz, D. R., Bolin, L. P., Chertow, G. M., … Supiano, M. A. (2016). Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 71(5), 649–55.

The effect of frequent hemodialysis on self-reported sleep quality: Frequent Hemodialysis Network Trials.
Unruh, M. L., Larive, B., Eggers, P. W., Garg, A. X., Gassman, J. J., Finkelstein, F. O., … Chertow, G. M. (2016). The effect of frequent hemodialysis on self-reported sleep quality: Frequent Hemodialysis Network Trials. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 31(6), 984–91.

How to Begin a Quality Improvement Project
Silver, S. A., Harel, Z., McQuillan, R., Weizman, A. V., Thomas, A., Chertow, G. M., … Chan, C. T. (2016). How to Begin a Quality Improvement Project. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 11(5), 893–900.

How to Measure and Interpret Quality Improvement Data
McQuillan, R. F., Silver, S. A., Harel, Z., Weizman, A., Thomas, A., Bell, C., … Nesrallah, G. (2016). How to Measure and Interpret Quality Improvement Data. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 11(5), 908–14.

How to Sustain Change and Support Continuous Quality Improvement
Silver, S. A., McQuillan, R., Harel, Z., Weizman, A. V., Thomas, A., Nesrallah, G., … Chertow, G. M. (2016). How to Sustain Change and Support Continuous Quality Improvement. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 11(5), 916–24.

Declining Rates of Inpatient Parathyroidectomy for Primary Hyperparathyroidism in the US.
Kim, S. M., Shu, A. D., Long, J., Montez-Rath, M. E., Leonard, M. B., Norton, J. A., & Chertow, G. M. (2016). Declining Rates of Inpatient Parathyroidectomy for Primary Hyperparathyroidism in the US. PloS One, 11(8).

Sex differences in obesity, dietary habits, and physical activity among urban middle-class Bangladeshis.
Saquib, J., Saquib, N., Stefanick, M. L., Khanam, M. A., Anand, S., Rahman, M., … Cullen, M. R. (2016). Sex differences in obesity, dietary habits, and physical activity among urban middle-class Bangladeshis. International Journal of Health Sciences, 10(3), 363–72.

Trends in Acute Kidney Injury, Associated Use of Dialysis, and Mortality After Cardiac Surgery, 1999 to 2008
Lenihan, C. R., Montez-Rath, M. E., Mangano, C. T. M., Chertow, G. M., & Winkelmayer, W. C. (2013). Trends in Acute Kidney Injury, Associated Use of Dialysis, and Mortality After Cardiac Surgery, 1999 to 2008. ANNALS OF THORACIC SURGERY, 95(1), 20–28.

The elderly patients on hemodialysis
Anand, S., Tamura, M. K., & Chertow, G. M. (2010). The elderly patients on hemodialysis. MINERVA UROLOGICA E NEFROLOGICA, 62(1), 87–101.

Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?
Mendoza, J. M., Sun, S., Chertow, G. M., Moran, J., Doss, S., & Schiller, B. (2011). Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach? NEPHROLOGY DIALYSIS TRANSPLANTATION, 26(4), 1281–87.

Analyzing Health-Related Quality of Life in the EVOLVE Trial: The Joint Impact of Treatment and Clinical Events.
Briggs, A. H., Parfrey, P. S., Khan, N., Tseng, S., Dehmel, B., Kubo, Y., … Belozeroff, V. (2016). Analyzing Health-Related Quality of Life in the EVOLVE Trial: The Joint Impact of Treatment and Clinical Events. Medical Decision Making , 36(8), 965–72.

Vitamin D Deficiency and Mortality in Patients Receiving Dialysis: The Comprehensive Dialysis Study
Anand, S., Chertow, G. M., Johansen, K. L., Grimes, B., Dalrymple, L. S., Kaysen, G. A., & Tamura, M. K. (2013). Vitamin D Deficiency and Mortality in Patients Receiving Dialysis: The Comprehensive Dialysis Study. JOURNAL OF RENAL NUTRITION, 23(6), 422–27.

Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)
de Zeeuw, D., Akizawa, T., Agarwal, R., Audhya, P., Bakrise, G. L., Chin, M., … Chertow, G. M. (2013). Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON). AMERICAN JOURNAL OF NEPHROLOGY, 37(3), 212–22.

Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial
Moe, S. M., Abdalla, S., Chertow, G. M., Parfrey, P. S., Block, G. A., Correa-Rotter, R., … Drueeke, T. B. (2015). Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 26(6), 1466–75.

Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind?
Leppert, J. T., Mittakanti, H. R., Thomas, I.-C., Lamberts, R. W., Sonn, G. A., Chung, B. I., … Brooks, J. D. (2016). Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind? Urology.

Hip Fracture in Patients With Non-Dialysis-Requiring Chronic Kidney Disease.
Kim, S. M., Long, J., Montez-Rath, M., Leonard, M., & Chertow, G. M. (2016). Hip Fracture in Patients With Non-Dialysis-Requiring Chronic Kidney Disease. Journal of Bone and Mineral Research , 31(10), 1803–9.

Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform
Chertow, G. M., Liu, J., Monde, K. L., Gilbertson, D. T., Brookhart, M. A., Beaubrun, A. C., … Collins, A. J. (2016). Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 27(10), 3129–38.

Results of human factors testing in a novel Hemodialysis system designed for ease of patient use
Wilcox, S. B., Carver, M., Yau, M., Sneeringer, P., Prichard, S., Alvarez, L., & Chertow, G. M. (2016). Results of human factors testing in a novel Hemodialysis system designed for ease of patient use. HEMODIALYSIS INTERNATIONAL, 20(4), 643–49.

Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions
Rocco, M. V., Chapman, A., Chertow, G. M., Cohen, D., Chen, J., Cutler, J. A., … Yee, J. (2016). Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions. AMERICAN JOURNAL OF NEPHROLOGY, 44(2), 130–40.

Effects of Physician Payment Reform on Provision of Home Dialysis
Erickson, K. F., Winkelmayer, W. C., Chertow, G. M., & Bhattacharya, J. (2016). Effects of Physician Payment Reform on Provision of Home Dialysis. AMERICAN JOURNAL OF MANAGED CARE, 22(6), E215-?

Medicare Reimbursement Reform for Provider Visits and Health Outcomes in Patients on Hemodialysis.
Erickson, K. F., Winkelmayer, W. C., Chertow, G. M., & Bhattacharya, J. (2014). Medicare Reimbursement Reform for Provider Visits and Health Outcomes in Patients on Hemodialysis. Forum for Health Economics & Policy, 17(1), 53–77.

Re-evaluation of re-hospitalization and rehabilitation in renal research.
Lin, E., Kurella Tamura, M., Montez-Rath, M. E., & Chertow, G. M. (2016). Re-evaluation of re-hospitalization and rehabilitation in renal research. Hemodialysis International. International Symposium on Home Hemodialysis.

Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis.
Lo, J. C., Beck, G. J., Kaysen, G. A., Chan, C. T., Kliger, A. S., Rocco, M. V., & Chertow, G. M. (2016). Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis. Hemodialysis International. International Symposium on Home Hemodialysis.

30-Day Readmissions after an Acute Kidney Injury Hospitalization.
Silver, S. A., Harel, Z., McArthur, E., Nash, D. M., Acedillo, R., Kitchlu, A., … Wald, R. (2016). 30-Day Readmissions after an Acute Kidney Injury Hospitalization. American Journal of Medicine.

30-Day Readmissions After an Acute Kidney Injury Hospitalization
Silver, S. A., Harel, Z., McArthur, E., Nash, D. M., Acedillo, R., Kitchlu, A., … Wald, R. (2017). 30-Day Readmissions After an Acute Kidney Injury Hospitalization. AMERICAN JOURNAL OF MEDICINE, 130(2), 163-?

Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism Two Randomized Clinical Trials
Block, G. A., Bushinsky, D. A., Cunningham, J., Drueke, T. B., Ketteler, M., Kewalramani, R., … Chertow, G. M. (2017). Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism Two Randomized Clinical Trials. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 317(2), 146–55.

Can twice weekly hemodialysis expand patient access under resource constraints?
Savla, D., Chertow, G. M., Meyer, T., & Anand, S. (2016). Can twice weekly hemodialysis expand patient access under resource constraints? Hemodialysis International. International Symposium on Home Hemodialysis.

Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.
Sirich, T. L., Fong, K., Larive, B., Beck, G. J., Chertow, G. M., Levin, N. W., … Meyer, T. W. (2017). Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial. Kidney International.

Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial
Pasch, A., Block, G. A., Bachtler, M., Smith, E. R., Jahnen-Dechent, W., Arampatzis, S., … Floege, J. (2017). Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 12(2), 315–22.

Estimating the Risk of Radiocontrast-Associated Nephropathy
Wilhelm-Leen, E., Montez-Rath, M. E., & Chertow, G. (2017). Estimating the Risk of Radiocontrast-Associated Nephropathy. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 28(2), 653–59.

Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform
Erickson, K. F., Winkelmayer, W. C., Chertow, G. M., & Bhattacharya, J. (2017). Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform. AMERICAN JOURNAL OF KIDNEY DISEASES, 69(2), 237–46.

Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism A Randomized Clinical Trial
Block, G. A., Bushinsky, D. A., Cheng, S., Cunningham, J., Dehmel, B., Drueke, T. B., … Chertow, G. M. (2017). Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism A Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 317(2), 156–64.

Cost of Acute Kidney Injury in Hospitalized Patients.
Silver, S. A., Long, J., Zheng, Y., & Chertow, G. M. (2017). Cost of Acute Kidney Injury in Hospitalized Patients. Journal of Hospital Medicine, 12(2), 70–76.

Metabolic Profiling of Impaired Cognitive Function in Patients Receiving Dialysis
Tamura, M. K., Chertow, G. M., Depner, T. A., Nissenson, A. R., Schiller, B., Mehta, R. L., … Sirich, T. L. (2016). Metabolic Profiling of Impaired Cognitive Function in Patients Receiving Dialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 27(12), 3780–87.

Predialysis volume overload and patient-reported sleep duration and quality in patients receiving hemodialysis.
Abreo, A. P., Dalrymple, L. S., Chertow, G. M., Kaysen, G. A., Herzog, C. A., & Johansen, K. L. (2017). Predialysis volume overload and patient-reported sleep duration and quality in patients receiving hemodialysis. Hemodialysis International. International Symposium on Home Hemodialysis, 21(1), 133–41.

Introduction of Biosimilar Therapeutics Into Nephrology Practice in the United States: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
Wish, J. B., Charytan, C., Chertow, G. M., Kalantar-Zadeh, K., Kliger, A. S., Rubin, R. J., … Fishbane, S. (2016). Introduction of Biosimilar Therapeutics Into Nephrology Practice in the United States: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. AMERICAN JOURNAL OF KIDNEY DISEASES, 68(6), 843–52.

Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis.
Garg, A. X., Suri, R. S., Eggers, P., Finkelstein, F. O., Greene, T., Kimmel, P. L., … Chertow, G. M. (2017). Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis. Kidney International, 91(3), 746–54.

Sarcopenia among patients receiving hemodialysis: weighing the evidence.
Kittiskulnam, P., Carrero, J. J., Chertow, G. M., Kaysen, G. A., Delgado, C., & Johansen, K. L. (2017). Sarcopenia among patients receiving hemodialysis: weighing the evidence. Journal of Cachexia, Sarcopenia and Muscle, 8(1), 57–68.

Prehabilitation for Kidney Transplant Candidates: Is it Time?
Cheng, X. S., Myers, J. N., Chertow, G. M., Rabkin, R., Chan, K. N., Chen, Y., & Tan, J. C. (2017). Prehabilitation for Kidney Transplant Candidates: Is it Time? Clinical Transplantation.

Home Dialysis in the Prospective Payment System Era.
Lin, E., Cheng, X. S., Chin, K.-K., Zubair, T., Chertow, G. M., Bendavid, E., & Bhattacharya, J. (2017). Home Dialysis in the Prospective Payment System Era. Journal of the American Society of Nephrology .

Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation
Cheng, X. S., Stedman, M. R., Chertow, G. M., Kim, W. R., & Tan, J. C. (2017). Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation. TRANSPLANTATION, 101(5), 1111–19.

Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind?
Leppert, J. T., Mittakanti, H. R., Thomas, I.-C., Lamberts, R. W., Sonn, G. A., Chung, B. I., … Brooks, J. D. (2017). Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind? UROLOGY, 100, 65–71.

Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis
Lo, J. C., Beck, G. J., Kaysen, G. A., Chan, C. T., Kliger, A. S., Rocco, M. V., & Chertow, G. M. (2017). Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis. HEMODIALYSIS INTERNATIONAL, 21(2), 190–96.

Prevalence of chronic kidney disease and risk factors for its progression: A cross-sectional comparison of Indians living in Indian versus US cities
Anand, S., Kondal, D., Montez-Rath, M., Zheng, Y., Shivashankar, R., Singh, K., … Kanaya, A. M. (2017). Prevalence of chronic kidney disease and risk factors for its progression: A cross-sectional comparison of Indians living in Indian versus US cities. PLOS ONE, 12(3).

HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes
Krishnan, S., Shimoda, M., Sacchi, R., Kailemia, M. J., Luxardi, G., Kaysen, G. A., … Zivkovic, A. M. (2017). HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes. SCIENTIFIC REPORTS, 7.

Consolidation in the Dialysis Industry, Patient Choice, and Local Market Competition
Erickson, K. F., Zheng, Y., Winkelmayer, W. C., Ho, V., Bhattacharya, J., & Chertow, G. M. (2017). Consolidation in the Dialysis Industry, Patient Choice, and Local Market Competition. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 12(3), 536–45.

Thyroid function in end stage renal disease and effects of frequent hemodialysis.
Lo, J. C., Beck, G. J., Kaysen, G. A., Chan, C. T., Kliger, A. S., Rocco, M. V., … Chertow, G. M. (2017). Thyroid function in end stage renal disease and effects of frequent hemodialysis. Hemodialysis International. International Symposium on Home Hemodialysis.

Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis.
Kittiskulnam, P., Chertow, G. M., Carrero, J. J., Delgado, C., Kaysen, G. A., & Johansen, K. L. (2017). Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis. Kidney International.

Factors Associated with Frailty and Its Trajectory among Patients on Hemodialysis.
Johansen, K. L., Dalrymple, L. S., Delgado, C., Chertow, G. M., Segal, M. R., Chiang, J., … Kaysen, G. A. (2017). Factors Associated with Frailty and Its Trajectory among Patients on Hemodialysis. Clinical Journal of the American Society of Nephrology .

The Pathogenesis of Ebola Virus Disease
Baseler, L., Chertow, D. S., Johnson, K. M., Feldmann, H., & Morens, D. M. (2017). The Pathogenesis of Ebola Virus Disease. ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 12, 12, 387–418.

Waste Informatics: Establishing Characteristics of Contemporary US Landfill Quantities and Practices
Powell, J. T., Pons, J. C., & Chertow, M. (2016). Waste Informatics: Establishing Characteristics of Contemporary US Landfill Quantities and Practices. ENVIRONMENTAL SCIENCE & TECHNOLOGY, 50(20), 10877–84.

BENIGN PLEURAL EFFUSIONS IN LONG-STANDING DIABETES-MELLITUS
Chertow, B. S., KADZIELAWA, R., & Burger, A. J. (1991). BENIGN PLEURAL EFFUSIONS IN LONG-STANDING DIABETES-MELLITUS. CHEST, 99(5), 1108–11.

Incident CKD after Radical or Partial Nephrectomy.
Leppert, J. T., Lamberts, R. W., Thomas, I.-C. C., Chung, B. I., Sonn, G. A., Skinner, E. C., … Brooks, J. D. (2017). Incident CKD after Radical or Partial Nephrectomy. Journal of the American Society of Nephrology : JASN.

Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine
Weisbord, S. D., Gallagher, M., Jneid, H., Garcia, S., Cass, A., Thwin, S.-S., … Palevsky, P. M. (2018). Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. NEW ENGLAND JOURNAL OF MEDICINE, 378(7), 603–14.

Population Reductions in Coronary Heart Disease Associated with Modest Decreases in Salt Intake: Projections from the CHD Policy Model
Bibbins-Domingo, K., Chertow, G., Moran, A., Coxson, P., & Goldman, L. (2009). Population Reductions in Coronary Heart Disease Associated with Modest Decreases in Salt Intake: Projections from the CHD Policy Model. CIRCULATION, 119(10), E294.

Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease EDITORIAL COMMENT
Bibbins-Domingo, K., Chertow, G. M., Coxson, P. G., Moran, A., Lightwood, J. M., Pletcher, M. J., & Goldman, L. (2010). Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease EDITORIAL COMMENT. OBSTETRICAL & GYNECOLOGICAL SURVEY, 65(7), 441–42.

Comparing Simultaneous Liver-Kidney Transplant Strategies: A Modified Cost-Effectiveness Analysis.
Cheng, X. S., Kim, W. R., Tan, J. C., Chertow, G. M., & Goldhaber-Fiebert, J. (2018). Comparing Simultaneous Liver-Kidney Transplant Strategies: A Modified Cost-Effectiveness Analysis. Transplantation.

Unplanned Emergency Department Visits and Hospital Admissions Following Ureteroscopy: Do Ureteral Stents Make a Difference?
Mittakanti, H. R., Conti, S. L., Pao, A. C., Chertow, G. M., Liao, J. C., Leppert, J. T., & Elliott, C. S. (2018). Unplanned Emergency Department Visits and Hospital Admissions Following Ureteroscopy: Do Ureteral Stents Make a Difference? Urology.

Lowering Blood Pressure to Lower the Risk of Cardiovascular Events in CKD
Chang, T. I., Owens, D. K., & Chertow, G. M. (2014). Lowering Blood Pressure to Lower the Risk of Cardiovascular Events in CKD. AMERICAN JOURNAL OF KIDNEY DISEASES, 63(6), 900–902.

Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD
Fung, E., Chang, T. I., Chertow, G. M., Thomas, I.-C., Asch, S. M., & Tamura, M. K. (2017). Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD. AMERICAN JOURNAL OF KIDNEY DISEASES, 70(5), 705–14.

FERRIC CITRATE REDUCES FIBROBLAST GROWTH FACTOR 23 LEVELS IN PATIENTS WITH MODERATE CHRONIC KIDNEY DISEASE
Block, G., Chertow, G., Fishbane, S., Rodriguez, M., Chen, M., Shemesh, S., … Wolf, M. (2014). FERRIC CITRATE REDUCES FIBROBLAST GROWTH FACTOR 23 LEVELS IN PATIENTS WITH MODERATE CHRONIC KIDNEY DISEASE. NEPHROLOGY DIALYSIS TRANSPLANTATION. OXFORD UNIV PRESS.

Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
Johnson, R. J., Bakris, G. L., Borghi, C., Chonchol, M. B., Feldman, D., Lanaspa, M. A., … Chertow, G. M. (2018). Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. AMERICAN JOURNAL OF KIDNEY DISEASES, 71(6), 851–65.

Antihypertensive medication withholding practices in hemodialysis: A survey study of patients and providers.
Haase, S. B., Chang, S., Schiller, B., Chertow, G. M., & Chang, T. I. (2018). Antihypertensive medication withholding practices in hemodialysis: A survey study of patients and providers. Hemodialysis International. International Symposium on Home Hemodialysis.

Declining Rates of Hip Fracture in End-Stage Renal Disease: Analysis From the 2003-2011 Nationwide Inpatient Sample
Kim, S. M., Liu, S., Long, J., Montez-Rath, M. E., Leonard, M. B., & Chertow, G. M. (2017). Declining Rates of Hip Fracture in End-Stage Renal Disease: Analysis From the 2003-2011 Nationwide Inpatient Sample. JOURNAL OF BONE AND MINERAL RESEARCH, 32(11), 2297–2303.

Dialysis versus Medical Management at Different Ages and Levels of Kidney Function in Veterans with Advanced CKD.
Kurella Tamura, M., Desai, M., Kapphahn, K. I., Thomas, I.-C., Asch, S. M., & Chertow, G. M. (2018). Dialysis versus Medical Management at Different Ages and Levels of Kidney Function in Veterans with Advanced CKD. Journal of the American Society of Nephrology : JASN.

Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis
Kaysen, G. A., Grimes, B., Dalrymple, L. S., Chertow, G. M., Ishida, J. H., Delgado, C., … Johansen, K. L. (2018). Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis. JOURNAL OF CLINICAL LIPIDOLOGY, 12(2), 481–87.

Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery
Swaminathan, M., Stafford-Smith, M., Chertow, G. M., Warnock, D. G., Paragamian, V., Brenner, R. M., … Mazer, C. D. (2018). Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 29(1), 260–67.

Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial
Still, C. H., Rodriguez, C. J., Wright, J. T., Craven, T. E., Bress, A. P., Chertow, G. M., … Wall, B. M. (2018). Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial. AMERICAN JOURNAL OF HYPERTENSION, 31(1), 97–107.

Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease
Chertow, G. M., Block, G. A., Neylan, J. F., Pergola, P. E., Uhlig, K., & Fishbane, S. (2017). Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease. PLOS ONE, 12(11), e0188712.

Chronic kidney disease care models in low- and middle-income countries: a systematic review
Stanifer, J. W., Von Isenburg, M., Chertow, G. M., & Anand, S. (2018). Chronic kidney disease care models in low- and middle-income countries: a systematic review. BMJ GLOBAL HEALTH, 3(2), e000728.

Causes of Death after a Hospitalization with AKI
Silver, S. A., Harel, Z., McArthur, E., Nash, D. M., Acedillo, R., Kitchlu, A., … Wald, R. (2018). Causes of Death after a Hospitalization with AKI. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 29(3), 1001–10.

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
Adkinson, N. F., Strauss, W. E., Macdougall, I. C., Bernard, K. E., Auerbach, M., Kaper, R. F., … Krop, J. S. (2018). Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial. AMERICAN JOURNAL OF HEMATOLOGY, 93(5), 683–90.

Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study
Lin, E., Chertow, G. M., Yan, B., Malcolm, E., & Goldhaber-Fiebert, J. D. (2018). Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study. PLOS MEDICINE, 15(3), e1002532.

Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)
Rocco, M. V., Sink, K. M., Lovato, L. C., Wolfgram, D. F., Wiegmann, T. B., Wall, B. M., … Chertow, G. M. (2018). Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT). AMERICAN JOURNAL OF KIDNEY DISEASES, 71(3), 352–61.

Associations of Body Mass Index and Body Fat With Markers of Inflammation and Nutrition Among Patients Receiving Hemodialysis
Delgado, C., Chertow, G. M., Kaysen, G. A., Dalrymple, L. S., Kornak, J., Grimes, B., & Johansen, K. L. (2017). Associations of Body Mass Index and Body Fat With Markers of Inflammation and Nutrition Among Patients Receiving Hemodialysis. AMERICAN JOURNAL OF KIDNEY DISEASES, 70(6), 817–25.

Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial
Floege, J., Tsirtsonis, K., Iles, J., Drueke, T. B., Chertow, G. M., & Parfrey, P. (2018). Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial. KIDNEY INTERNATIONAL, 93(6), 1475–82.

Dosing of Etelcalcetide and Cinacalcet for Secondary Hyperparathyroidism Reply
Block, G. A., & Chertow, G. M. (2017). Dosing of Etelcalcetide and Cinacalcet for Secondary Hyperparathyroidism Reply. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 317(20), 2132–33.

Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control
Beddhu, S., Chertow, G. M., Cheung, A. K., Cushman, W. C., Rahman, M., Greene, T., … Whelton, P. K. (2018). Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control. CIRCULATION, 137(2), 134–43.

Perioperative THR-184 and AKI after Cardiac Surgery
Himmelfarb, J., Chertow, G. M., McCullough, P. A., Mesana, T., Shaw, A. D., Sundt, T. M., … Tardif, J.-C. (2018). Perioperative THR-184 and AKI after Cardiac Surgery. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 29(2), 670–79.

Do attributes of persons with chronic kidney disease differ in low-income and middle-income countries compared with high-income countries? Evidence from population-based data in six countries
Anand, S., Zheng, Y., Montez-Rath, M. E., Wei, W. J., Perico, N., Carminati, S., … Chertow, G. M. (2017). Do attributes of persons with chronic kidney disease differ in low-income and middle-income countries compared with high-income countries? Evidence from population-based data in six countries. BMJ GLOBAL HEALTH, 2(4), e000453.

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
Chin, M. P., Bakris, G. L., Block, G. A., Chertow, G. M., Goldsberry, A., Inker, L. A., … Meyer, C. J. (2018). Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study. AMERICAN JOURNAL OF NEPHROLOGY, 47(1), 40–47.

Infrequent Provision of Palliative Care to Patients with Dialysis-Requiring AKI
Chong, K., Silver, S. A., Long, J., Zheng, Y., Pankratz, V. S., Unruh, M. L., & Chertow, G. M. (2017). Infrequent Provision of Palliative Care to Patients with Dialysis-Requiring AKI. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 12(11), 1744–52.

The Economic Consequences of Acute Kidney Injury
Silver, S. A., & Chertow, G. M. (2017). The Economic Consequences of Acute Kidney Injury. NEPHRON, 137(4), 297–301.

Updated guidelines for the diagnosis and management of high blood pressure: implications for clinical practice in nephrology
Wyatt, C. M., & Chertow, G. M. (2018). Updated guidelines for the diagnosis and management of high blood pressure: implications for clinical practice in nephrology. KIDNEY INTERNATIONAL, 93(4), 768–70.

Acute Kidney Injury Due to Diarrheal Illness Requiring Hospitalization: Data from the National Inpatient Sample.
Bradshaw, C., Zheng, Y., Silver, S. A., Chertow, G. M., Long, J., & Anand, S. (2018). Acute Kidney Injury Due to Diarrheal Illness Requiring Hospitalization: Data from the National Inpatient Sample. Journal of General Internal Medicine.

EFFECT OF BARDOXOLONE METHYL TREATMENT ON URINARY ALBUMIN IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE - POST-HOC ANALYSIS FROM BEAM AND BEACON
Rossing, P., Block, G., Chertow, G., Chin, M., Goldsberry, A., McCullough, P., … Pergola, P. (2018). EFFECT OF BARDOXOLONE METHYL TREATMENT ON URINARY ALBUMIN IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE - POST-HOC ANALYSIS FROM BEAM AND BEACON. NEPHROLOGY DIALYSIS TRANSPLANTATION, 33.

BASELINE LEVELS OF FGF23 AND EFFECTS OF ETELCALCETIDE
Vervloet, M., Cooper, K., Block, G., Chertow, G., Fouqueray, B., Moe, S., … Oberbauer, R. (2018). BASELINE LEVELS OF FGF23 AND EFFECTS OF ETELCALCETIDE. NEPHROLOGY DIALYSIS TRANSPLANTATION, 33.

Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemia
Pergola, P. E., Fishbane, S., LeWinter, R. D., Neylan, J. F., Uhlig, K., Block, G. A., & Chertow, G. M. (2018). Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemia. AMERICAN JOURNAL OF HEMATOLOGY, 93(6), E154–E156.

BARDOXOLONE METHYL PREVENTS EGFR DECLINE IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 4 AND TYPE 2 DIABETES - POST-HOC ANALYSES FROM BEACON
Wanner, C., Bakris, G., Block, G., Chin, M., Goldsberry, A., Inker, L., … Chertow, G. (2018). BARDOXOLONE METHYL PREVENTS EGFR DECLINE IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 4 AND TYPE 2 DIABETES - POST-HOC ANALYSES FROM BEACON. NEPHROLOGY DIALYSIS TRANSPLANTATION, 33.

Response by Beddhu et al to Letters Regarding Article, "Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control"
Beddhu, S., Chertow, G. M., Cheung, A. K., Cushman, W. C., Greene, T., Wei, G., … Whelton, P. K. (2018). Response by Beddhu et al to Letters Regarding Article, "Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control". CIRCULATION, 137(24), 2668–69.

DECREASES IN WEIGHT WITH BARDOXOLONE METHYL IN OBESE PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 4 AND TYPE 2 DIABETES - POST-HOC ANALYSES FROM BEACON
Rossing, P., Appel, G., Block, G., Chertow, G., Chin, M., Coyne, D., … Raskin, P. (2018). DECREASES IN WEIGHT WITH BARDOXOLONE METHYL IN OBESE PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 4 AND TYPE 2 DIABETES - POST-HOC ANALYSES FROM BEACON. NEPHROLOGY DIALYSIS TRANSPLANTATION, 33.

Benefits and risks of intensive blood-pressure lowering in advanced chronic kidney disease
Cheung, A. K., Chertow, G. M., Greene, T., Kimmel, P. L., Rahman, M., Reboussin, D., & Rocco, M. (2018). Benefits and risks of intensive blood-pressure lowering in advanced chronic kidney disease. JOURNAL OF INTERNAL MEDICINE, 284(1), 106–7.

Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials
Beddhu, S., Greene, T., Boucher, R., Cushman, W. C., Wei, G., Stoddard, G., … Chertow, G. M. (2018). Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials. LANCET DIABETES & ENDOCRINOLOGY, 6(7), 555–63.

Mandating Staffing Ratios in Hemodialysis Facilities California SB 349 and Unintended Consequences
Rastogi, A., & Chertow, G. M. (2018). Mandating Staffing Ratios in Hemodialysis Facilities California SB 349 and Unintended Consequences. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13(7), 1110–12.

Risk-benefit profile of intensive blood pressure treatment reply
Beddhu, S., Greene, T., Boucher, R., Cushman, W. C., Wei, G., Cheung, A. K., … Chertow, G. M. (2018). Risk-benefit profile of intensive blood pressure treatment reply. LANCET DIABETES & ENDOCRINOLOGY, 6(8), 602.

Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis
Lozano-Ortega, G., Waser, N., Bensink, M. E., Goring, S., Bennett, H., Block, G. A., … Belozeroff, V. (2018). Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 7(7), 693–707.

Use of novel oral anticoagulants in patients with end-stage renal disease
Winkelmayer, W. C., Herzog, C. A., Montez-Rath, M. E., Chang, T. I., & Chertow, G. M. (2015). Use of novel oral anticoagulants in patients with end-stage renal disease. HEMODIALYSIS INTERNATIONAL, 19(1), 150–53.

Use of Estimating Equations for Dosing Antimicrobials in Patients with Acute Kidney Injury Not Receiving Renal Replacement Therapy
Awdishu, L., Connor, A. I., Bouchard, J., Macedo, E., Chertow, G. M., & Mehta, R. L. (2018). Use of Estimating Equations for Dosing Antimicrobials in Patients with Acute Kidney Injury Not Receiving Renal Replacement Therapy. JOURNAL OF CLINICAL MEDICINE, 7(8).

Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System.
Brady, B. M., Zhao, B., Niu, J., Winkelmayer, W. C., Milstein, A., Chertow, G. M., & Erickson, K. F. (2018). Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System. JAMA Internal Medicine.

Small increases in serum magnesium levels by dapagliflozin and normalisation of hypomagnesaemia in patients with type 2 diabetes
Toto, R., Goldenberg, R., Chertow, G. M., Cain, V., Stefansson, B. V., Sjostrom, C. D., & Sartipy, P. (2018). Small increases in serum magnesium levels by dapagliflozin and normalisation of hypomagnesaemia in patients with type 2 diabetes. DIABETOLOGIA, 61, S316.

Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.
Chertow, G. M., Appel, G. B., Block, G. A., Chin, M. P., Coyne, D. W., Goldsberry, A., … Rossing, P. (2018). Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease. Journal of Diabetes and Its Complications.

Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants
Supiano, M. A., Lovato, L., Ambrosius, W. T., Bates, J., Beddhu, S., Drawz, P., … Chonchol, M. (2018). Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants. PLOS ONE, 13(9), e0203305.

A response by Strauss et al. to "a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia"
Strauss, W. E., Adkinson, N. F., Macdougall, I. C., Auerbach, M., Kaper, R. F., Chertow, G. M., & Krop, J. S. (2018). A response by Strauss et al. to "a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia". AMERICAN JOURNAL OF HEMATOLOGY, 93(9), E232–E233.

Donation, Not Disease! A Multiple-Hit Hypothesis on Development of Post-Donation Kidney Disease.
Cheng, X. S., Glassock, R. J., Lentine, K. L., Chertow, G. M., & Tan, J. C. (2017). Donation, Not Disease! A Multiple-Hit Hypothesis on Development of Post-Donation Kidney Disease. Current Transplantation Reports, 4(4), 320–26.

Payer Type, Race/Ethnicity, and the Timing of Surgical Management of Urinary Stone Disease.
Brubaker, W. D., Dallas, K., Elliott, C. S., Pao, A. C., Chertow, G., Leppert, J. T., & Conti, S. L. (2018). Payer Type, Race/Ethnicity, and the Timing of Surgical Management of Urinary Stone Disease. Journal of Endourology.

Planning for Hemodialysis
Isom, R. T., & Chertow, G. M. (2015). Planning for Hemodialysis. CHRONIC RENAL DISEASE, 751–64.

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
Beddhu, S., Chertow, G. M., Greene, T., Whelton, P. K., Ambrosius, W. T., Cheung, A. K., … Cushman, W. C. (2018). Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT. Journal of the American Heart Association, 7(18), e009326.

Bioelectrical Impedance Analysis Measures and Clinical Outcomes in CKD
Bansal, N., Zelnick, L. R., Himmelfarb, J., & Chertow, G. M. (2018). Bioelectrical Impedance Analysis Measures and Clinical Outcomes in CKD. AMERICAN JOURNAL OF KIDNEY DISEASES, 72(5), 662–72.

Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses.
Block, G. A., Pergola, P. E., Fishbane, S., Martins, J. G., LeWinter, R. D., Uhlig, K., … Chertow, G. M. (2018). Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association.

PREOPERATIVE KIDNEY FUNCTION TRENDS: IMPROVING ESTIMATES OF BASELINE KIDNEY FUNCTION PRIOR TO KIDNEY CANCER SURGERY
Sun, A., Thomas, C., Ganesan, C., Sylman, J., Pao, A., Wagner, T., … Leppert, J. (2018). PREOPERATIVE KIDNEY FUNCTION TRENDS: IMPROVING ESTIMATES OF BASELINE KIDNEY FUNCTION PRIOR TO KIDNEY CANCER SURGERY. JOURNAL OF UROLOGY, 199(4), E362.

Prognostic relevance of visit-to-visit office blood pressure variability in Systolic Blood Pressure Intervention Trial: Same data, different conclusions?
Chang, T. I., Reboussin, D. M., Chertow, G. M., Cheung, A. K., Cushman, W. C., Kostis, W. J., … Papademetriou, V. (2018). Prognostic relevance of visit-to-visit office blood pressure variability in Systolic Blood Pressure Intervention Trial: Same data, different conclusions? Journal of Clinical Hypertension (Greenwich, Conn.), 20(11), 1644–45.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.
Ginsberg, C., Craven, T. E., Chonchol, M. B., Cheung, A. K., Sarnak, M. J., Ambrosius, W. T., … Shlipak, M. G. (2018). PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT. Clinical Journal of the American Society of Nephrology : CJASN.

Risk Factors, Incidence and Cost of Prolonged Hospitalization After Acute Respiratory Failure
Marmor, M., Liu, S., Long, J., Chertow, G., & Rogers, A. (2018). Risk Factors, Incidence and Cost of Prolonged Hospitalization After Acute Respiratory Failure. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197.

Would government compensation of living kidney donors exploit the poor? An empirical analysis.
Held, P. J., McCormick, F., Chertow, G. M., Peters, T. G., & Roberts, J. P. (2018). Would government compensation of living kidney donors exploit the poor? An empirical analysis. PloS One, 13(11), e0205655.

Randomized trial of intravenous iron-induced hypophosphatemia.
Wolf, M., Chertow, G. M., Macdougall, I. C., Kaper, R., Krop, J., & Strauss, W. (2018). Randomized trial of intravenous iron-induced hypophosphatemia. JCI Insight, 3(23).

The Terrible Toll of the Kidney Shortage
McCormick, F., Held, P. J., & Chertow, G. M. (2018). The Terrible Toll of the Kidney Shortage. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 29(12), 2775–76.

Ferumoxytol for the treatment of iron deficiency anemia
Auerbach, M., Chertow, G. M., & Rosner, M. (2018). Ferumoxytol for the treatment of iron deficiency anemia. EXPERT REVIEW OF HEMATOLOGY, 11(10), 829–34.

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design
Bangalore, S., Maron, D. J., Fleg, J. L., O'Brien, S. M., Herzog, C. A., Stone, G. W., … Hochman, J. S. (2018). International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design. AMERICAN HEART JOURNAL, 205, 42–52.

Market Competition and Health Outcomes in Heniodialysis
Erickson, K. F., Zheng, Y., Ho, V., Winkelmayer, W. C., Bhattacharya, J., & Chertow, G. M. (2018). Market Competition and Health Outcomes in Heniodialysis. HEALTH SERVICES RESEARCH, 53(5), 3680–3703.

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Mc Causland, F. R., Claggett, B., Burdmann, E. A., Chertow, G. M., Cooper, M. E., Eckardt, K.-U., … Pfeffer, M. A. (2018). Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation.

Prior Hospitalization Burden and the Relatedness of 30-Day Readmissions in Patients Receiving Hemodialysis.
Lin, E., Bhattacharya, J., & Chertow, G. M. (2019). Prior Hospitalization Burden and the Relatedness of 30-Day Readmissions in Patients Receiving Hemodialysis. Journal of the American Society of Nephrology : JASN.

Prospective Biopsy-Based Study of Chronic Kidney Disease of Unknown Etiology in Sri Lanka.
Anand, S., Montez-Rath, M. E., Adasooriya, D., Ratnatunga, N., Kambham, N., Wazil, A., … Nanayakkara, N. (2019). Prospective Biopsy-Based Study of Chronic Kidney Disease of Unknown Etiology in Sri Lanka. Clinical Journal of the American Society of Nephrology : CJASN.

Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis.
Schwantes-An, T.-H., Liu, S., Stedman, M., Decker, B. S., Wetherill, L., Edenberg, H. J., … Moe, S. M. (2019). Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis. American Journal of Nephrology, 49(2), 125–32.

Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with End-stage Kidney Disease Receiving Maintenance Hemodialysis.
Stubbs, J. R., Stedman, M. R., Liu, S., Long, J., Franchetti, Y., West, R. E., … Nolin, T. D. (2019). Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with End-stage Kidney Disease Receiving Maintenance Hemodialysis. Clinical Journal of the American Society of Nephrology : CJASN.

Market Consolidation and Mortality in Patients Initiating Hemodialysis.
Erickson, K. F., Winkelmayer, W. C., Ho, V., Bhattacharya, J., & Chertow, G. M. (2019). Market Consolidation and Mortality in Patients Initiating Hemodialysis. Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research, 22(1), 69–76.

Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population.
Gilbertson, D. T., Rothman, K. J., Chertow, G. M., Bradbury, B. D., Brookhart, M. A., Liu, J., … Wetmore, J. B. (2019). Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population. Journal of the American Society of Nephrology : JASN.

Differential Molecular Modeling Predictions of Mid and Conventional Dialysate Flows.
Leypoldt, J. K., Prichard, S., Chertow, G. M., & Alvarez, L. (2019). Differential Molecular Modeling Predictions of Mid and Conventional Dialysate Flows. Blood Purification, 1–8.

Chronic Kidney Disease and the Adiposity Paradox: Valid or Confounded?
Ziolkowski, S. L., Long, J., Baker, J. F., Chertow, G. M., & Leonard, M. B. (2019). Chronic Kidney Disease and the Adiposity Paradox: Valid or Confounded? Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation.

Relative sarcopenia and mortality and the modifying effects of chronic kidney disease and adiposity.
Ziolkowski, S. L., Long, J., Baker, J. F., Chertow, G. M., & Leonard, M. B. (2019). Relative sarcopenia and mortality and the modifying effects of chronic kidney disease and adiposity. Journal of Cachexia, Sarcopenia and Muscle.

Updates in Management and Timing of Dialysis in Acute Kidney Injury.
Yu, M. K., Kamal, F., & Chertow, G. M. (2019). Updates in Management and Timing of Dialysis in Acute Kidney Injury. Journal of Hospital Medicine, 14, E1–E7.

Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents
Haase, V. H., Chertow, G. M., Block, G. A., Pergola, P. E., deGoma, E. M., Khawaja, Z., … McCullough, P. A. (2019). Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents. NEPHROLOGY DIALYSIS TRANSPLANTATION, 34(1), 90–99.

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
Block, G. A., Rosenbaum, D. P., Yan, A., Greasley, P. J., Chertow, G. M., & Wolf, M. (2019). The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia. NEPHROLOGY DIALYSIS TRANSPLANTATION, 34(2), 339–46.

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism.
Bushinsky, D. A., Chertow, G. M., Cheng, S., Deng, H., Kopyt, N., Martin, K. J., … Block, G. A. (2019). One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association.

Treatment of metabolic acidosis with an intestinal binder.
Song, S., & Chertow, G. M. (2019). Treatment of metabolic acidosis with an intestinal binder. Lancet (London, England).

Paying for Hemodialysis in Kerala, India: A Description of Household Financial Hardship in the Context of Medical Subsidy
Bradshaw, C., Gracious, N., Narayanan, R., Narayanan, S., Safeer, M., Nair, G. M., … Anand, S. (2019). Paying for Hemodialysis in Kerala, India: A Description of Household Financial Hardship in the Context of Medical Subsidy. KIDNEY INTERNATIONAL REPORTS, 4(3), 390–98.

Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial.
Block, G. A., Rosenbaum, D. P., Yan, A., & Chertow, G. M. (2019). Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial. Journal of the American Society of Nephrology : JASN.

Hypertension Hot Potato - Anatomy of the Angiotensin-Receptor Blocker Recalls.
Byrd, J. B., Chertow, G. M., & Bhalla, V. (2019). Hypertension Hot Potato - Anatomy of the Angiotensin-Receptor Blocker Recalls. The New England Journal of Medicine.

An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism.
Block, G. A., Chertow, G. M., Sullivan, J. T., Deng, H., Mather, O., Tomlin, H., & Serenko, M. (2019). An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism. PloS One, 14(3), e0213774.

Giving supplemental fluid to older nursing home residents is safe but may not reduce under-hydration
Stotts, N. A., Hopf, H. W., Kayser-Jones, J., Chertow, G., Cooper, B. A., & Wu, H. S. (2008). Giving supplemental fluid to older nursing home residents is safe but may not reduce under-hydration. WOUND REPAIR AND REGENERATION, 16(2), A27.

Increased fluid alone does not increase hydroxyproline levels in older nursing home residents at-risk for pressure ulcers
Stotts, N. A., Hopf, H. W., Kayser-Jones, J., Chertow, G., Cooper, B. A., & Wu, H. S. (2008). Increased fluid alone does not increase hydroxyproline levels in older nursing home residents at-risk for pressure ulcers. WOUND REPAIR AND REGENERATION, 16(2), A26.

Frailty Among Patients Receiving Hemodialysis: Evolution of Components and Associations With Mortality.
Johansen, K. L., Delgado, C., Kaysen, G. A., Chertow, G. M., Chiang, J., Dalrymple, L. S., … Grimes, B. A. (2019). Frailty Among Patients Receiving Hemodialysis: Evolution of Components and Associations With Mortality. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 74(3), 380–86.

Low testosterone is associated with frailty, muscle wasting and physical dysfunction among men receiving hemodialysis: a longitudinal analysis.
Chiang, J. M., Kaysen, G. A., Segal, M., Chertow, G. M., Delgado, C., & Johansen, K. L. (2018). Low testosterone is associated with frailty, muscle wasting and physical dysfunction among men receiving hemodialysis: a longitudinal analysis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association.

Angiotensin-related genetic determinants of cardiovascular disease in patients undergoing hemodialysis.
Moe, S. M., Long, J., Schwantes-An, T.-H. L., Decker, B. S., Wetherill, L., Edenberg, H. J., … Chertow, G. M. (2018). Angiotensin-related genetic determinants of cardiovascular disease in patients undergoing hemodialysis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association.

IgA nephropathy: toward more specific diagnosis (and rescue of snails)
Floege, J. (2018). IgA nephropathy: toward more specific diagnosis (and rescue of snails). KIDNEY INTERNATIONAL, 93(3), 542–44.

Effectiveness of Quality Improvement Strategies for the Management of CKD A Meta-Analysis
Silver, S. A., Bell, C. M., Chertow, G. M., Shah, P. S., Shojania, K., Wald, R., & Harel, Z. (2017). Effectiveness of Quality Improvement Strategies for the Management of CKD A Meta-Analysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 12(10), 1601–14.

Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial)
Chang, T. I., Reboussin, D. M., Chertow, G. M., Cheung, A. K., Cushman, W. C., Kostis, W. J., … Papademetriou, V. (2017). Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial). HYPERTENSION, 70(4), 751-+.

Effects of Intensive BP Control in CKD
Cheung, A. K., Rahman, M., Reboussin, D. M., Craven, T. E., Greene, T., Kimmel, P. L., … Yee, J. (2017). Effects of Intensive BP Control in CKD. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 28(9), 2812–23.

Glycovariations in Key HDL-Associated Glycoproteins Differentiate Between Clinical Groups and Affect the Immunomodulatory Capacity of HDL
Zivkovic, A. M., Krishnan, S., Shimoda, M., Sacchi, R., Muchena, J. K., Luxardi, G., … Lebrilla, C. B. (2017). Glycovariations in Key HDL-Associated Glycoproteins Differentiate Between Clinical Groups and Affect the Immunomodulatory Capacity of HDL. FASEB JOURNAL, 31.

Calcium-Sensing Receptor Genotype and Response to Cinacalcet in Patients Undergoing Hemodialysis
Moe, S. M., Wetherill, L., Decker, B. S., Lai, D., Abdalla, S., Long, J., … Chertow, G. M. (2017). Calcium-Sensing Receptor Genotype and Response to Cinacalcet in Patients Undergoing Hemodialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 12(7), 1128–38.

Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis
Block, G. A., Rosenbaum, D. P., Leonsson-Zachrisson, M., Astrand, M., Johansson, S., Knutsson, M., … Chertow, G. M. (2017). Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 28(6), 1933–42.

Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
Fishbane, S., Block, G. A., Loram, L., Neylan, J., Pergola, P. E., Uhlig, K., & Chertow, G. M. (2017). Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 28(6), 1851–58.

Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis
Harel, Z., Chertow, G. M., Shah, P. S., Harel, S., Dorian, P., Yan, A. T., … Wald, R. (2017). Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis. CANADIAN JOURNAL OF CARDIOLOGY, 33(6), 737–46.

THE INNO(2)VATE PHASE 3 PROGRAM OF VADADUSTAT FOR TREATMENT OF ANEMIA IN DIALYSIS-DEPENDENT CKD: RATIONALE AND STUDY DESIGN
Winkelmayer, W., Block, G., Chertow, G., Fishbane, S., Komatsu, Y., McCullough, P., … Maroni, B. (2017). THE INNO(2)VATE PHASE 3 PROGRAM OF VADADUSTAT FOR TREATMENT OF ANEMIA IN DIALYSIS-DEPENDENT CKD: RATIONALE AND STUDY DESIGN. AMERICAN JOURNAL OF KIDNEY DISEASES, 69(4), A102.

FERRIC CITRATE INCREASES HEMOGLOBIN IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY ANEMIA.
Pergola, P. E., Fishbane, S., Neylan, J. F., Uhlig, K., & Chertow, G. M. (2017). FERRIC CITRATE INCREASES HEMOGLOBIN IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY ANEMIA. AMERICAN JOURNAL OF KIDNEY DISEASES, 69(4), A76.

ANALYSIS OF A SINGLE-ARM EXTENSION STUDY EVALUATING ETELCALETIDE STARTING DOSE FOR TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON HEMODIALYSIS
Cheng, S., Block, G., Dehmel, B., Deng, H., & Chertow, G. (2017). ANALYSIS OF A SINGLE-ARM EXTENSION STUDY EVALUATING ETELCALETIDE STARTING DOSE FOR TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON HEMODIALYSIS. AMERICAN JOURNAL OF KIDNEY DISEASES, 69(4), A34.

Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Model
Brunelli, S. M., Sibbel, S. P., Van Wyck, D., Sharma, A., Hsieh, A., & Chertow, G. M. (2017). Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Model. DRUGS IN R&D, 17(1), 159–66.

Potential Effects of Medicare Payment Policy Changes on Hospitalization-Based Outcomes Research
Beaubrun, A. C., Gilbertson, D. T., Chertow, G. M., Rothman, K. J., Winkelmayer, W. C., Monda, K. L., … Bradbury, B. D. (2016). Potential Effects of Medicare Payment Policy Changes on Hospitalization-Based Outcomes Research. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25, 143–44.

New Policies, New Sources of Error: Impact of Recent Medicare Policies on Database Research
Gilbertson, D. T., Liu, J., Beaubrun, A. C., Chertow, G. M., Rothman, K. J., Winkelmayer, W. C., … Bradbury, B. D. (2016). New Policies, New Sources of Error: Impact of Recent Medicare Policies on Database Research. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25, 144.

Clinical trials of intensive versus less intensive control of hypertension: HOPE or HYPE?
Wyatt, C. M., & Chertow, G. M. (2016). Clinical trials of intensive versus less intensive control of hypertension: HOPE or HYPE? KIDNEY INTERNATIONAL, 90(3), 460–65.

ONE YEAR EFFICACY AND SAFETY OF INTRAVENOUS (IV) ETELCALCETIDE (AMG 416) IN PATIENTS ON HEMODIALYSIS (HD) WITH SECONDARY HYPERPARATHYROIDISM (SHPT)
Bushinsky, D. A., Block, G. A., Cheng, S., Deng, H., Torres, P. U., Vervloet, M., & Chertow, G. M. (2016). ONE YEAR EFFICACY AND SAFETY OF INTRAVENOUS (IV) ETELCALCETIDE (AMG 416) IN PATIENTS ON HEMODIALYSIS (HD) WITH SECONDARY HYPERPARATHYROIDISM (SHPT). NEPHROLOGY DIALYSIS TRANSPLANTATION, 31, 13–14.

Early to Dialyze Healthy and Wise?
Chertow, G. M., & Winkelmayer, W. C. (2016). Early to Dialyze Healthy and Wise? JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 315(20), 2171–72.

ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials
Wyatt, C. M., Shineski, M., Chertow, G. M., & Bangalore, S. (2016). ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials. KIDNEY INTERNATIONAL, 89(6), 1178–79.

How to Use Quality Improvement Tools in Clinical Practice: A Primer for Nephrologists
Chan, C. T., Chertow, G. M., Nesrallah, G., & Bell, C. M. (2016). How to Use Quality Improvement Tools in Clinical Practice: A Primer for Nephrologists. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 11(5), 891–92.

Misclassification of Obesity by Body Mass Index Among Patients Receiving Hemodialysis
Kittiskulnam, P., Chertow, G. M., Kaysen, G. A., Delgado, C., Dalrymple, L. S., & Johansen, K. L. (2016). Misclassification of Obesity by Body Mass Index Among Patients Receiving Hemodialysis. AMERICAN JOURNAL OF KIDNEY DISEASES, 67(4), 709–11.

Ambulatory care after acute kidney injury: an opportunity to improve patient outcomes.
Silver, S. A., Goldstein, S. L., Harel, Z., Harvey, A., Rompies, E. J., Adhikari, N. K., … Wald, R. (2015). Ambulatory care after acute kidney injury: an opportunity to improve patient outcomes. Canadian Journal of Kidney Health and Disease, 2, 36.

AURYXIA (FERRIC CITRATE), AN ORAL IRON-BASED PHOSPHATE BINDER SIGNIFICANTLY IMPROVES SERUM IRON MEASURES IN PATIENTS WITH STAGE 3, 4 AND 5 CHRONIC KIDNEY DISEASE (CKD)
Fishbane, S., Block, G. A., Loram, L. C., & Chertow, G. M. (2015). AURYXIA (FERRIC CITRATE), AN ORAL IRON-BASED PHOSPHATE BINDER SIGNIFICANTLY IMPROVES SERUM IRON MEASURES IN PATIENTS WITH STAGE 3, 4 AND 5 CHRONIC KIDNEY DISEASE (CKD). AMERICAN JOURNAL OF KIDNEY DISEASES, 65(4), A35.

AURYXIA (FERRIC CITRATE) EFFECTIVELY REDUCES SERUM PHOSPHATE AND FIBROBLAST GROWTH FACTOR 23 (FGF23) LEVELS IN PATIENTS WITH STAGES 3-5 CHRONIC KIDNEY DISEASE (CKD)
Block, G. A., Chertow, G. M., Fishbane, S., Loram, L. C., & Wolf, M. (2015). AURYXIA (FERRIC CITRATE) EFFECTIVELY REDUCES SERUM PHOSPHATE AND FIBROBLAST GROWTH FACTOR 23 (FGF23) LEVELS IN PATIENTS WITH STAGES 3-5 CHRONIC KIDNEY DISEASE (CKD). AMERICAN JOURNAL OF KIDNEY DISEASES, 65(4), A23.

Nutrition in Kidney Disease Preface
Byham-Gray, L. D., Burrowes, J. D., & Chertow, G. M. (2014). Nutrition in Kidney Disease Preface. NUTRITION IN KIDNEY DISEASE, 2ND EDITION, IX-X.

THE RELATION BETWEEN ANTIHYPERTENSIVE MEDICATION AND SEXUAL FUNCTION IN WOMEN: BASELINE DATA FROM THE SPRINT STUDY
Thomas, H. N., Evans, G. W., Berlowitz, D., Bonds, D. E., Chertow, G. M., Conroy, M. B., … Hess, R. (2014). THE RELATION BETWEEN ANTIHYPERTENSIVE MEDICATION AND SEXUAL FUNCTION IN WOMEN: BASELINE DATA FROM THE SPRINT STUDY. JOURNAL OF GENERAL INTERNAL MEDICINE, 29, S231.

THE EFFECT OF CINACALCET ON ATHEROSCLEROTIC AND NON-ATHEROSCLEROTIC EVENTS IN HAEMODIALYSIS PATIENTS IN THE EVOLVE CLINICAL TRIAL
Wheeler, D. C., Abdalla, S., Chertow, G., Parfrey, P., & Herzog, C. (2014). THE EFFECT OF CINACALCET ON ATHEROSCLEROTIC AND NON-ATHEROSCLEROTIC EVENTS IN HAEMODIALYSIS PATIENTS IN THE EVOLVE CLINICAL TRIAL. NEPHROLOGY DIALYSIS TRANSPLANTATION, 29, 233.

A DOUBLE-BLIND PLACEBO CONTROLLED RANDOMIZED TRIAL OF FERRIC CITRATE COORDINATION COMPLEX FOR THE TREATMENT OF IRON-DEFICIENCY ANEMIA AND REDUCTION OF SERUM PHOSPHATE IN PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Block, G., Fishbane, S., Shemesh, S., Sharma, A., Wolf, M., & Chertow, G. (2014). A DOUBLE-BLIND PLACEBO CONTROLLED RANDOMIZED TRIAL OF FERRIC CITRATE COORDINATION COMPLEX FOR THE TREATMENT OF IRON-DEFICIENCY ANEMIA AND REDUCTION OF SERUM PHOSPHATE IN PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE. NEPHROLOGY DIALYSIS TRANSPLANTATION, 29, 151.

THE EFFECTS OF CINACALCET IN OLDER AND YOUNGER PATIENTS ON HEMODIALYSIS: THE EVOLVE TRIAL
Parfrey, P. S., Drueke, T., Block, G. A., Kubo, Y., & Chertow, G. M. (2014). THE EFFECTS OF CINACALCET IN OLDER AND YOUNGER PATIENTS ON HEMODIALYSIS: THE EVOLVE TRIAL. NEPHROLOGY DIALYSIS TRANSPLANTATION, 29, 47.

EFFECTS OF CINACALCET ON FRACTURE EVENTS IN PATIENTS RECEIVING HEMODIALYSIS: THE EVOLVE TRIAL
Drueke, T. B., Moe, S. M., Abdalla, S., Parfrey, P. S., & Chertow, G. M. (2014). EFFECTS OF CINACALCET ON FRACTURE EVENTS IN PATIENTS RECEIVING HEMODIALYSIS: THE EVOLVE TRIAL. NEPHROLOGY DIALYSIS TRANSPLANTATION, 29, 41.

LONG-TERM EFFECTS OF FREQUENT IN-CENTER HEMODIALYSIS: FHN DAILY TRIAL
Kliger, A. S., Chertow, G. M., Levin, N. W., Beck, G. J., Daugirdas, J. T., Eggers, P. W., … Greene, T. (2014). LONG-TERM EFFECTS OF FREQUENT IN-CENTER HEMODIALYSIS: FHN DAILY TRIAL. NEPHROLOGY DIALYSIS TRANSPLANTATION, 29, 37–38.

MORTALITY DURING EXTENDED FOLLOW-UP IN THE FREQUENT HEMODIALYSIS NETWORK NOCTURNAL TRIAL
Rocco, M., Daugirdas, J., Greene, T., Lockridge, R., Chan, C., Pierratos, A., … Grp, F. H. N. T. (2014). MORTALITY DURING EXTENDED FOLLOW-UP IN THE FREQUENT HEMODIALYSIS NETWORK NOCTURNAL TRIAL. NEPHROLOGY DIALYSIS TRANSPLANTATION, 29, 37.

Long-Term Safety and Efficacy of a Novel Iron-Containing Phosphate Binder, JTT-751, in Patients Receiving Hemodialysis
Yokoyama, K., Akiba, T., Fukagawa, M., Nakayama, M., Sawada, K., Kumagai, Y., … Hirakata, H. (2014). Long-Term Safety and Efficacy of a Novel Iron-Containing Phosphate Binder, JTT-751, in Patients Receiving Hemodialysis. JOURNAL OF RENAL NUTRITION, 24(4), 261–67.

ZERENEX (TM) (FERRIC CITRATE) FOR THE TREATMENT OF IRON-DEFICIENCY ANEMIA AND REDUCTION OF SERUM PHOSHATE IN NON-DIALYSIS DEPENDENT CKD
Block, G. A., Fishbane, S., Shemesh, S., Sharma, A., & Chertow, G. M. (2014). ZERENEX (TM) (FERRIC CITRATE) FOR THE TREATMENT OF IRON-DEFICIENCY ANEMIA AND REDUCTION OF SERUM PHOSHATE IN NON-DIALYSIS DEPENDENT CKD. AMERICAN JOURNAL OF KIDNEY DISEASES, 63(5), A118.

A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis
Yokoyama, K., Akiba, T., Fukagawa, M., Nakayama, M., Sawada, K., Kumagai, Y., … Hirakata, H. (2014). A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis. NEPHROLOGY DIALYSIS TRANSPLANTATION, 29(5), 1053–60.

A Pint of Sweat Will Save a Gallon of Blood A Call for Randomized Trials of Anticoagulation in End- Stage Renal Disease
Granger, C. B., & Chertow, G. M. (2014). A Pint of Sweat Will Save a Gallon of Blood A Call for Randomized Trials of Anticoagulation in End- Stage Renal Disease. CIRCULATION, 129(11), 1190–92.

Obesity Prevalence Soars among Urban Middle-class in Bangladesh
Saquib, J., Saquib, N., Anand, S., Khanam, M., Chertow, G., & Cullen, M. (2013). Obesity Prevalence Soars among Urban Middle-class in Bangladesh. CIRCULATION, 127(12).

DIABETIC SEVERITY AND RISK OF KIDNEY STONE DISEASE
Weinberg, A., Patel, C., Chertow, G., & Leppert, J. (2013). DIABETIC SEVERITY AND RISK OF KIDNEY STONE DISEASE. JOURNAL OF UROLOGY. ELSEVIER SCIENCE INC.

Cinacalcet for Cardiovascular Disease in Patients Undergoing Dialysis
Goldsmith, D. J., & Lamb, E. J. (2013). Cinacalcet for Cardiovascular Disease in Patients Undergoing Dialysis. NEW ENGLAND JOURNAL OF MEDICINE, 368(19), 1843.

Frequent versus Standard Hemodialysis REPLY
Chertow, G. M., Levin, N. W., & Kliger, A. S. (2011). Frequent versus Standard Hemodialysis REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 364(10), 976.

Bardoxolone Methyl in Type 2 Diabetes and Advanced Chronic Kidney Disease REPLY
Chertow, G. M., & de Zeeuw, D. (2014). Bardoxolone Methyl in Type 2 Diabetes and Advanced Chronic Kidney Disease REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 370(18), 1768.

Cinacalcet for Cardiovascular Disease in Patients Undergoing Dialysis
Locatelli, F., Pontoriero, G., & Tentori, F. (2013). Cinacalcet for Cardiovascular Disease in Patients Undergoing Dialysis. NEW ENGLAND JOURNAL OF MEDICINE, 368(19), 1843.

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J., Charytan, D. M., … Mahaffey, K. W. (2019). Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. The New England Journal of Medicine.

Paying for Hemodialysis in Kerala, India: A Description of Household Financial Hardship in the Context of Medical Subsidy.
Bradshaw, C., Gracious, N., Narayanan, R., Narayanan, S., Safeer, M., Nair, G. M., … Anand, S. (2019). Paying for Hemodialysis in Kerala, India: A Description of Household Financial Hardship in the Context of Medical Subsidy. Kidney International Reports, 4(3), 390–398.

Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Macdougall, I. C., Bircher, A. J., Eckardt, K.-U. U., Obrador, G. T., Pollock, C. A., Stenvinkel, P., … Chertow, G. M. (2016). Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. Kidney International, 89(1), 28–39.

Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT.
Chertow, G. M., Beddhu, S., Lewis, J. B., Toto, R. D., & Cheung, A. K. (2016). Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT. Journal of the American Society of Nephrology : JASN, 27(1), 40–3.

Risk prediction models for contrast induced nephropathy: systematic review.
Silver, S. A., Shah, P. M., Chertow, G. M., Harel, S., Wald, R., & Harel, Z. (2015). Risk prediction models for contrast induced nephropathy: systematic review. BMJ (Clinical Research Ed.), 351, h4395.

Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis.
Chang, T. I., Flythe, J. E., Brunelli, S. M., Muntner, P., Greene, T., Cheung, A. K., & Chertow, G. M. (2013). Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis. Journal of Human Hypertension.

Bardoxolone Methyl in Type 2 Diabetes and Advanced Chronic Kidney Disease REPLY
Himmelfarb, J., & Tuttle, K. R. (2014). Bardoxolone Methyl in Type 2 Diabetes and Advanced Chronic Kidney Disease REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 370(18), 1768–69.

Bardoxolone Methyl in Type 2 Diabetes and Advanced Chronic Kidney Disease
Chartoumpekis, D. V., & Sykiotis, G. P. (2014). Bardoxolone Methyl in Type 2 Diabetes and Advanced Chronic Kidney Disease. NEW ENGLAND JOURNAL OF MEDICINE, 370(18), 1767.

Cinacalcet for Cardiovascular Disease in Patients Undergoing Dialysis REPLY
Chertow, G. M., & Parfrey, P. S. (2013). Cinacalcet for Cardiovascular Disease in Patients Undergoing Dialysis REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 368(19), 1844–45.

Outcomes after left ventricular assist device implantation in patients with acute kidney injury.
Silver, S. A., Long, J., Zheng, Y., Goldstone, A. B., Franz, D., Chang, T. I., & Chertow, G. M. (2019). Outcomes after left ventricular assist device implantation in patients with acute kidney injury. The Journal of Thoracic and Cardiovascular Surgery.

Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis
Stubbs, J. R., Stedman, M. R., Liu, S., Long, J., Franchetti, Y., West, R. E., … Nolin, T. D. (2019). Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14(2), 261–67.

Dialysis versus Medical Management at Different Ages and Levels of Kidney Function in Veterans with Advanced CKD
Tamura, M. K., Desai, M., Kapphahn, K. I., Thomas, I.-C., Asch, S. M., & Chertow, G. M. (2018). Dialysis versus Medical Management at Different Ages and Levels of Kidney Function in Veterans with Advanced CKD. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 29(8), 2169–77.

Challenges in Assessing the Burden of Hospitalized Heart Failure in End-stage Kidney Disease.
Wang, K. M., & Chertow, G. M. (2019). Challenges in Assessing the Burden of Hospitalized Heart Failure in End-stage Kidney Disease. Journal of Cardiac Failure.

Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial
Block, G. A., Rosenbaum, D. P., Yan, A., & Chertow, G. M. (2019). Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 30(4), 641–52.

Relative sarcopenia and mortality and the modifying effects of chronic kidney disease and adiposity
Ziolkowski, S. L., Long, J., Baker, J. F., Chertow, G. M., & Leonard, M. B. (2019). Relative sarcopenia and mortality and the modifying effects of chronic kidney disease and adiposity. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 10(2), 338–46.

Payer Type, Race/Ethnicity, and the Timing of Surgical Management of Urinary Stone Disease
Brubaker, W. D., Dallas, K. B., Elliott, C. S., Pao, A. C., Chertow, G. M., Leppert, J. T., & Conti, S. L. (2019). Payer Type, Race/Ethnicity, and the Timing of Surgical Management of Urinary Stone Disease. JOURNAL OF ENDOUROLOGY, 33(2), 152–58.

Hypertension Hot Potato - Anatomy of the Angiotensin-Receptor Blocker Recalls
Byrd, J. B., Chertow, G. M., & Bhalla, V. (2019). Hypertension Hot Potato - Anatomy of the Angiotensin-Receptor Blocker Recalls. NEW ENGLAND JOURNAL OF MEDICINE, 380(17), 1589–91.

An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism
Block, G. A., Chertow, G. M., Sullivan, J. T., Deng, H., Mather, O., Tomlin, H., & Serenko, M. (2019). An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism. PLOS ONE, 14(3).

Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population
Gilbertson, D. T., Rothman, K. J., Chertow, G. M., Bradbury, B. D., Brookhart, M. A., Liu, J., … Wetmore, J. B. (2019). Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 30(2), 346–53.

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Mc Causland, F. R., Claggett, B., Burdmann, E. A., Chertow, G. M., Cooper, M. E., Eckardt, K.-U., … Pfeffer, M. A. (2019). Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). AMERICAN JOURNAL OF KIDNEY DISEASES, 73(3), 309–15.

Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease
Chertow, G. M., Appel, G. B., Block, G. A., Chin, M. P., Coyne, D. W., Goldsberry, A., … Rossing, P. (2018). Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 32(12), 1113–17.

Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System
Brady, B. M., Zhao, B., Niu, J., Winkelmayer, W. C., Milstein, A., Chertow, G. M., & Erickson, K. F. (2018). Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System. JAMA INTERNAL MEDICINE, 178(10), 1358–67.

Comparing Simultaneous Liver-Kidney Transplant Strategies: A Modified Cost-Effectiveness Analysis
Cheng, X. S., Kim, W. R., Tan, J. C., Chertow, G. M., & Goldhaber-Fiebert, J. (2018). Comparing Simultaneous Liver-Kidney Transplant Strategies: A Modified Cost-Effectiveness Analysis. TRANSPLANTATION, 102(5), E219–E228.

Association of Hospitalization and Mortality Among Patients Initiating Dialysis With Hemodialysis Facility Ownership and Acquisitions.
Erickson, K. F., Zhao, B., Niu, J., Winkelmayer, W. C., Bhattacharya, J., Chertow, G. M., & Ho, V. (2019). Association of Hospitalization and Mortality Among Patients Initiating Dialysis With Hemodialysis Facility Ownership and Acquisitions. JAMA Network Open, 2(5), e193987.

Treatment of metabolic acidosis with an intestinal binder
Song, S., & Chertow, G. M. (2019). Treatment of metabolic acidosis with an intestinal binder. LANCET, 393(10179), 1387–88.

Updates in Management and Timing of Dialysis in Acute Kidney Injury
Yu, M. K., Kamal, F., & Chertow, G. M. (2019). Updates in Management and Timing of Dialysis in Acute Kidney Injury. JOURNAL OF HOSPITAL MEDICINE, 14(4), 232–38.

Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis
Schwantes-An, T.-H., Liu, S., Stedman, M., Decker, B. S., Wetherill, L., Edenberg, H. J., … Moe, S. M. (2019). Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis. AMERICAN JOURNAL OF NEPHROLOGY, 49(2), 125–32.

Market Consolidation and Mortality in Patients Initiating Hemodialysis
Erickson, K. F., Winkelmayer, W. C., Ho, V., Bhattacharya, J., & Chertow, G. M. (2019). Market Consolidation and Mortality in Patients Initiating Hemodialysis. VALUE IN HEALTH, 22(1), 69–76.

Prospective Biopsy-Based Study of CKD of Unknown Etiology in Sri Lanka
Anand, S., Montez-Rath, M. E., Adasooriya, D., Ratnatunga, N., Kambham, N., Wazil, A., … Nanayakkara, N. (2019). Prospective Biopsy-Based Study of CKD of Unknown Etiology in Sri Lanka. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14(2), 224–32.

Prior Hospitalization Burden and the Relatedness of 30-Day Readmissions in Patients Receiving Hemodialysis
Lin, E., Bhattacharya, J., & Chertow, G. M. (2019). Prior Hospitalization Burden and the Relatedness of 30-Day Readmissions in Patients Receiving Hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 30(2), 323–35.

Randomized trial of intravenous iron-induced hypophosphatemia
Wolf, M., Chertow, G. M., Macdougall, L. C., Kaper, R., Krop, J., & Strauss, W. (2018). Randomized trial of intravenous iron-induced hypophosphatemia. JCI INSIGHT, 3(23).

Would government compensation of living kidney donors exploit the poor? An empirical analysis
Held, P. J., McCormick, F., Chertow, G. M., Peters, T. G., & Roberts, J. P. (2018). Would government compensation of living kidney donors exploit the poor? An empirical analysis. PLOS ONE, 13(11).

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT
Ginsberg, C., Craven, T. E., Chonchol, M. B., Cheung, A. K., Sarnak, M. J., Ambrosius, W. T., … Shlipak, M. G. (2018). PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13(12), 1816–24.

Prognostic relevance of visit-to-visit office blood pressure variability in Systolic Blood Pressure Intervention Trial: Same data, different conclusions?
Chang, T. I., Reboussin, D. M., Chertow, G. M., Cheung, A. K., Cushman, W. C., Kostis, W. J., … Papademetriou, V. (2018). Prognostic relevance of visit-to-visit office blood pressure variability in Systolic Blood Pressure Intervention Trial: Same data, different conclusions? JOURNAL OF CLINICAL HYPERTENSION, 20(11), 1644–45.

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT
Beddhu, S., Chertow, G. M., Greene, T., Whelton, P. K., Ambrosius, W. T., Cheung, A. K., … Cushman, W. C. (2018). Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(18).

Frailty Among Patients Receiving Hemodialysis: Evolution of Components and Associations With Mortality
Johansen, K. L., Delgado, C., Kaysen, G. A., Chertow, G. M., Chiang, J., Dalrymple, L. S., … Grimes, B. A. (2019). Frailty Among Patients Receiving Hemodialysis: Evolution of Components and Associations With Mortality. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 74(3), 380–86.

Acute Kidney Injury Due to Diarrheal Illness Requiring Hospitalization: Data from the National Inpatient Sample
Bradshaw, C., Zheng, Y., Silver, S. A., Chertow, G. M., Long, J., & Anand, S. (2018). Acute Kidney Injury Due to Diarrheal Illness Requiring Hospitalization: Data from the National Inpatient Sample. JOURNAL OF GENERAL INTERNAL MEDICINE, 33(9), 1520–27.

Unplanned Emergency Department Visits and Hospital Admissions Following Ureteroscopy: Do Ureteral Stents Make a Difference?
Mittakanti, H. R., Conti, S. L., Pao, A. C., Chertow, G. M., Liao, J. C., Leppert, J. T., & Elliott, C. S. (2018). Unplanned Emergency Department Visits and Hospital Admissions Following Ureteroscopy: Do Ureteral Stents Make a Difference? UROLOGY, 117, 44–49.

Prehabilitation for kidney transplant candidates: Is it time?
Cheng, X. S., Myers, J. N., Chertow, G. M., Rabkin, R., Chan, K. N., Chen, Y., & Tan, J. C. (2017). Prehabilitation for kidney transplant candidates: Is it time? CLINICAL TRANSPLANTATION, 31(8).

The effect of increased frequency of hemodialysis on vitamin C concentrations: an ancillary study of the randomized Frequent Hemodialysis Network (FHN) daily trial
Raimann, J. G., Abbas, S. R., Liu, L., Larive, B., Beck, G., Kotanko, P., … Kwok, S. (2019). The effect of increased frequency of hemodialysis on vitamin C concentrations: an ancillary study of the randomized Frequent Hemodialysis Network (FHN) daily trial. BMC NEPHROLOGY, 20, 179.

Patterns of diuretic use in the intensive care unit.
McCoy, I. E., Chertow, G. M., & Chang, T. I.-H. (2019). Patterns of diuretic use in the intensive care unit. PloS One, 14(5), e0217911.

Differential Molecular Modeling Predictions of Mid and Conventional Dialysate Flows
Leypoldt, J. K., Prichard, S., Chertow, G. M., & Alvarez, L. (2019). Differential Molecular Modeling Predictions of Mid and Conventional Dialysate Flows. BLOOD PURIFICATION, 47(4), 369–76.

IMPACT OF ETELCALCETIDE ON FGF23 LEVELS DURING THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON HEMODIALYSIS
Wolf, M., Block, G., Chertow, G., Cooper, K., Fouqueray, B., Moe, S., … Oberbauer, R. (2017). IMPACT OF ETELCALCETIDE ON FGF23 LEVELS DURING THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON HEMODIALYSIS. NEPHROLOGY DIALYSIS TRANSPLANTATION, 32.

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., … Mahaffey, K. W. (2019). Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. NEW ENGLAND JOURNAL OF MEDICINE, 380(24), 2295–2306.

Defining a willingness-to-transplant threshold in an era of organ scarcity: Simultaneous liver-kidney transplant as a case example.
Cheng, X. S., Goldhaber-Fiebert, J., Tan, J. C., Chertow, G. M., Kim, W. R., & Wall, A. E. (2019). Defining a willingness-to-transplant threshold in an era of organ scarcity: Simultaneous liver-kidney transplant as a case example. Transplantation.

Influence of prediabetes on the effects of intensive systolic blood pressure control on kidney events.
Rathi, N., Whelton, P. K., Chertow, G. M., Cushman, W. C., Cheung, A. K., Wei, G., … Beddhu, S. (2019). Influence of prediabetes on the effects of intensive systolic blood pressure control on kidney events. American Journal of Hypertension.

A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD.
Block, G. A., Block, M. S., Smits, G., Mehta, R., Isakova, T., Wolf, M., & Chertow, G. M. (2019). A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD. Journal of the American Society of Nephrology : JASN.

Understanding the role of the cytoprotective transcription factor nuclear factor erythroid 2-related factor 2-lessons from evolution, the animal kingdom and rare progeroid syndromes.
Stenvinkel, P., Meyer, C. J., Block, G. A., Chertow, G. M., & Shiels, P. G. (2019). Understanding the role of the cytoprotective transcription factor nuclear factor erythroid 2-related factor 2-lessons from evolution, the animal kingdom and rare progeroid syndromes. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association.

Low testosterone is associated with frailty, muscle wasting and physical dysfunction among men receiving hemodialysis: a longitudinal analysis
Chiang, J. M., Kaysen, G. A., Segal, M., Chertow, G. M., Delgado, C., & Johansen, K. L. (2019). Low testosterone is associated with frailty, muscle wasting and physical dysfunction among men receiving hemodialysis: a longitudinal analysis. NEPHROLOGY DIALYSIS TRANSPLANTATION, 34(5), 802–10.

Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients.
Cunningham, J., Block, G. A., Chertow, G. M., Cooper, K., Evenepoel, P., Iles, J., … Bushinsky, D. A. (2019). Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients. Kidney International Reports, 4(7), 987–94.

A phase II trial showing improvements in calcific uraemic arteriolopathy wound healing, pain and quality of life during SNF472 treatment
McMullen, E., Sinha, S., Gould, L., Brandenburg, V., Chertow, G., Miller, S., … Perello, J. (2019). A phase II trial showing improvements in calcific uraemic arteriolopathy wound healing, pain and quality of life during SNF472 treatment. BRITISH JOURNAL OF DERMATOLOGY, 181, 39–40.

Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.
Beddhu, S., Shen, J., Cheung, A. K., Kimmel, P. L., Chertow, G. M., Wei, G., … Greene, T. (2019). Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT. Journal of the American Society of Nephrology : JASN.

Toward Greater Scrutiny of Dialysate Flow: Reply to the Letter to the Editor of Dr. Molano-Triviño and Colleagues.
Alvarez, L., Leypoldt, J. K., Prichard, S., & Chertow, G. M. (2019). Toward Greater Scrutiny of Dialysate Flow: Reply to the Letter to the Editor of Dr. Molano-Triviño and Colleagues. Blood Purification, 1–2.

Removing Disincentives to Kidney Donation: A Quantitative Analysis.
McCormick, F., Held, P. J., Chertow, G. M., Peters, T. G., & Roberts, J. P. (2019). Removing Disincentives to Kidney Donation: A Quantitative Analysis. Journal of the American Society of Nephrology : JASN.

Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.
Rossing, P., Block, G. A., Chin, M. P., Goldsberry, A., Heerspink, H. J., McCullough, P. A., … Chertow, G. M. (2019). Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease. Kidney International.

Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: A post hoc analysis of 10 randomized, placebo-controlled trials.
Toto, R. D., Goldenberg, R., Chertow, G. M., Cain, V., Stefánsson, B. V., Sjöström, C. D., & Sartipy, P. (2019). Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: A post hoc analysis of 10 randomized, placebo-controlled trials. Journal of Diabetes and Its Complications, 107402.

Prevalence of twenty-four hour urine testing in Veterans with urinary stone disease.
Ganesan, C., Thomas, I.-C. C., Song, S., Sun, A. J., Sohlberg, E. M., Kurella Tamura, M., … Pao, A. C. (2019). Prevalence of twenty-four hour urine testing in Veterans with urinary stone disease. PloS One, 14(8), e0220768.

Association of Hospitalization and Mortality Among Patients Initiating Dialysis With Hemodialysis Facility Ownership and Acquisitions
Erickson, K. F., Zhao, B., Niu, J., Winkelmayer, W. C., Bhattacharya, J., Chertow, G. M., & Ho, V. (2019). Association of Hospitalization and Mortality Among Patients Initiating Dialysis With Hemodialysis Facility Ownership and Acquisitions. JAMA NETWORK OPEN, 2(5).

Long-term Trends and Clinical Outcomes of Inpatient Percutaneous Renal Biopsies in the United States, 2001-2013
Charu, V., O'Shaughnessy, M., Chertow, G., & Kambham, N. (2019). Long-term Trends and Clinical Outcomes of Inpatient Percutaneous Renal Biopsies in the United States, 2001-2013. LABORATORY INVESTIGATION, 99.

Long-term Trends and Clinical Outcomes of Inpatient Percutaneous Renal Biopsies in the United States, 2001-2013
Charu, V., O'Shaughnessy, M., Chertow, G., & Kambham, N. (2019). Long-term Trends and Clinical Outcomes of Inpatient Percutaneous Renal Biopsies in the United States, 2001-2013. MODERN PATHOLOGY, 32.

Challenges in Assessing the Burden of Hospitalized Heart Failure in End-Stage Kidney Disease
Wang, K. M., & Chertow, G. M. (2019). Challenges in Assessing the Burden of Hospitalized Heart Failure in End-Stage Kidney Disease. JOURNAL OF CARDIAC FAILURE, 25(7), 534–36.

Estimated effects of early diuretic use in critical illness.
McCoy, I. E., Montez-Rath, M. E., Chertow, G. M., & Chang, T. I. (2019). Estimated effects of early diuretic use in critical illness. Critical Care Explorations, 1(7).

Effects of Selonsertib in Patients with Diabetic Kidney Disease.
Chertow, G. M., Pergola, P. E., Chen, F., Kirby, B. J., Sundy, J. S., & Patel, U. D. (2019). Effects of Selonsertib in Patients with Diabetic Kidney Disease. Journal of the American Society of Nephrology : JASN.

Modification of eGFR-Based CKD Definitions: Perfect, or Enemy of the Good?
Chertow, G. M., & Beddhu, S. (2019). Modification of eGFR-Based CKD Definitions: Perfect, or Enemy of the Good? Journal of the American Society of Nephrology : JASN.

Asymmetric dimethylarginine, erythropoietin resistance, and anemia in CKD
Sirich, T. L., & Chertow, G. M. (2019). Asymmetric dimethylarginine, erythropoietin resistance, and anemia in CKD. ANNALS OF TRANSLATIONAL MEDICINE, 7.

Testing two (of several) intravenous iron dosing strategies in hemodialysis
Yu, M. K., & Chertow, G. M. (2019). Testing two (of several) intravenous iron dosing strategies in hemodialysis. ANNALS OF TRANSLATIONAL MEDICINE, 7.

Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease.
Rhee, J. J., Han, J., Montez-Rath, M. E., Kim, S. H., Cullen, M. R., Stafford, R. S., … Chertow, G. M. (2019). Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease. Journal of Diabetes and Its Complications, 107423.

Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial
Sirich, T. L., Fong, K., Larive, B., Beck, G. J., Chertow, G. M., Levin, N. W., … Meyer, T. W. (2017). Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial. KIDNEY INTERNATIONAL, 91(5), 1186–92.

Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses
Block, G. A., Pergola, P. E., Fishbane, S., Martins, J. G., LeWinter, R. D., Uhlig, K., … Chertow, G. M. (2019). Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses. NEPHROLOGY DIALYSIS TRANSPLANTATION, 34(7), 1115–24.

Testing two (of several) intravenous iron dosing strategies in hemodialysis.
Yu, M. K., & Chertow, G. M. (2019). Testing two (of several) intravenous iron dosing strategies in hemodialysis. Annals of Translational Medicine, 7(Suppl 3), S129.

Asymmetric dimethylarginine, erythropoietin resistance, and anemia in CKD.
Sirich, T. L., & Chertow, G. M. (2019). Asymmetric dimethylarginine, erythropoietin resistance, and anemia in CKD. Annals of Translational Medicine, 7(Suppl 3), S86.

Percutaneous Kidney Biopsy and the Utilization of Blood Transfusion and Renal Angiography Among Hospitalized Adults
Charu, V., O'Shaughnessy, M. M., Chertow, G. M., & Kambham, N. (2019). Percutaneous Kidney Biopsy and the Utilization of Blood Transfusion and Renal Angiography Among Hospitalized Adults. KIDNEY INTERNATIONAL REPORTS, 4(10), 1435–45.

Current Status of Angiotensin Receptor Blocker Recalls.
Gunasekaran, P. M., Chertow, G. M., Bhalla, V., & Byrd, J. B. (2019). Current Status of Angiotensin Receptor Blocker Recalls. Hypertension (Dallas, Tex. : 1979), HYPERTENSIONAHA11913955.

The cost of procuring deceased donor kidneys: Evidence from OPO cost reports 2013-2017.
Held, P. J., Bragg-Gresham, J. L., Peters, T., Chertow, G. M., McCormick, F., & Roberts, J. P. (2019). The cost of procuring deceased donor kidneys: Evidence from OPO cost reports 2013-2017. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Percutaneous Kidney Biopsy and the Utilization of Blood Transfusion and Renal Angiography Among Hospitalized Adults.
Charu, V., O'Shaughnessy, M. M., Chertow, G. M., & Kambham, N. (2019). Percutaneous Kidney Biopsy and the Utilization of Blood Transfusion and Renal Angiography Among Hospitalized Adults. Kidney International Reports, 4(10), 1435–1445.

Safety and efficacy of the Tablo hemodialysis system for in-center and home hemodialysis.
Plumb, T. J., Alvarez, L., Ross, D. L., Lee, J. J., Mulhern, J. G., Bell, J. L., … Aragon, M. A. (2019). Safety and efficacy of the Tablo hemodialysis system for in-center and home hemodialysis. Hemodialysis International. International Symposium on Home Hemodialysis.

Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans.
Song, S., Thomas, I.-C. C., Ganesan, C., Sohlberg, E. M., Chertow, G. M., Liao, J. C., … Leppert, J. T. (2019). Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans. Clinical Journal of the American Society of Nephrology : CJASN.

Slowing Progression of Cardiovascular Calcification with SNF472 in Patients on Hemodialysis: Results of a Randomized, Phase 2b Study.
Raggi, P., Bellasi, A., Bushinsky, D., Bover, J., Rodriguez, M., Ketteler, M., … Chertow, G. M. (2019). Slowing Progression of Cardiovascular Calcification with SNF472 in Patients on Hemodialysis: Results of a Randomized, Phase 2b Study. Circulation.

Preparing for Hemodialysis
Isom, R. T., & Chertow, G. M. (2020). Preparing for Hemodialysis. CHRONIC RENAL DISEASE, 2ND EDITION, 1157–73.

Exploring Care Attributes of Nephrologists Ranking Favorably on Measures of Value.
Brady, B. M., Ragavan, M. V., Simon, M., Chertow, G. M., & Milstein, A. (2019). Exploring Care Attributes of Nephrologists Ranking Favorably on Measures of Value. Journal of the American Society of Nephrology : JASN.

Chronic Kidney Disease and the Adiposity Paradox: Valid or Confounded?
Ziolkowski, S. L., Long, J., Baker, J. F., Chertow, G. M., & Leonard, M. B. (2019). Chronic Kidney Disease and the Adiposity Paradox: Valid or Confounded? JOURNAL OF RENAL NUTRITION, 29(6), 521–28.

Urinary Stone Disease in Pregnancy: A Claims-Based Analysis of 1.4 Million Patients.
Sohlberg, E. M., Brubaker, W. D., Zhang, C. A., Anderegg, L. D., Dallas, K., Song, S., … Conti, S. L. (2019). Urinary Stone Disease in Pregnancy: A Claims-Based Analysis of 1.4 Million Patients. The Journal of Urology, 101097JU0000000000000657.

A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PHASE 2B STUDY TO ASSESS THE EFFECT OF SNF472 ADDED TO STANDARD OF CARE ON PROGRESSION OF CARDIOVASCULAR CALCIFICATION IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE HAEMODIALYSIS (CALIPSO STUDY)
Raggi, P., Bellasi, A., Bover Sanjuan, J., Mariano Rodriguez, J., Ketteler, M., Sinha, S., … Perello, J. (2019). A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PHASE 2B STUDY TO ASSESS THE EFFECT OF SNF472 ADDED TO STANDARD OF CARE ON PROGRESSION OF CARDIOVASCULAR CALCIFICATION IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE HAEMODIALYSIS (CALIPSO STUDY). NEPHROLOGY DIALYSIS TRANSPLANTATION, 34.

DESIGN OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF SNF472 FOR THE TREATMENT OF CALCIFIC UREMIC ARTERIOLOPATHY (CALCIPHYLAXIS)
Sinha, S., Chertow, G., Brandenburg, V., Gould, L., Miller, S., Salcedo, C., … Perello, J. (2019). DESIGN OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF SNF472 FOR THE TREATMENT OF CALCIFIC UREMIC ARTERIOLOPATHY (CALCIPHYLAXIS). NEPHROLOGY DIALYSIS TRANSPLANTATION, 34.

A double-blind, randomized, placebo-controlled pilot trial to evaluate safety and efficacy of vorapaxar on arteriovenous fistula maturation.
Olivier, C. B., Sundaram, V., Chertow, G. M., Shashidhar, S., McDonnell, L. K., Ding, V. Y., … Mell, M. (2019). A double-blind, randomized, placebo-controlled pilot trial to evaluate safety and efficacy of vorapaxar on arteriovenous fistula maturation. The Journal of Vascular Access, 1129729819887269.

Acute Kidney Injury in Children Hospitalized With Diarrheal Illness in the United States.
Bradshaw, C., Han, J., Chertow, G. M., Long, J., Sutherland, S. M., & Anand, S. (2019). Acute Kidney Injury in Children Hospitalized With Diarrheal Illness in the United States. Hospital Pediatrics.

Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease
Rhee, J. J., Han, J., Montez-Rath, M. E., Kim, S. H., Cullen, M. R., Stafford, R. S., … Chertow, G. M. (2019). Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 33(11).

Angiotensin-related genetic determinants of cardiovascular disease in patients undergoing hemodialysis
Moe, S. M., Long, J., Schwantes-An, T.-H. L., Decker, B. S., Wetherill, L., Edenberg, H. J., … Chertow, G. M. (2019). Angiotensin-related genetic determinants of cardiovascular disease in patients undergoing hemodialysis. NEPHROLOGY DIALYSIS TRANSPLANTATION, 34(11), 1924–31.

Safety-Net Care for Maintenance Dialysis in the United States.
Erickson, K. F., Shen, J. I., Zhao, B., Winkelmayer, W. C., Chertow, G. M., Ho, V., & Bhattacharya, J. (2019). Safety-Net Care for Maintenance Dialysis in the United States. Journal of the American Society of Nephrology : JASN.

Effect of Intensive vs Standard Blood Pressure Treatment Upon Erectile Function in Hypertensive Men: Findings From the Systolic Blood Pressure Intervention Trial.
Foy, C. G., Newman, J. C., Russell, G. B., Berlowitz, D. R., Bates, J. T., Burgner, A. M., … Wadley, V. G. (2019). Effect of Intensive vs Standard Blood Pressure Treatment Upon Erectile Function in Hypertensive Men: Findings From the Systolic Blood Pressure Intervention Trial. The Journal of Sexual Medicine.

Central venous pressure and the risk of diuretic-associated acute kidney injury in patients after cardiac surgery.
McCoy, I. E., Montez-Rath, M. E., Chertow, G. M., & Chang, T. I. (2019). Central venous pressure and the risk of diuretic-associated acute kidney injury in patients after cardiac surgery. American Heart Journal, 221, 67–73.

Outcomes after left ventricular assist device implantation in patients with acute kidney injury
Silver, S. A., Long, J., Zheng, Y., Goldstone, A. B., Franz, D., Chang, T. I., & Chertow, G. M. (2020). Outcomes after left ventricular assist device implantation in patients with acute kidney injury. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 159(2), 477-+.

Screening Rates for Primary Aldosteronism in Resistant Hypertension: A Cohort Study.
Jaffe, G., Gray, Z., Krishnan, G., Stedman, M., Zheng, Y., Han, J., … Bhalla, V. (2020). Screening Rates for Primary Aldosteronism in Resistant Hypertension: A Cohort Study. Hypertension (Dallas, Tex. : 1979), HYPERTENSIONAHA11914359.

Effect of SNF472 on Progression of Cardiovascular Calcification in Patients on Hemodialysis (Results of a Phase 2 Randomized Controlled Study: CaLIPSO)
Raggi, P., Bellasi, A., Bover, J., Rodriguez, M., Ketteler, M., Sinha, S., … Perello, J. (2019). Effect of SNF472 on Progression of Cardiovascular Calcification in Patients on Hemodialysis (Results of a Phase 2 Randomized Controlled Study: CaLIPSO). CIRCULATION, 140(25), E967.

Apixaban versus Warfarin for Stroke Prevention in Patients With End Stage Renal Disease on Hemodialysis and Atrial Fibrillation: Results of a Randomized Clinical Trial Assessing Safety
Pokorney, S. D., Chertow, G. M., Al-Khalidi, H., Gallup, D., Dignacco, P., Mussina, K., … Granger, C. B. (2019). Apixaban versus Warfarin for Stroke Prevention in Patients With End Stage Renal Disease on Hemodialysis and Atrial Fibrillation: Results of a Randomized Clinical Trial Assessing Safety. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS.

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial.
Heerspink, H. J., Stefansson, B. V., Chertow, G. M., Correa-Rotter, R., Greene, T., Hou, F.-F. F., … Wheeler, D. C. (2020). Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 35(2), 274–82.

AKI-A Relevant Safety End Point?
McCoy, I. E., & Chertow, G. M. (2020). AKI-A Relevant Safety End Point? American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation.

Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis.
Wolf, M., Block, G. A., Chertow, G. M., Cooper, K., Fouqueray, B., Moe, S. M., … Oberbauer, R. (2020). Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis. Clinical Kidney Journal, 13(1), 75–84.

The Urine Albumin-Creatinine Ratio and Kidney Function after Nephrectomy.
Sun, A. J., Thomas, I.-C., Velaer, K. N., Ganesan, C., Song, S., Pao, A. C., … Leppert, J. T. (2020). The Urine Albumin-Creatinine Ratio and Kidney Function after Nephrectomy. The Journal of Urology, 101097JU0000000000001005.

The ongoing search for a robust clinical prediction model of ICU AKI
McCoy, I. E., & Chertow, G. M. (2020). The ongoing search for a robust clinical prediction model of ICU AKI. CLINICAL NEPHROLOGY, 93(3), 160–62.

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Advanced Chronic Kidney Disease.
Stanifer, J. W., Pokorney, S. D., Chertow, G. M., Hohnloser, S. H., Wojdyla, D. M., Garonzik, S., … Granger, C. B. (2020). Apixaban versus Warfarin in Patients with Atrial Fibrillation and Advanced Chronic Kidney Disease. Circulation.

Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease.
Ginsberg, C., Zelnick, L. R., Block, G. A., Chertow, G. M., Chonchol, M., Hoofnagle, A., … de Boer, I. H. (2020). Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association.

Management of Coronary Disease in Patients with Advanced Kidney Disease.
Bangalore, S., Maron, D. J., O'Brien, S. M., Fleg, J. L., Kretov, E. I., Briguori, C., … Hochman, J. S. (2020). Management of Coronary Disease in Patients with Advanced Kidney Disease. The New England Journal of Medicine.

Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.
Spertus, J. A., Jones, P. G., Maron, D. J., Mark, D. B., O'Brien, S. M., Fleg, J. L., … Bangalore, S. (2020). Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease. The New England Journal of Medicine.

Dedicated kidney disease-focused outcome trials with sodium-glucose cotransporter-2 inhibitors: Lessons from CREDENCE and expectations from DAPA-HF, DAPA-CKD, and EMPA-KIDNEY.
Rhee, J. J., Jardine, M. J., Chertow, G. M., & Mahaffey, K. W. (2020). Dedicated kidney disease-focused outcome trials with sodium-glucose cotransporter-2 inhibitors: Lessons from CREDENCE and expectations from DAPA-HF, DAPA-CKD, and EMPA-KIDNEY. Diabetes, Obesity & Metabolism, 22 Suppl 1, 46–54.

OPEN-LABEL STUDY OF THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF DM199 IN SUBJECTS WITH DIABETES AND CHRONIC KIDNEY DISEASE
Marbury, T., Alcorn, H., Bakris, G., Bermudez, M. I., Agarwal, R., Herzog, C., … Canas, G. (2020). OPEN-LABEL STUDY OF THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF DM199 IN SUBJECTS WITH DIABETES AND CHRONIC KIDNEY DISEASE. AMERICAN JOURNAL OF KIDNEY DISEASES, 75(4), 542–43.

Innovation in hemodialysis: Using the Biodesign process to identify unmet needs.
Augustin, D. A., Chertow, G. M., & Azagury, D. E. (2020). Innovation in hemodialysis: Using the Biodesign process to identify unmet needs. The Journal of Vascular Access, 1129729820913692.

Targeting Vascular Calcification in Chronic Kidney Disease.
Nelson, A. J., Raggi, P., Wolf, M., Gold, A. M., Chertow, G. M., & Roe, M. T. (2020). Targeting Vascular Calcification in Chronic Kidney Disease. JACC. Basic to Translational Science, 5(4), 398–412.

The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.
Ilkun, O. L., Greene, T., Cheung, A. K., Whelton, P. K., Wei, G., Boucher, R. E., … Beddhu, S. (2020). The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes. Diabetes Care.

Physical Performance Testing in Kidney Transplant Candidates at the Top of the Waitlist.
Cheng, X. S., Myers, J., Han, J., Stedman, M. R., Watford, D. J., Lee, J., … Tan, J. C. (2020). Physical Performance Testing in Kidney Transplant Candidates at the Top of the Waitlist. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation.

Early Delays in Insurance Coverage and Long-term Use of Home-based Peritoneal Dialysis.
Lin, E., Chertow, G. M., Bhattacharya, J., & Lakdawalla, D. (2020). Early Delays in Insurance Coverage and Long-term Use of Home-based Peritoneal Dialysis. Medical Care, 58(7), 632–42.

Screening Rates for the Diagnostic Workup of Resistant Hypertension
Jaffe, G. M., Krishnan, G., Stedman, M., Chertow, G. M., Leppert, J. T., & Bhalla, V. (2017). Screening Rates for the Diagnostic Workup of Resistant Hypertension. HYPERTENSION. LIPPINCOTT WILLIAMS & WILKINS.

Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trials (SPRINT): A Randomized Control Trial
Still, C. H., Rodriguez, C. J., Wright, J. T., Craven, T. E., Bress, A. P., Chertow, G. M., … Wall, B. M. (2017). Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trials (SPRINT): A Randomized Control Trial. HYPERTENSION, 70.

Patient and Provider Characteristics Associated With Sodium-Glucose Cotransporter 2 Inhibitor Prescription in Patients With Diabetes and Proteinuric Chronic Kidney Disease.
McCoy, I. E., Han, J., Montez-Rath, M. E., Chertow, G. M., & Rhee, J. J. (2020). Patient and Provider Characteristics Associated With Sodium-Glucose Cotransporter 2 Inhibitor Prescription in Patients With Diabetes and Proteinuric Chronic Kidney Disease. Clinical Diabetes : a Publication of the American Diabetes Association, 38(3), 240–47.

Analysis of Primary Hyperparathyroidism Screening Among US Veterans With Kidney Stones.
Ganesan, C., Weia, B., Thomas, I.-C., Song, S., Velaer, K., Seib, C. D., … Pao, A. C. (2020). Analysis of Primary Hyperparathyroidism Screening Among US Veterans With Kidney Stones. JAMA Surgery.

Intradialytic Symptoms and Recovery Time in Patients on Thrice-Weekly In-Center Hemodialysis: A Cross-sectional Online Survey.
Alvarez, L., Brown, D., Hu, D., Chertow, G. M., Vassalotti, J. A., & Prichard, S. (2019). Intradialytic Symptoms and Recovery Time in Patients on Thrice-Weekly In-Center Hemodialysis: A Cross-sectional Online Survey. Kidney Medicine, 2(2), 125–30.

The "Advancing American Kidney Health" Executive Order: Challenges and Opportunities for the Large Dialysis Organizations.
Lin, E., Ginsburg, P. B., Chertow, G. M., & Berns, J. S. (2020). The "Advancing American Kidney Health" Executive Order: Challenges and Opportunities for the Large Dialysis Organizations. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation.

Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference.
Edmonston, D. L., Roe, M. T., Block, G., Conway, P. T., Dember, L. M., DiBattiste, P. M., … Wolf, M. (2020). Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation.

SNF472 CONSISTENTLY SLOWS PROGRESSION OF CORONARY CALCIFICATION IN PATIENTS ON HEMODIALYSIS: SUBGROUP ANALYSIS OF THE CALIPSO STUDY
Raggi, P., Bellasi, A., Bushinsky, D., Bover, J., Rodriguez, M., Ketteler, M., … Chertow, G. (2020). SNF472 CONSISTENTLY SLOWS PROGRESSION OF CORONARY CALCIFICATION IN PATIENTS ON HEMODIALYSIS: SUBGROUP ANALYSIS OF THE CALIPSO STUDY. NEPHROLOGY DIALYSIS TRANSPLANTATION, 35, 92.

Does really central venous pressure affect the risk of diuretic-associated acute kidney injury after cardiac surgery?
McCoy, I., Montez-Rath, M., Chertow, G., & Chang, T. (2020). Does really central venous pressure affect the risk of diuretic-associated acute kidney injury after cardiac surgery? American Heart Journal, 226, 252.

Patient-reported outcomes from the investigational device exemption study of the Tablo hemodialysis system.
Chertow, G. M., Alvarez, L., Plumb, T. J., Prichard, S. S., & Aragon, M. (2020). Patient-reported outcomes from the investigational device exemption study of the Tablo hemodialysis system. Hemodialysis International. International Symposium on Home Hemodialysis.

Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKD.
Lewis, J. H., Jadoul, M., Block, G. A., Chin, M. P., Ferguson, D. A., Goldsberry, A., … Chertow, G. M. (2020). Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKD. Clinical and Translational Science.

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.
Wheeler, D. C., Stefansson, B. V., Batiushin, M., Bilchenko, O., Cherney, D. Z., Chertow, G. M., … Heerspink, H. J. (2020). The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association.

SNF472 CONSISTENTLY SLOWS PROGRESSION OF CORONARY CALCIFICATION IN PATIENTS ON HEMODIALYSIS: SUBGROUP ANALYSIS OF THE CALIPSO STUDY
Raggi, P., Bellasi, A., Bushinsky, D., Bover, J., Rodriquez, M., Ketteler, M., … Chertow, G. (2020). SNF472 CONSISTENTLY SLOWS PROGRESSION OF CORONARY CALCIFICATION IN PATIENTS ON HEMODIALYSIS: SUBGROUP ANALYSIS OF THE CALIPSO STUDY. NEPHROLOGY DIALYSIS TRANSPLANTATION, 35, 92.

Dapagliflozin in Patients with Chronic Kidney Disease.
Heerspink, H. J., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F. F., … Wheeler, D. C. (2020). Dapagliflozin in Patients with Chronic Kidney Disease. The New England Journal of Medicine.

Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.
Anand, S., Montez-Rath, M., Han, J., Bozeman, J., Kerschmann, R., Beyer, P., … Chertow, G. M. (2020). Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. Lancet (London, England).

Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in the EVOLVE trial.
Block, G. A., Chertow, G. M., Cooper, K., Xing, S., Fouqueray, B., Halperin, M., & Danese, M. D. (2020). Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in the EVOLVE trial. Hemodialysis International. International Symposium on Home Hemodialysis.

Self-care training using the Tablo hemodialysis system.
Plumb, T. J., Alvarez, L., Ross, D. L., Lee, J. J., Mulhern, J. G., Bell, J. L., … Aragon, M. A. (2020). Self-care training using the Tablo hemodialysis system. Hemodialysis International. International Symposium on Home Hemodialysis.

Alport Syndrome Classification and Management.
Warady, B. A., Agarwal, R., Bangalore, S., Chapman, A., Levin, A., Stenvinkel, P., … Chertow, G. M. (2020). Alport Syndrome Classification and Management. Kidney Medicine, 2(5), 639–49.

Factors Associated With Failure to Achieve the Intensive Blood Pressure Target in the Systolic Blood Pressure Intervention Trial (SPRINT).
Wang, K. M., Stedman, M. R., Chertow, G. M., & Chang, T. I. (2020). Factors Associated With Failure to Achieve the Intensive Blood Pressure Target in the Systolic Blood Pressure Intervention Trial (SPRINT). Hypertension (Dallas, Tex. : 1979), HYPERTENSIONAHA12016155.

Cardiovascular Safety and Efficacy of Vadadust for the Treatment of Anemia in Non-Dialysis Dependent CKD: Design and Baseline Characteristics.
Chertow, G. M., Pergola, P. E., Agarwal, R., Block, G. A., Farag, Y. M., Jardine, A. G., … Eckardt, K.-U. (2020). Cardiovascular Safety and Efficacy of Vadadust for the Treatment of Anemia in Non-Dialysis Dependent CKD: Design and Baseline Characteristics. American Heart Journal.

Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease.
McMurray, J. J., Wheeler, D. C., Stefansson, B. V., Jongs, N., Postmus, D., Correa-Rotter, R., … Heerspink, H. J. (2020). Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease. Circulation.

Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials.
Eckardt, K.-U., Agarwal, R., Farag, Y. M., Jardine, A. G., Khawaja, Z., Koury, M. J., … Chertow, G. M. (2020). Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association.

Toward telemedicine-compatible physical functioning assessments in kidney transplant candidates.
Watford, D. J., Cheng, X. S., Han, J., Stedman, M. R., Chertow, G. M., & Tan, J. C. (2020). Toward telemedicine-compatible physical functioning assessments in kidney transplant candidates. Clinical Transplantation, e14173.

Laboratory-wide association study of survival with prostate cancer.
Sohlberg, E. M., Thomas, I.-C., Yang, J., Kapphahn, K., Velaer, K. N., Goldstein, M. K., … Leppert, J. T. (2020). Laboratory-wide association study of survival with prostate cancer. Cancer.

Correlates and Consequences of High Serum Irisin Concentration in Patients on Hemodialysis: A Longitudinal Analysis.
Chiang, J. M., Delgado, C., Kaysen, G. A., Segal, M. R., Chertow, G. M., & Johansen, K. L. (2020). Correlates and Consequences of High Serum Irisin Concentration in Patients on Hemodialysis: A Longitudinal Analysis. Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation.

Reducing the Shortage of Transplant Kidneys: A Lost Opportunity for the US Health Resources and Services Administration (HRSA).
McCormick, F., Held, P. J., Chertow, G. M., Peters, T. G., & Roberts, J. P. (2020). Reducing the Shortage of Transplant Kidneys: A Lost Opportunity for the US Health Resources and Services Administration (HRSA). American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation.

Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO Trial.
Raggi, P., Bellasi, A., Sinha, S., Bover, J., Rodriguez, M., Ketteler, M., … Chertow, G. M. (2020). Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO Trial. Kidney International Reports, 5(12), 2178–82.

Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial.
Wheeler, D. C., Stefánsson, B. V., Jongs, N., Chertow, G. M., Greene, T., Hou, F. F., … Heerspink, H. J. (2021). Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial. The Lancet. Diabetes & Endocrinology, 9(1), 22–31.

Prolonged Hospitalization Following Acute Respiratory Failure.
Marmor, M., Liu, S., Long, J., Chertow, G. M., & Rogers, A. J. (2020). Prolonged Hospitalization Following Acute Respiratory Failure. Chest.

Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD)
McMurray, J. J. V., Wheeler, D. C., Stefansson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., … Heerspink, H. J. L. (2020). Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD). JOURNAL OF CARDIAC FAILURE, 26(12), 1111.

Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD)
McMurray, J. J., Wheeler, D. C., Stefansson, B. V., Rotter, R. C., Chertow, G. M., Greene, T., … Heerspink, H. J. L. (2020). Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD). CIRCULATION, 142(24), E482–E483.

Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
Wheeler, D. C., Stefansson, B., Jongs, N., Chertow, G. M., Greene, T., Hou, F. F., … Heerspink, H. J. L. (2021). Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial. LANCET DIABETES & ENDOCRINOLOGY, 9(1), 22–31.

Combination treatment with tenapanor and sevelamer synergistically reduces urinary phosphorus excretion in rats.
King, A. J., Kohler, J., Fung, C., Jiang, Z., Quach, A., Kumaraswamy, P., … Rosenbaum, D. P. (2021). Combination treatment with tenapanor and sevelamer synergistically reduces urinary phosphorus excretion in rats. American Journal of Physiology. Renal Physiology, 320(1), F133–F144.

Aldosterone sensitivity: an opportunity for investigation into the pathogenesis of hypertension.
Gray, Z., Tu, W., Chertow, G. M., & Bhalla, V. (2021). Aldosterone sensitivity: an opportunity for investigation into the pathogenesis of hypertension. American Journal of Physiology. Renal Physiology.

And Then There Were Three: Effects of Pretransplant Dialysis on Multiorgan Transplantation.
Cheng, X. S., Han, J., Stedman, M. R., Chertow, G. M., & Tan, J. C. (2021). And Then There Were Three: Effects of Pretransplant Dialysis on Multiorgan Transplantation. Transplantation Direct, 7(2), e657.

Pharmacokinetics of apixaban in patients with end stage renal disease on hemodialysis and atrial fibrillation: results from the RENAL-AF trial
Pokorney, S., Garonzik, S., Chertow, G. M., Washam, J. B., Mussina, K., Bansal, N., … Granger, C. B. (2020). Pharmacokinetics of apixaban in patients with end stage renal disease on hemodialysis and atrial fibrillation: results from the RENAL-AF trial. EUROPEAN HEART JOURNAL, 41, 3373.

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
Bushinsky, D. A., Chertow, G. M., Cheng, S., Deng, H., Kopyt, N., Martin, K. J., … Block, G. A. (2020). One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism. NEPHROLOGY DIALYSIS TRANSPLANTATION, 35(10), 1769–78.

Urate Lowering With Combination Therapy in CKD: Reason for Optimism or Einstein's Definition of Insanity?
Jalal, D. I., & Chertow, G. M. (2021). Urate Lowering With Combination Therapy in CKD: Reason for Optimism or Einstein's Definition of Insanity? American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation.

Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification.
Bellasi, A., Raggi, P., Bover, J., Bushinsky, D. A., Chertow, G. M., Ketteler, M., … Perello, J. (2021). Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification. Clinical Kidney Journal, 14(1), 366–74.

Race and Place in ESKD.
Watford, D. J., & Chertow, G. M. (2021). Race and Place in ESKD. Kidney International Reports, 6(2), 252–53.

Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes.
Beddhu, S., Boucher, R. E., Sun, J., Balu, N., Chonchol, M., Navaneethan, S., … Yuan, C. (2021). Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes. BMC Nephrology, 22(1), 69.

Osteoporosis, Fractures, and Bone Mineral Density Screening in Veterans With Kidney Stone Disease.
Ganesan, C., Thomas, I.-C., Romero, R., Song, S., Conti, S., Elliott, C., … Pao, A. C. (2021). Osteoporosis, Fractures, and Bone Mineral Density Screening in Veterans With Kidney Stone Disease. Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research.

Association of 152 Biomarker Reference Intervals with All-Cause Mortality in Participants of a General United States Survey from 1999 to 2010.
Pho, N., Manrai, A. K., Leppert, J. T., Chertow, G. M., Ioannidis, J. P., & Patel, C. J. (2021). Association of 152 Biomarker Reference Intervals with All-Cause Mortality in Participants of a General United States Survey from 1999 to 2010. Clinical Chemistry, 67(3), 500–507.

Estimated Impact of Novel Coronavirus-19 and Transplant Center Inactivity on ESRD-related Patient Mortality in the United States.
Peters, T. G., Bragg-Gresham, J. L., Klopstock, A. C., Roberts, J. P., Chertow, G., McCormick, F., & Held, P. J. (2021). Estimated Impact of Novel Coronavirus-19 and Transplant Center Inactivity on ESRD-related Patient Mortality in the United States. Clinical Transplantation, e14292.

A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY).
Pergola, P. E., Rosenbaum, D. P., Yang, Y., & Chertow, G. M. (2021). A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY). Journal of the American Society of Nephrology : JASN.

Effect of a Home-Based Exercise Program on Indices of Physical Function and Quality of Life in Elderly Maintenance Hemodialysis Patients.
Myers, J., Chan, K., Chen, Y., Lit, Y., Patti, A., Massaband, P., … Rabkin, R. (2021). Effect of a Home-Based Exercise Program on Indices of Physical Function and Quality of Life in Elderly Maintenance Hemodialysis Patients. Kidney & Blood Pressure Research, 1–11.

Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.
Chertow, G. M., Appel, G. B., Andreoli, S., Bangalore, S., Block, G. A., Chapman, A. B., … Pergola, P. E. (2021). Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome. American Journal of Nephrology, 1–10.

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
Heerspink, H. J., Sjostrom, C. D., Jongs, N., Chertow, G. M., Kosiborod, M., Hou, F. F., … Wheeler, D. C. (2021). Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial. European Heart Journal, 42(13), 1216–27.

Removing Race from eGFR calculations: Implications for Urologic Care.
Vilson, F. L., Schmidt, B., White, L., Soerensen, S. J., Ganesan, C., Pao, A. C., … Leppert, J. T. (2021). Removing Race from eGFR calculations: Implications for Urologic Care. Urology.

Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study.
Bushinsky, D. A., Raggi, P., Bover, J., Ketteler, M., Bellasi, A., Rodriguez, M., … Chertow, G. M. (2021). Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study. Clinical Journal of the American Society of Nephrology : CJASN.

Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S.
Anand, S., Montez-Rath, M. E., Han, J., Garcia, P., Bozeman, J., Kerschmann, R., … Chertow, G. M. (2021). Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S. PloS One, 16(4), e0249466.

A pre-specified analysis of the DAPA-CKD trial indicates effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy.
Wheeler, D. C., Toto, R. D., Stefansson, B. V., Jongs, N., Chertow, G. M., Greene, T., … Heerspink, H. J. (2021). A pre-specified analysis of the DAPA-CKD trial indicates effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy. Kidney International.

The Organ Procurement Costs of Expanding Deceased Donor Organ Acceptance Criteria: Evidence from a Cost Function Model.
Cheng, X. S., Held, P. J., Dor, A., Bragg-Gresham, J. L., Tan, J. C., Scandling, J. D., … Roberts, J. P. (2021). The Organ Procurement Costs of Expanding Deceased Donor Organ Acceptance Criteria: Evidence from a Cost Function Model. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Targeting Sedentary Behavior in CKD: A Pilot and Feasibility Randomized Controlled Trial.
Lyden, K., Boucher, R., Wei, G., Zhou, N., Christensen, J., Chertow, G. M., … Beddhu, S. (2021). Targeting Sedentary Behavior in CKD: A Pilot and Feasibility Randomized Controlled Trial. Clinical Journal of the American Society of Nephrology : CJASN.

Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD)
McMurray, J. J., Wheeler, D. C., Stefansson, B. V., Rotter, R. C., Chertow, G. M., Greene, T., … Heerspink, H. J. L. (2020). Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD). CIRCULATION, 142(24), E482–E483.

Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
Chertow, G. M., Pergola, P. E., Farag, Y. M., Agarwal, R., Arnold, S., Bako, G., … Eckardt, K.-U. (2021). Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD. The New England Journal of Medicine, 384(17), 1589–1600.

Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
Eckardt, K.-U., Agarwal, R., Aswad, A., Awad, A., Block, G. A., Bacci, M. R., … Chertow, G. M. (2021). Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis. The New England Journal of Medicine, 384(17), 1601–12.

SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey.
Garcia, P., Montez-Rath, M. E., Moore, H., Flotte, J., Fults, C., Block, M. S., … Anand, S. (2021). SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey. Journal of the American Society of Nephrology : JASN.

National Estimates of CKD Prevalence and Potential Impact of Estimating Glomerular Filtration Rate Without Race.
Duggal, V., Thomas, I.-C., Montez-Rath, M. E., Chertow, G. M., & Kurella Tamura, M. (2021). National Estimates of CKD Prevalence and Potential Impact of Estimating Glomerular Filtration Rate Without Race. Journal of the American Society of Nephrology : JASN.

Barriers to ACEI/ARB Use in Proteinuric Chronic Kidney Disease: An Observational Study.
McCoy, I. E., Han, J., Montez-Rath, M. E., & Chertow, G. M. (2021). Barriers to ACEI/ARB Use in Proteinuric Chronic Kidney Disease: An Observational Study. Mayo Clinic Proceedings.

Cost Structures of US Organ Procurement Organizations.
Held, P. J., Bragg-Gresham, J. L., Peters, T. G., McCormick, F., Chertow, G., Vaughan, W. P., & Roberts, J. P. (2021). Cost Structures of US Organ Procurement Organizations. Transplantation.

Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis.
Anand, S., Montez-Rath, M. E., Han, J., Garcia, P., Cadden, L. C., Hunsader, P., … Parsonnet, J. (2021). Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis. Annals of Internal Medicine.

SARS-COV-2 VACCINE ACCEPTABILITY IN PATIENTS ON DIALYSIS: A NATIONWIDE SURVEY
Garcia, P., Montez-Rath, M., Moore, H., Flotte, J., Fults, C., Block, M., … Anand, S. (2021). SARS-COV-2 VACCINE ACCEPTABILITY IN PATIENTS ON DIALYSIS: A NATIONWIDE SURVEY. AMERICAN JOURNAL OF KIDNEY DISEASES. W B SAUNDERS CO-ELSEVIER INC.

SNF472: mechanism of action and results from clinical trials.
Sinha, S., Raggi, P., & Chertow, G. M. (2021). SNF472: mechanism of action and results from clinical trials. Current Opinion in Nephrology and Hypertension, 30(4), 424–429.

Performance versus Risk Factor-Based Approaches to Coronary Artery Disease Screening in Waitlisted Kidney Transplant Candidates.
Cheng, X. S., Watford, D. J., Arashi, H., Stedman, M. R., Chertow, G. M., Tan, J. C., & Fearon, W. F. (2021). Performance versus Risk Factor-Based Approaches to Coronary Artery Disease Screening in Waitlisted Kidney Transplant Candidates. Cardiorenal Medicine, 1–11.

Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.
Anand, S., Montez-Rath, M., Han, J., Garcia, P., Cadden, L. C., Hunsader, P., … Chertow, G. (2021). Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis. Journal of the American Society of Nephrology : JASN.

Karnofsky Performance Score-Failure to Thrive as a Frailty Proxy?
Stedman, M. R., Watford, D. J., Chertow, G. M., & Tan, J. C. (2021). Karnofsky Performance Score-Failure to Thrive as a Frailty Proxy? Transplantation Direct, 7(7), e708.

Antibody Response to COVID-19 vaccination in Patients Receiving Dialysis.
Anand, S., Montez-Rath, M. E., Han, J., Garcia, P., Cadden, L. C., Hunsader, P., … Chertow, G. M. (2021). Antibody Response to COVID-19 vaccination in Patients Receiving Dialysis. MedRxiv : the Preprint Server for Health Sciences.

Reply to the Editorial Comment on: Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology. 2021.
Soerensen, S. J., Thomas, I.-C., Schmidt, B., Daskivich, T., Skolarus, T. A., Jackson, C., … Leppert, J. T. (2021). Reply to the Editorial Comment on: Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology. 2021. Urology.

Body Composition Changes Following Dialysis Initiation and Cardiovascular and Mortality Outcomes in CRIC (Chronic Renal Insufficiency Cohort): A Bioimpedance Analysis Substudy.
Wang, K., Zelnick, L. R., Chertow, G. M., Himmelfarb, J., & Bansal, N. (2021). Body Composition Changes Following Dialysis Initiation and Cardiovascular and Mortality Outcomes in CRIC (Chronic Renal Insufficiency Cohort): A Bioimpedance Analysis Substudy. Kidney Medicine, 3(3), 327.

Invasive Management of Coronary Artery Disease in Advanced Renal Disease.
Karimi Galougahi, K., Chadban, S., Mehran, R., Bangalore, S., Chertow, G. M., & Ali, Z. A. (2021). Invasive Management of Coronary Artery Disease in Advanced Renal Disease. Kidney International Reports, 6(6), 1513–1524.

Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial.
Persson, F., Rossing, P., Vart, P., Chertow, G. M., Hou, F. F., Jongs, N., … Heerspink, H. J. (2021). Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial. Diabetes Care.

HOSPITALIZATION IN PATIENTS RECEIVING MAINTENANCE DIALYSIS WITH HYPERPHOSPHATEMIA RANDOMIZED TO TENAPANOR OR SEVELAMER
Stephenson, B., Chertow, G., Yang, Y., & Rosenbaum, D. (2021). HOSPITALIZATION IN PATIENTS RECEIVING MAINTENANCE DIALYSIS WITH HYPERPHOSPHATEMIA RANDOMIZED TO TENAPANOR OR SEVELAMER. VALUE IN HEALTH. ELSEVIER SCIENCE INC.

Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
Anand, S., Montez-Rath, M., Han, J., Cadden, L. C., Hunsader, P., Kerschmann, R., … Chertow, G. M. (2021). Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic. JAMA Network Open, 4(7), e2116572.

Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease.
Chertow, G., Vart, P., Jongs, N., Toto, R., Gorriz, J. L., Hou, F. F., … Heerspink, H. (2021). Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease. Journal of the American Society of Nephrology : JASN.

The potential roles of osmotic and non-osmotic sodium handling in mediating effects of SGLT2 inhibitors on heart failure.
Bjornstad, P., Greasley, P. J., Wheeler, D. C., Chertow, G. M., Langkilde, A. M., Heerspink, H. J., & van Raalte, D. H. (2021). The potential roles of osmotic and non-osmotic sodium handling in mediating effects of SGLT2 inhibitors on heart failure. Journal of Cardiac Failure.

Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2
Stenvinkel, P., Chertow, G. M., Devarajan, P., Levin, A., Andreoli, S. P., Bangalore, S., & Warady, B. A. (2021). Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2. KIDNEY INTERNATIONAL REPORTS, 6(7), 1775–1787.

Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2.
Stenvinkel, P., Chertow, G. M., Devarajan, P., Levin, A., Andreoli, S. P., Bangalore, S., & Warady, B. A. (2021). Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2. Kidney International Reports, 6(7), 1775–1787.

Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency
Brady, B. M., Zhao, B., Dang, B. N., Winkelmayer, W. C., Chertow, G. M., & Erickson, K. F. (2021). Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(7), 1052–1060.

Primary Nephrotic Syndrome and Risks of ESKD, Cardiovascular Events, and Death: The Kaiser Permanente Nephrotic Syndrome Study.
Go, A. S., Tan, T. C., Chertow, G. M., Ordonez, J. D., Fan, D., Law, D., … Parikh, R. V. (2021). Primary Nephrotic Syndrome and Risks of ESKD, Cardiovascular Events, and Death: The Kaiser Permanente Nephrotic Syndrome Study. Journal of the American Society of Nephrology : JASN.

Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting.
Fishbane, S., Charytan, D. M., Chertow, G. M., Ford, M., Kovesdy, C. P., Pergola, P. E., … Spinowitz, B. (2021). Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting. Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation.

The Contribution of Known Familial Cardiovascular Disease Genes to Sudden Cardiac Death in Patients Undergoing Hemodialysis
Schwantes-An, T.-H., Vatta, M., Abreu, M., Wetherill, L., Edenberg, H. J., Foroud, T. M., … Moe, S. M. (2021). The Contribution of Known Familial Cardiovascular Disease Genes to Sudden Cardiac Death in Patients Undergoing Hemodialysis. CARDIORENAL MEDICINE.

Effects of Dapagliflozin in Patients With Kidney Disease, With and Without HeartFailure.
McMurray, J. J., Wheeler, D. C., Stefansson, B. V., Jongs, N., Postmus, D., Correa-Rotter, R., … Heerspink, H. J. (2021). Effects of Dapagliflozin in Patients With Kidney Disease, With and Without HeartFailure. JACC. Heart Failure.

The Contribution of Known Familial Cardiovascular Disease Genes to Sudden Cardiac Death in Patients Undergoing Hemodialysis.
Schwantes-An, T.-H. H., Vatta, M., Abreu, M., Wetherill, L., Edenberg, H. J., Foroud, T. M., … Moe, S. M. (2021). The Contribution of Known Familial Cardiovascular Disease Genes to Sudden Cardiac Death in Patients Undergoing Hemodialysis. Cardiorenal Medicine, 11(4), 174–183.

THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH EGFR < 30 ML/MIN/1.73M2: FINDINGS FROM THE DAPA-CKD TRIAL
Chertow, G., Vart, P., Jongs, N., Toto, R., Gorriz, J. L., Hou, F. F., … Heerspink, H. J. L. (2021). THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH EGFR < 30 ML/MIN/1.73M2: FINDINGS FROM THE DAPA-CKD TRIAL. NEPHROLOGY. WILEY.

AUTHOR REPLY.
Soerensen, S. J., Thomas, I.-C. C., Schmidt, B., Daskivich, T. J., Skolarus, T. A., Jackson, C., … Leppert, J. T. (2021). AUTHOR REPLY. Urology, 155, 76.

Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure.
Kurella Tamura, M., Gaussoin, S., Pajewski, N. M., Zaharchuk, G., Freedman, B. I., Rapp, S. R., … Nasrallah, I. M. (2021). Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation.

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
Heerspink, H. J., Cherney, D., Postmus, D., Stefánsson, B. V., Chertow, G. M., Dwyer, J. P., … Wheeler, D. C. (2021). A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function. Kidney International.

Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS).
Velaer, K., Thomas, I.-C. C., Yang, J., Kapphahn, K., Metzner, T. J., Golla, A., … Leppert, J. T. (2021). Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS). Urologic Oncology.

Inside CKD: modelling the clinical and economic impact of routine screening for albuminuria in people with type 2 diabetes
Nolan, S., Arnlov, J., Batista, M. C., Chadban, S., Chertow, G. M., De Nicola, L., … Wish, J. (2021). Inside CKD: modelling the clinical and economic impact of routine screening for albuminuria in people with type 2 diabetes. DIABETOLOGIA. SPRINGER.

Inside CKD: modelling the direct economic burden of concomitant chronic kidney disease and type 2 diabetes
Power, A., Arnlov, J., Batista, M. C., Card-Gowers, J., Chadban, S., Chertow, G. M., … Wish, J. (2021). Inside CKD: modelling the direct economic burden of concomitant chronic kidney disease and type 2 diabetes. DIABETOLOGIA. SPRINGER.

Inside CKD: modelling the future global burden of chronic kidney disease in patients with type 2 diabetes
Tangri, N., Arnlov, J., Batista, M. C., Chadban, S., Chertow, G. M., De Nicola, L., … Wish, J. (2021). Inside CKD: modelling the future global burden of chronic kidney disease in patients with type 2 diabetes. DIABETOLOGIA. SPRINGER.

Efficacy and safety of dapagliflozin on kidney and cardiovascular outcomes by baseline albuminuria: a secondary analysis of the DAPA-CKD trial
Heerspink, H. J. L., Waijer, S. W., Vart, P., Cherney, D. Z. I., Chertow, G., Langkilde, A. M., … Wheeler, D. (2021). Efficacy and safety of dapagliflozin on kidney and cardiovascular outcomes by baseline albuminuria: a secondary analysis of the DAPA-CKD trial. DIABETOLOGIA. SPRINGER.

Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency.
Brady, B. M., Zhao, B., Dang, B. N., Winkelmayer, W. C., Chertow, G. M., & Erickson, K. F. (2021). Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency. Clinical Journal of the American Society of Nephrology : CJASN, 16(7), 1052–1060.

Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
Heerspink, H. J., Jongs, N., Chertow, G. M., Langkilde, A. M., McMurray, J. J., Correa-Rotter, R., … Greene, T. (2021). Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial. The Lancet. Diabetes & Endocrinology.

Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
Jongs, N., Greene, T., Chertow, G. M., McMurray, J. J., Langkilde, A. M., Correa-Rotter, R., … Heerspink, H. J. (2021). Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial. The Lancet. Diabetes & Endocrinology.

COVID19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis.
Garcia, P., Anand, S., Han, J., Montez-Rath, M., Sun, S., Shang, T., … Abra, G. (2021). COVID19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis. Journal of the American Society of Nephrology : JASN.

Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study.
Parikh, R. V., Tan, T. C., Fan, D., Law, D., Salyer, A. S., Yankulin, L., … Go, A. S. (2021). Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study. PloS One, 16(10), e0257674.

The Predialysis Serum Sodium Level Modifies the Effect of Hemodialysis Frequency on Left-Ventricular Mass: The Frequent Hemodialysis Network Trials.
Raimann, J. G., Chan, C. T., Daugirdas, J. T., Depner, T., Greene, T., Kaysen, G. A., … Levin, N. W. (2021). The Predialysis Serum Sodium Level Modifies the Effect of Hemodialysis Frequency on Left-Ventricular Mass: The Frequent Hemodialysis Network Trials. Kidney & Blood Pressure Research, 1–9.

Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease. Reply.
Chertow, G. M., & Eckardt, K.-U. (2021). Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease. Reply. The New England Journal of Medicine, 385(16), e56.

COVID19 vaccine type and humoral immune response in patients receiving dialysis.
Garcia, P., Anand, S., Han, J., Montez-Rath, M., Sun, S., Shang, T., … Abra, G. (2021). COVID19 vaccine type and humoral immune response in patients receiving dialysis. MedRxiv : the Preprint Server for Health Sciences.

TWENTY-FOUR HOUR URINE TESTING AND URINARY STONE DISEASE RECURRENCE IN VETERANS
Song, S., Thomas, I.-C., Ganesan, C., Velaer, K., Chertow, G., Pao, A., & Leppert, J. (2021). TWENTY-FOUR HOUR URINE TESTING AND URINARY STONE DISEASE RECURRENCE IN VETERANS. JOURNAL OF UROLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Challenging Assumptions of Outcomes and Costs Comparing Peritoneal and Hemodialysis.
Lin, E., Lung, K. I., Chertow, G. M., Bhattacharya, J., & Lakdawalla, D. (2021). Challenging Assumptions of Outcomes and Costs Comparing Peritoneal and Hemodialysis. Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research, 24(11), 1592–1602.

Obesity and Incident Kidney Disease: Busting the Myth of Metabolically Healthy Obesity.
Anand, S., Chertow, G. M., & Beddhu, S. (2021). Obesity and Incident Kidney Disease: Busting the Myth of Metabolically Healthy Obesity. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation.

Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease
Chertow, G. M., & Eckardt, K.-U. (2021). Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease. NEW ENGLAND JOURNAL OF MEDICINE, 385(16).

Poor Reliability of Karnofsky Performance Score in Kidney Transplant Candidates
Stedman, M. R., Watford, D. J., Chertow, G. M., & Tan, J. C. (2021). Poor Reliability of Karnofsky Performance Score in Kidney Transplant Candidates. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY.

INSIDE CKD: MODELLING THE IMPACT OF IMPROVED SCREENING FOR CHRONIC KIDNEY DISEASE IN THE AMERICAS AND ASIA-PACIFIC REGION
Garcia Sanchez, J. J., Sultan, A. A., Batista, M. C., Cabrera, C., Card-Gowers, J., Chadban, S., … Xu, M. (2021). INSIDE CKD: MODELLING THE IMPACT OF IMPROVED SCREENING FOR CHRONIC KIDNEY DISEASE IN THE AMERICAS AND ASIA-PACIFIC REGION. NEPHROLOGY DIALYSIS TRANSPLANTATION. OXFORD UNIV PRESS.

INSIDE CKD: MODELLING THE ECONOMIC BURDEN OF CHRONIC KIDNEY DISEASE IN THE AMERICAS AND THE ASIA-PACIFIC REGION USING PATIENT-LEVEL MICROSIMULATION
Sultan, A. A., Batista, M. C., Cabrera, C., Card-Gowers, J., Chadban, S., Chertow, G., … Xu, M. (2021). INSIDE CKD: MODELLING THE ECONOMIC BURDEN OF CHRONIC KIDNEY DISEASE IN THE AMERICAS AND THE ASIA-PACIFIC REGION USING PATIENT-LEVEL MICROSIMULATION. NEPHROLOGY DIALYSIS TRANSPLANTATION. OXFORD UNIV PRESS.

DAPAGLIFLOZIN DECREASES ALBUMINURIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH AND WITHOUT TYPE 2 DIABETES: INSIGHTS FROM THE DAPA-CKD TRIAL
Jong, N., Chertow, G., Hou, F. F., McMurray, J., Correa-Rotter, R., Rossing, P., … Heerspink, H. L. (2021). DAPAGLIFLOZIN DECREASES ALBUMINURIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH AND WITHOUT TYPE 2 DIABETES: INSIGHTS FROM THE DAPA-CKD TRIAL. NEPHROLOGY DIALYSIS TRANSPLANTATION. OXFORD UNIV PRESS.

Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials.
Rossing, P., Inzucchi, S. E., Vart, P., Jongs, N., Docherty, K. F., Jhund, P. S., … Heerspink, H. J. (2021). Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials. The Lancet. Diabetes & Endocrinology.

Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: A prespecified analysis of the DAPA-CKD trial.
Wheeler, D. C., Jongs, N., Stefansson, B. V., Chertow, G. M., Greene, T., Hou, F. F., … Heerspink, H. J. (2021). Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: A prespecified analysis of the DAPA-CKD trial. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association.

The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure
Heerspink, J. L., Wheeler, D. C., Vart, P., Jongs, N., Hou, F. F., Langkilde, A. M., … McMurray, J. J. V. (2021). The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS.

SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis.
Anand, S., Montez-Rath, M. E., Han, J., Garcia, P., Cadden, L. C., Hunsader, P., … Parsonnet, J. (1800). SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis. Annals of Internal Medicine.

SARS-CoV-2 vaccine antibody response and breakthrough infection in dialysis.
Anand, S., Montez-Rath, M. E., Han, J., Garcia, P., Cadden, L. C., Hunsader, P., … Parsonnet, J. (2021). SARS-CoV-2 vaccine antibody response and breakthrough infection in dialysis. MedRxiv : the Preprint Server for Health Sciences.

Quetelet (Body Mass) Index and Effects of Dapagliflozin in CKD.
Chertow, G. M., Vart, P., Jongs, N., Langkilde, A. M., McMurray, J. J., Correa-Rotter, R., … Heerspink, H. J. (1800). Quetelet (Body Mass) Index and Effects of Dapagliflozin in CKD. Diabetes, Obesity & Metabolism.

Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer.
Schmidt, B., Velaer, K. N., Thomas, I.-C., Ganesan, C., Song, S., Pao, A. C., … Leppert, J. T. (1800). Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer. European Urology Open Science, 35, 29–36.

The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis.
Sinha, S., Gould, L. J., Nigwekar, S. U., Serena, T. E., Brandenburg, V., Moe, S. M., … Chertow, G. M. (1800). The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis. Clinical Kidney Journal, 15(1), 136–144.

Cardiovascular outcomes associated with prescription of SGLT-2 inhibitors versus DPP-4 inhibitors in patients with diabetes mellitus and chronic kidney disease.
Rhee, J. J., Han, J., Montez-Rath, M. E., Kim, S. H., Cullen, M. R., Stafford, R. S., … Chertow, G. M. (1800). Cardiovascular outcomes associated with prescription of SGLT-2 inhibitors versus DPP-4 inhibitors in patients with diabetes mellitus and chronic kidney disease. Diabetes, Obesity & Metabolism.

Twenty-four-hour Urine Testing and Urinary Stone Disease Recurrence in Veterans
Song, S., Thomas, I.-C., Ganesan, C., Velaer, K. N., Chertow, G. M., Pao, A. C., & Leppert, J. T. (2022). Twenty-four-hour Urine Testing and Urinary Stone Disease Recurrence in Veterans. UROLOGY, 159, 33–40.

Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease.
Tisdale, R. L., Cusick, M. M., Aluri, K. Z., Handley, T. J., Joyner, A. K., Salomon, J. A., … Owens, D. K. (2022). Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease. Journal of General Internal Medicine.

INSIDE CKD: PROJECTING THE ECONOMIC BURDEN OF CHRONIC KIDNEY DISEASE USING PATIENT-LEVEL MICROSIMULATION
Mennini, F. S., Cabrera, C. S., Card-Gowers, J., Chertow, G. M., De Nicola, L., Halimi, J. M., … Sanchez, G. J. J. (2022). INSIDE CKD: PROJECTING THE ECONOMIC BURDEN OF CHRONIC KIDNEY DISEASE USING PATIENT-LEVEL MICROSIMULATION. VALUE IN HEALTH. ELSEVIER SCIENCE INC.

Breaking the Barriers to Innovation in Kidney Care.
Nissenson, A., Chertow, G., & Conway, P. (2022). Breaking the Barriers to Innovation in Kidney Care. Clinical Journal of the American Society of Nephrology : CJASN.

Utility of Phosphate Binder Equivalent Dose Concept Reply
Pergola, P. E., Rosenbaum, D. P., Yang, Y., & Chertow, G. M. (2021). Utility of Phosphate Binder Equivalent Dose Concept Reply. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 32(7), 1824–1825.

Changing the Trajectory of Heart Failure and Kidney Disease.
Rangaswami, J., Bhalla, V., Chertow, G., Harrington, R., Staruschenko, A., Tuttle, K., & Braunwald, E. (2022). Changing the Trajectory of Heart Failure and Kidney Disease. Clinical Journal of the American Society of Nephrology : CJASN.

The Kidney Protective Effects of the Sodium-Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists.
Provenzano, M., Jongs, N., Vart, P., Stefansson, B. V., Chertow, G. M., Langkilde, A. M., … Heerspink, H. J. (2022). The Kidney Protective Effects of the Sodium-Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists. Kidney International Reports, 7(3), 436–443.

Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017.
Cheng, X. S., Han, J., Braggs-Gresham, J. L., Held, P. J., Busque, S., Roberts, J. P., … Dor, A. (2022). Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017. JAMA Network Open, 5(3), e221847.

Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD.
Briguori, C., Mathew, R. O., Huang, Z., Mavromatis, K., Hickson, L. T. J., Lau, W. L., … Bangalore, S. (2022). Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD. Journal of the American Heart Association, e022003.

Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: AnADAPT-DES Substudy.
Mohebi, R., Karimi Galougahi, K., Garcia, J. J., Horst, J., Ben-Yehuda, O., Radhakrishnan, J., … Ali, Z. A. (2022). Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: AnADAPT-DES Substudy. JACC. Cardiovascular Interventions.

Dysgeusia and Dysosmia in Chronic Kidney Disease: NHANES 2011-2014.
Vengalasetti, Y. V., Chertow, G. M., & Popat, R. (2021). Dysgeusia and Dysosmia in Chronic Kidney Disease: NHANES 2011-2014. Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation.

SARS-CoV-2 infection during the Omicron surge among patients receiving dialysis: the role of circulating receptor-binding domain antibodies and vaccine doses.
Montez-Rath, M. E., Garcia, P., Han, J., Cadden, L. C., Hunsader, P., Morgan, C., … Chertow, G. M. (2022). SARS-CoV-2 infection during the Omicron surge among patients receiving dialysis: the role of circulating receptor-binding domain antibodies and vaccine doses. MedRxiv : the Preprint Server for Health Sciences.

SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients.
Wang, A. X., Busque, S., Kuo, J., Singh, U., Roeltgen, K., Pinsky, B. A., … Lenihan, C. R. (2022). SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients. Kidney360, 3(1), 133–143.

Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis: A Cluster Randomized Trial.
Chang, T. I., Tatoian, E. T., Montez-Rath, M. E., & Chertow, G. M. (2021). Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis: A Cluster Randomized Trial. Kidney360, 2(11), 1752–1760.

Emerging Role of Clinical Genetics in CKD.
Devarajan, P., Chertow, G. M., Susztak, K., Levin, A., Agarwal, R., Stenvinkel, P., … Warady, B. A. (2022). Emerging Role of Clinical Genetics in CKD. Kidney Medicine, 4(4), 100435.

Baseline Diastolic Blood Pressure and Cardiovascular Outcomes in SPRINT Participants with Chronic Kidney Disease.
Chang, T. I., Wei, G., Boucher, R., Kramer, H., Chertow, G. M., Cheung, A. K., … Beddhu, S. (2020). Baseline Diastolic Blood Pressure and Cardiovascular Outcomes in SPRINT Participants with Chronic Kidney Disease. Kidney360, 1(5), 368–375.

SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis.
Garcia, P., Han, J., Montez-Rath, M., Sun, S., Shang, T., Parsonnet, J., … Abra, G. (2022). SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis. Clinical Journal of the American Society of Nephrology : CJASN.

THE TABLO HEMODIALYSIS SYSTEM INCREASES PATIENT LIKELIHOOD FOR HHD ADOPTION
Saffer, T., Aragon, M., & Chertow, G. (2022). THE TABLO HEMODIALYSIS SYSTEM INCREASES PATIENT LIKELIHOOD FOR HHD ADOPTION. AMERICAN JOURNAL OF KIDNEY DISEASES. W B SAUNDERS CO-ELSEVIER INC.

TABLO HEMODIALYSIS SYSTEMS COULD INCREASE RECOMMENDATIONS OF HOME HEMODIALYSIS FOR PATIENTS
Saffer, T., Aragon, M., & Chertow, G. (2022). TABLO HEMODIALYSIS SYSTEMS COULD INCREASE RECOMMENDATIONS OF HOME HEMODIALYSIS FOR PATIENTS. AMERICAN JOURNAL OF KIDNEY DISEASES. W B SAUNDERS CO-ELSEVIER INC.

Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial.
Waijer, S. W., Vart, P., Cherney, D. Z., Chertow, G. M., Jongs, N., Langkilde, A. M., … Heerspink, H. J. (2022). Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial. Diabetologia.

Risk prediction models for contrast induced nephropathy: systematic review.
Risk prediction models for contrast induced nephropathy: systematic review. (2015). BMJ (Clinical Research Ed.), 351, h5401.

Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions.
Vart, P., Correa-Rotter, R., Hou, F. F., Jongs, N., Chertow, G. M., Langkilde, A. M., … Heerspink, H. J. (2022). Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions. Kidney International Reports, 7(4), 699–707.

Trends in Coronary Artery Disease Screening before Kidney Transplantation.
Cheng, X. S., Liu, S., Han, J., Stedman, M. R., Chertow, G. M., Tan, J. C., & Fearon, W. F. (2022). Trends in Coronary Artery Disease Screening before Kidney Transplantation. Kidney360, 3(3), 516–523.

APOL1 INHIBITION BY VX-147 AS A TARGETED THERAPY FOR APOL1-MEDIATED KIDNEY DISEASE
Pollak, M., Friedman, D., Barisoni, L., Falk, R., Gipson, D., Lipkowitz, M., … Chertow, G. (2022). APOL1 INHIBITION BY VX-147 AS A TARGETED THERAPY FOR APOL1-MEDIATED KIDNEY DISEASE. AMERICAN JOURNAL OF KIDNEY DISEASES. W B SAUNDERS CO-ELSEVIER INC.

<p>Emerging Role of Clinical Genetics in CKD & nbsp;</p>
Devarajan, P., Chertow, G. M., Susztak, K., Levin, A., Agarwal, R., Stenvinkel, P., … Warady, B. A. (2022).

Emerging Role of Clinical Genetics in CKD & nbsp;

KIDNEY MEDICINE, 4(4).

Projecting the Economic Impact of Compensating Living Kidney Donors in the United States: Cost-Benefit Analysis Demonstrates Substantial Patient and Societal Gains.
McCormick, F., Held, P. J., Chertow, G. M., Peters, T. G., & Roberts, J. P. (2022). Projecting the Economic Impact of Compensating Living Kidney Donors in the United States: Cost-Benefit Analysis Demonstrates Substantial Patient and Societal Gains. Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research.

Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease.
Koury, M. J., Agarwal, R., Chertow, G. M., Eckardt, K.-U., Fishbane, S., Ganz, T., … Winkelmayer, W. C. (2022). Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease. American Journal of Hematology.

Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function.
Bangalore, S., Hochman, J. S., Stevens, S. R., Jones, P. G., Spertus, J. A., O'Brien, S. M., … Maron, D. J. (2022). Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function. JAMA Cardiology.

EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE ACCORDING TO BACKGROUND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKER DOSE
Heerspink, H. L., Jong, N., Stefansson, B., Chertow, G., Langkilde, A. M., Mcmurray, J., … Wheeler, D. (2022). EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE ACCORDING TO BACKGROUND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKER DOSE. NEPHROLOGY DIALYSIS TRANSPLANTATION. OXFORD UNIV PRESS.

CARDIOVASCULAR EVENTS IN PATIENTS WITH ANEMIA ASSOCIATED WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE: REGIONAL ANALYSIS OF PATIENTS NOT PREVIOUSLY TREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS IN THE PRO2TECT TRIAL
Winkelmayer, W., Arnold, S., Burke, S., Chertow, G., Eckardt, K.-U., Luo, W., … Parfrey, P. (2022). CARDIOVASCULAR EVENTS IN PATIENTS WITH ANEMIA ASSOCIATED WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE: REGIONAL ANALYSIS OF PATIENTS NOT PREVIOUSLY TREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS IN THE PRO2TECT TRIAL. NEPHROLOGY DIALYSIS TRANSPLANTATION. OXFORD UNIV PRESS.

CARDIOVASCULAR EVENTS IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE AND ANEMIA: REGIONAL ANALYSIS OF PATIENTS PREVIOUSLY TREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS IN THE PRO2TECT TRIAL
Parfrey, P., Chertow, G., Eckardt, K.-U., Burke, S., Luo, W., Minga, T., & Winkelmayer, W. (2022). CARDIOVASCULAR EVENTS IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE AND ANEMIA: REGIONAL ANALYSIS OF PATIENTS PREVIOUSLY TREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS IN THE PRO2TECT TRIAL. NEPHROLOGY DIALYSIS TRANSPLANTATION. OXFORD UNIV PRESS.

SARS-CoV-2 Infection during the Omicron Surge among Patients Receiving Dialysis: The Role of Circulating Receptor-Binding Domain Antibodies and Vaccine Doses.
Montez-Rath, M. E., Garcia, P., Han, J., Cadden, L. C., Hunsader, P., Morgan, C., … Anand, S. (2022). SARS-CoV-2 Infection during the Omicron Surge among Patients Receiving Dialysis: The Role of Circulating Receptor-Binding Domain Antibodies and Vaccine Doses. Journal of the American Society of Nephrology : JASN.

Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with Chronic Kidney Disease.
Jongs, N., Chertow, G., Greene, T., McMurray, J., Langkilde, A. M., Correa-Rotter, R., … Heerspink, H. (2022). Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with Chronic Kidney Disease. Journal of the American Society of Nephrology : JASN.

Cardiovascular Effects of Home Dialysis Therapies: A Scientific Statement From the American Heart Association
Sarnak, M. J., Auguste, B. L., Brown, E., Chang, A. R., Chertow, G. M., Hannan, M., … Chan, C. T. (2022). Cardiovascular Effects of Home Dialysis Therapies: A Scientific Statement From the American Heart Association. CIRCULATION, 146(11), E146–E164.

Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study
Ziolkowski, S., Liu, S., Montez-Rath, M. E., Denburg, M., Winkelmayer, W. C., Chertow, G. M., & O'Shaughnessy, M. M. (2022). Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study. CLINICAL KIDNEY JOURNAL.

Parathyroidectomy and Cinacalcet Use in Medicare-Insured Kidney Transplant Recipients.
Wang, A. X., Liu, S., Montez-Rath, M. E., Chertow, G. M., & Lenihan, C. R. (2022). Parathyroidectomy and Cinacalcet Use in Medicare-Insured Kidney Transplant Recipients. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation.

Testosterone concentrations andoutcomes in hemodialysis patients of the EVOLVE trial.
Nilsson, E., Stenvinkel, P., Liu, S., Stedman, M. R., Chertow, G. M., & Floege, J. (2022). Testosterone concentrations andoutcomes in hemodialysis patients of the EVOLVE trial. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association.

Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM)
Block, G. A., Bleyer, A. J., Silva, A. L., Weiner, D. E., Lynn, R., Yang, Y., … Chertow, G. M. (2021). Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM). KIDNEY360, 2(10), 1600–1610.

Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria
Heerspink, H. J. L., Chertow, G. M., Jongs, N., Correa-Rotter, R., Rossing, P., Sjostrom, C. D., … Wheeler, D. C. (2022). Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY.

EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ALBUMINURIA, WITH AND WITHOUT DIABETES, BY USE AND NON-USE OF CARDIOVASCULAR MEDICATIONS: DAPA-CKD TRIAL
Correa-Rotter, R., Chertow, G., Mark, P., Nowicki, M., Vart, P., Niels, J., … Heerspink, H. (2022). EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ALBUMINURIA, WITH AND WITHOUT DIABETES, BY USE AND NON-USE OF CARDIOVASCULAR MEDICATIONS: DAPA-CKD TRIAL. NEPHROLOGY. WILEY.

Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis.
McEwan, P., Boyce, R., Sanchez, J. J., Sjostrom, C. D., Stefansson, B., Nolan, S., … Heerspink, H. J. (2022). Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association.

National Imaging Trends for Suspected Urinary Stone Disease in the Emergency Department.
Ganesan, C., Stedman, M. R., Liu, S., Conti, S. L., Chertow, G. M., Leppert, J. T., & Pao, A. C. (2022). National Imaging Trends for Suspected Urinary Stone Disease in the Emergency Department. JAMA Internal Medicine.

APOL1 G3 Variant Is Associated with Cardiovascular Mortality and Sudden Cardiac Death in Patients Receiving Maintenance Hemodialysis of European Ancestry.
Schwantes-An, T.-H., Robinson-Cohen, C., Liu, S., Zheng, N., Stedman, M., Wetherill, L., … Moe, S. M. (2022). APOL1 G3 Variant Is Associated with Cardiovascular Mortality and Sudden Cardiac Death in Patients Receiving Maintenance Hemodialysis of European Ancestry. Cardiorenal Medicine, 1–7.

Apixaban for Patients with Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
Pokorney, S. D., Chertow, G. M., Al-Khalidi, H. R., Gallup, D., Dignaco, P., Mussina, K., … Granger, C. B. (2022). Apixaban for Patients with Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial. Circulation.

Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria.
Heerspink, H. J., Chertow, G. M., Jongs, N., Correa-Rotter, R., Rossing, P., Sjöström, C. D., … Wheeler, D. C. (2022). Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria. Clinical Journal of the American Society of Nephrology : CJASN, 17(11), 1665–1668.

Risks for Anaphylaxis With Intravenous Iron Formulations.
Dave, C. V., Brittenham, G. M., Carson, J. L., & Setoguchi, S. (2022). Risks for Anaphylaxis With Intravenous Iron Formulations. Annals of Internal Medicine, 175(11), W143–W144.

Risks for Anaphylaxis With Intravenous Iron Formulations.
Al-Samkari, H., Glaspy, J. A., Means, R. T., Chertow, G. M., & Auerbach, M. (2022). Risks for Anaphylaxis With Intravenous Iron Formulations. Annals of Internal Medicine, 175(11), W143.

Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study.
Ziolkowski, S., Liu, S., Montez-Rath, M. E., Denburg, M., Winkelmayer, W. C., Chertow, G. M., & O'Shaughnessy, M. M. (2022). Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study. Clinical Kidney Journal, 15(12), 2245–2257.

Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes.
Vart, P., Vaduganathan, M., Jongs, N., Remuzzi, G., Wheeler, D. C., Hou, F. F., … Heerspink, H. J. (2022). Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes. Clinical Journal of the American Society of Nephrology : CJASN.

Effects of Bardoxolone Methyl in Alport Syndrome.
Warady, B. A., Pergola, P. E., Agarwal, R., Andreoli, S., Appel, G. B., Bangalore, S., … Chertow, G. M. (2022). Effects of Bardoxolone Methyl in Alport Syndrome. Clinical Journal of the American Society of Nephrology : CJASN.

Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKD.
Schechter, M., Jongs, N., Chertow, G. M., Mosenzon, O., McMurray, J. J., Correa-Rotter, R., … Heerspink, H. J. (2022). Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKD. Annals of Internal Medicine.

Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure.
Tardif, J.-C., Rouleau, J., Chertow, G. M., Al-Shurbaji, A., Lisovskaja, V., Gustavson, S., … Pfeffer, M. A. (2022). Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure. ESC Heart Failure.

Association of Pretransplant Coronary Heart Disease Testing With Early Kidney Transplant Outcomes.
Cheng, X. S., Liu, S., Han, J., Stedman, M. R., Baiocchi, M., Tan, J. C., … Fearon, W. F. (2023). Association of Pretransplant Coronary Heart Disease Testing With Early Kidney Transplant Outcomes. JAMA Internal Medicine.

Overall Adverse Event Profile of Vadadustat for the Treatment of Anemia Associated With Chronic Kidney Disease in Phase 3 Trials
Agarwal, R., Anand, S., Eckardt, K.-U., Luo, W., Parfrey, P. S., Sarnak, M. J., … Chertow, G. M. (2022). Overall Adverse Event Profile of Vadadustat for the Treatment of Anemia Associated With Chronic Kidney Disease in Phase 3 Trials. AMERICAN JOURNAL OF NEPHROLOGY.

Authors' Reply.
Pergola, P. E., Rosenbaum, D. P., Yang, Y., & Chertow, G. M. (2021). Authors' Reply. Journal of the American Society of Nephrology : JASN, 32(7), 1824–1825.

Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study.
Beernink, J. M., Persson, F., Jongs, N., Laverman, G. D., Chertow, G. M., McMurray, J. J., … Heerspink, H. J. (2023). Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study. Diabetes Care.

Cardiovascular Drug Use After Acute Kidney Injury Among Hospitalized Patients With a History of Myocardial Infarction.
Meraz-Muñoz, A. Y., Jeyakumar, N., Luo, B., Beaubien-Souligny, W., Chanchlani, R., Clark, E. G., … Silver, S. A. (2023). Cardiovascular Drug Use After Acute Kidney Injury Among Hospitalized Patients With a History of Myocardial Infarction. Kidney International Reports, 8(2), 294–304.

Effects of dapagliflozin on cardiovascular and kidney events by baseline eGFR and UACR in patients with type 2 diabetes mellitus: a patient-level pooled analysis of DECLARE-TIMI 58 and DAPA-CKD trials
Moura, F., Wiviott, S., Chertow, G., Dwyer, J., Gause-Nilsson, Johansson, P., … Heerspink, H. (2022). Effects of dapagliflozin on cardiovascular and kidney events by baseline eGFR and UACR in patients with type 2 diabetes mellitus: a patient-level pooled analysis of DECLARE-TIMI 58 and DAPA-CKD trials. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS.

Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Yi, T. W., Smyth, B., Di Tanna, G. L., Arnott, C., Cardoza, K., Kang, A., … Jardine, M. (2023). Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation.

The potential roles of galectin-3 in AKI and CKD.
Wang, F., Zhou, L., Eliaz, A., Hu, C., Qiang, X., Ke, L., … Peng, Z. (2023). The potential roles of galectin-3 in AKI and CKD. Frontiers in Physiology, 14, 1090724.

Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants.
Egbuna, O., Zimmerman, B., Manos, G., Fortier, A., Chirieac, M. C., Dakin, L. A., … Chertow, G. M. (2023). Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. The New England Journal of Medicine, 388(11), 969–979.

Feasibility and Acceptability of SARS-CoV-2 Screening among Patients Receiving Hemodialysis: A Pilot Study.
Anand, S., Montez-Rath, M., Varkila, M., Yu, X., Block, M., Brillhart, S., … Block, G. (2023). Feasibility and Acceptability of SARS-CoV-2 Screening among Patients Receiving Hemodialysis: A Pilot Study. Clinical Journal of the American Society of Nephrology : CJASN.

Clinically Indicated, Equitable Care for Ischemic Heart Disease in CKD: A Call to Action.
Fielding-Singh, V., & Chertow, G. M. (2023). Clinically Indicated, Equitable Care for Ischemic Heart Disease in CKD: A Call to Action. Journal of the American Society of Nephrology : JASN, 34(4), 525–526.

Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism.
Seib, C. D., Ganesan, C., Furst, A., Pao, A. C., Chertow, G. M., Leppert, J. T., … Tamura, M. K. (2023). Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism. Annals of Internal Medicine.

Kidney Stone Events after Kidney Transplant in the United States.
Ganesan, C., Holmes, M., Liu, S., Montez-Rath, M., Conti, S., Chang, T. C., … Pao, A. C. (2023). Kidney Stone Events after Kidney Transplant in the United States. Clinical Journal of the American Society of Nephrology : CJASN.

Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis.
Sarnak, M. J., Agarwal, R., Boudville, N., Chowdhury, P. C., Eckardt, K.-U. U., Gonzalez, C. R., … Chertow, G. M. (2023). Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association.

Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial.
Vart, P., Jongs, N., Wheeler, D. C., Heerspink, H. J., Langkilde, A. M., & Chertow, G. M. (2023). Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open, 6(4), e2310877.

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial.
Chertow, G. M., Correa-Rotter, R., Vart, P., Jongs, N., McMurray, J. J., Rossing, P., … Heerspink, H. J. (2023). Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial. Journal of the American Heart Association, e028739.

Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials.
Heerspink, H. L., Jongs, N., Neuen, B., Schloemer, P., Vaduganathan, M., Inker, L., … Perkovic, V. (2023). Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials. Kidney International.

Deceased Donor Kidney Transplantation for Older Transplant Candidates: A New Microsimulation Model for Determining Risks and Benefits.
Kaufmann, M. B., Tan, J. C., Chertow, G. M., & Goldhaber-Fiebert, J. D. (2023). Deceased Donor Kidney Transplantation for Older Transplant Candidates: A New Microsimulation Model for Determining Risks and Benefits. Medical Decision Making : an International Journal of the Society for Medical Decision Making, 272989X231172169.

Population-Wide Screening for Chronic Kidney Disease : A Cost-Effectiveness Analysis.
Cusick, M. M., Tisdale, R. L., Chertow, G. M., Owens, D. K., & Goldhaber-Fiebert, J. D. (2023). Population-Wide Screening for Chronic Kidney Disease : A Cost-Effectiveness Analysis. Annals of Internal Medicine.

Groundwater constituents and the incidence of kidney cancer.
Soerensen, S. J., Montez-Rath, M. E., Cheng, I., Gomez, S. L., Oh, D. L., Jackson, C., … Leppert, J. T. (2023). Groundwater constituents and the incidence of kidney cancer. Cancer.

Class I and II Human Leukocyte Antigen Serotypes Associated with End-Stage Kidney Disease due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease
Afolabi, H., Zhang, B., O'Shaughnessy, M., Chertow, G., Lafayette, R., & Charu, V. (2023). Class I and II Human Leukocyte Antigen Serotypes Associated with End-Stage Kidney Disease due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease. LABORATORY INVESTIGATION. ELSEVIER SCIENCE INC.

Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. Reply.
Egbuna, O., & Chertow, G. M. (2023). Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. Reply. The New England Journal of Medicine, 388(26), 2491.

Heterogeneous treatment effects of intensive glycemic control on kidney microvascular outcomes in ACCORD.
Charu, V., Liang, J. W., Chertow, G. M., Li, Z. J., Montez-Rath, M. E., Geldsetzer, P., … Tamura, M. K. (2023). Heterogeneous treatment effects of intensive glycemic control on kidney microvascular outcomes in ACCORD. MedRxiv : the Preprint Server for Health Sciences.

Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients.
Parfrey, P. S., Burke, S. K., Chertow, G. M., Eckardt, K.-U., Jardine, A. G., Lewis, E. F., … Winkelmayer, W. C. (2023). Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients. Kidney Medicine, 5(7), 100667.

Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Naive Patients.
Winkelmayer, W. C., Arnold, S., Burke, S. K., Chertow, G. M., Eckardt, K.-U., Jardine, A. G., … Parfrey, P. S. (2023). Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Naive Patients. Kidney Medicine, 5(7), 100666.

Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease.
Schechter, M., Chertow, G. M., & Heerspink, H. J. (2023). Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease. Annals of Internal Medicine, 176(7), eL230070.

Use of Wastewater Metrics to Track COVID-19 in the US.
Varkila, M. R., Montez-Rath, M. E., Salomon, J. A., Yu, X., Block, G. A., Owens, D. K., … Anand, S. (2023). Use of Wastewater Metrics to Track COVID-19 in the US. JAMA Network Open, 6(7), e2325591.

Disparities in the Timing of Preoperative Hemodialysis Among Patients With End-Stage Kidney Disease.
Fielding-Singh, V., Vanneman, M. W., Morris, A. M., Chertow, G. M., & Lin, E. (2023). Disparities in the Timing of Preoperative Hemodialysis Among Patients With End-Stage Kidney Disease. JAMA Network Open, 6(7), e2326326.

Hypocitraturia and Risk of Bone Disease in Patients With Kidney Stone Disease
Ganesan, C., Thomas, I.-C., Montez-Rath, M. E., Chertow, G. M., Leppert, J. T., & Pao, A. C. (2023). Hypocitraturia and Risk of Bone Disease in Patients With Kidney Stone Disease. JBMR PLUS.

Efficacy and Safety of Dapagliflozin in Patients with Chronic Kidney Disease across the Spectrum of Frailty.
Vart, P., Butt, J. H., Jongs, N., Schechter, M., Chertow, G. M., Wheeler, D. C., … Heerspink, H. J. (2023). Efficacy and Safety of Dapagliflozin in Patients with Chronic Kidney Disease across the Spectrum of Frailty. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences.

AMBIENT HEAT EXPOSURE AND ESTIMATED GLOMERULAR FILTRATION RATE TRAJECTORY: A POST-HOC ANALYSIS OF THE DAPA-CKD TRIAL
Zhang, Z., Ileerspink, H. L., Chertow, G., Correa-Rotter, R., Gasparrini, A., Jong, N., … Ben Caplin. (2023). AMBIENT HEAT EXPOSURE AND ESTIMATED GLOMERULAR FILTRATION RATE TRAJECTORY: A POST-HOC ANALYSIS OF THE DAPA-CKD TRIAL. NEPHROLOGY DIALYSIS TRANSPLANTATION. OXFORD UNIV PRESS.

EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH CKD ACROSS THE SPECTRUM OF AGE AND BY SEX
Yu, M., Vart, P., Heerspink, H. L., Jong, N., Correa-Rotter, R., Mcmurray, J., … Chertow, G. (2023). EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH CKD ACROSS THE SPECTRUM OF AGE AND BY SEX. NEPHROLOGY DIALYSIS TRANSPLANTATION. OXFORD UNIV PRESS.

REASONS FOR DIALYSIS INITIATION AND SAFETY OF DAPAGLIFLOZIN AMONG DIALYSIS PARTICIPANTS: NEW INSIGHTS FROMDAPA-CKD
Heerspink, H. L., Wheeler, D. C., Jong, N., Correa-Rotter, R., Rossing, P., Gansevoort, R., … Chertow, G. (2023). REASONS FOR DIALYSIS INITIATION AND SAFETY OF DAPAGLIFLOZIN AMONG DIALYSIS PARTICIPANTS: NEW INSIGHTS FROMDAPA-CKD. NEPHROLOGY DIALYSIS TRANSPLANTATION. OXFORD UNIV PRESS.

APOL1 GENOTYPING AND PROTEINURIC KIDNEY DISEASE IN EUROPE
Knebelmann, B., Bramham, K., Mccafferty, K., Zaidan, M., Torres, P. A. U., Audard, V., … Chertow, G. (2023). APOL1 GENOTYPING AND PROTEINURIC KIDNEY DISEASE IN EUROPE. NEPHROLOGY DIALYSIS TRANSPLANTATION. OXFORD UNIV PRESS.

Using Relative Survival to Estimate the Burden of Kidney Failure.
Stedman, M. R., Tamura, M. K., & Chertow, G. M. (2023). Using Relative Survival to Estimate the Burden of Kidney Failure. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation.

Hypocitraturia and Risk of Bone Disease in Patients With Kidney Stone Disease.
Ganesan, C., Thomas, I.-C. C., Montez-Rath, M. E., Chertow, G. M., Leppert, J. T., & Pao, A. C. (2023). Hypocitraturia and Risk of Bone Disease in Patients With Kidney Stone Disease. JBMR Plus, 7(9), e10786.

Market Competition and Anemia Management in the United States following Dialysis Payment Reform.
Bhatnagar, A., Parvathareddy, V., Winkelmayer, W. C., Chertow, G. M., & Erickson, K. F. (2023). Market Competition and Anemia Management in the United States following Dialysis Payment Reform. Medical Care.

Performance characteristics of a prototype dialysate turbidity monitoring system to detect peritonitis in patients receiving peritoneal dialysis.
Briggs, B., Garcia-Garcia, G., Ibarra-Hernandez, M., Alcantar-Vallin, L., Walker, G., Yu, E., … Chertow, G. M. (2023). Performance characteristics of a prototype dialysate turbidity monitoring system to detect peritonitis in patients receiving peritoneal dialysis. Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis, 8968608231195532.

The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease.
Afolabi, H., Zhang, B. M., O'Shaughnessy, M., Chertow, G. M., Lafayette, R., & Charu, V. (2023). The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation.

Implications of a Race Term in GFR Estimates Used to Predict AKI After Coronary Intervention.
Uzendu, A., Kennedy, K., Chertow, G., Amin, A. P., Giri, J. S., Rymer, J. A., … Spertus, J. A. (2023). Implications of a Race Term in GFR Estimates Used to Predict AKI After Coronary Intervention. JACC. Cardiovascular Interventions, 16(18), 2309–2320.

Contemporary Methods for Predicting Acute Kidney Injury After Coronary Intervention.
Uzendu, A., Kennedy, K., Chertow, G., Amin, A. P., Giri, J. S., Rymer, J. A., … Spertus, J. A. (2023). Contemporary Methods for Predicting Acute Kidney Injury After Coronary Intervention. JACC. Cardiovascular Interventions, 16(18), 2294–2305.

Muscle Mass and Serum Creatinine Concentration by Race and Ethnicity Among Hemodialysis Patients.
Delgado, C., Powe, N. R., Chertow, G. M., Grimes, B., & Johansen, K. L. (2023). Muscle Mass and Serum Creatinine Concentration by Race and Ethnicity Among Hemodialysis Patients. Journal of the American Society of Nephrology : JASN.

Inaxaplin for Proteinuric Kidney Disease in Persons with Two <i>APOL1</i> Variants
Egbuna, O., & Chertow, G. M. (2023). Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. NEW ENGLAND JOURNAL OF MEDICINE, 388(26), 2491.

Use of wastewater metrics to track COVID-19 in the U.S.: a national time-series analysis over the first three quarters of 2022.
Varkila, M., Montez-Rath, M., Salomon, J., Yu, X., Block, G., Owens, D. K., … Anand, S. (2023). Use of wastewater metrics to track COVID-19 in the U.S.: a national time-series analysis over the first three quarters of 2022. MedRxiv : the Preprint Server for Health Sciences.

Tenapanor Improves Long-term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study.
Silva, A. L., Chertow, G. M., Hernandez, G. T., Lynn, R. I., Tietjen, D. P., Rosenbaum, D. P., … Edelstein, S. (2023). Tenapanor Improves Long-term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study. Kidney360.

Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials.
Fletcher, R. A., Jongs, N., Chertow, G. M., McMurray, J. J., Arnott, C., Jardine, M. J., … Neuen, B. L. (2023). Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials. Journal of the American Society of Nephrology : JASN.

Report From a Multidisciplinary Symposium on the Future of Living Kidney Donor Transplantation.
Peters, T. G., Fung, J. J., Radcliffe-Richards, J., Satel, S., Roth, A. E., McCormick, F., … Ojo, A. (2023). Report From a Multidisciplinary Symposium on the Future of Living Kidney Donor Transplantation. Progress in Transplantation (Aliso Viejo, Calif.), 15269248231212911.

Association of Bioimpedance Parameters with Increases in Blood Pressure during Hemodialysis.
Elsayed, E., Farag, Y. M., Ravi, K. S., Chertow, G. M., & McCausland, F. R. (2023). Association of Bioimpedance Parameters with Increases in Blood Pressure during Hemodialysis. Clinical Journal of the American Society of Nephrology : CJASN.

Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD.
Charu, V., Liang, J. W., Chertow, G. M., Li, J., Montez-Rath, M. E., Geldsetzer, P., … Tamura, M. K. (2023). Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD. Journal of the American Society of Nephrology : JASN.

Estimating Life Years from Transplant in Older Candidates
Stedman, M., Ahearn, P., Liu, C. K., Chertow, G. M., & Tan, J. C. (2023). Estimating Life Years from Transplant in Older Candidates. AMERICAN JOURNAL OF TRANSPLANTATION. ELSEVIER SCIENCE INC.

Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex.
Yu, M. K., Vart, P., Jongs, N., Correa-Rotter, R., Rossing, P., McMurray, J. J., … Chertow, G. M. (2023). Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex. Journal of General Internal Medicine.

Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease.
Rhee, J. J., Han, J., Montez-Rath, M. E., & Chertow, G. M. (2024). Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, Obesity & Metabolism.

Population-Wide Screening for Chronic Kidney Disease.
Cusick, M. M., Tisdale, R. L., Chertow, G. M., Owens, D. K., & Goldhaber-Fiebert, J. D. (2024). Population-Wide Screening for Chronic Kidney Disease. Annals of Internal Medicine, 177(1), eL230370.

Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis.
Bansal, S., Boucher, R., Shen, J., Wei, G., Chertow, G. M., Whelton, P. K., … Beddhu, S. (2024). Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis. Clinical Journal of the American Society of Nephrology : CJASN.

Dapagliflozin and Anemia in Patients with Chronic Kidney Disease.
Koshino, A., Schechter, M., Chertow, G. M., Vart, P., Jongs, N., Toto, R. D., … Heerspink, H. J. (2023). Dapagliflozin and Anemia in Patients with Chronic Kidney Disease. NEJM Evidence, 2(6), EVIDoa2300049.

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Active Kidney Involvement in the United States: 2016-2020.
Tao, J., Liu, S., Montez-Rath, M., Charu, V., & Chertow, G. M. (2024). Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Active Kidney Involvement in the United States: 2016-2020. Glomerular Diseases, 4(1), 33–42.

Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria.
Heerspink, H. J., Provenzano, M., Vart, P., Jongs, N., Correa-Rotter, R., Rossing, P., … Chertow, G. M. (2024). Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria. American Heart Journal.

Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial.
McEwan, P., Davis, J. A., Gabb, P. D., Wheeler, D. C., Rossing, P., Chertow, G. M., … Garcia Sanchez, J. J. (2024). Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial. Clinical Kidney Journal, 17(2), sfae025.

Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification.
Perello, J., Alberti, J., Torres, J. V., Ferrer, M. D., Perez, M. M., Bassissi, F., … Salcedo, C. (2024). Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification. Frontiers in Pharmacology, 15, 1325186.

Bias and Accuracy of Glomerular Filtration Rate Estimating Equations in the US: A Systematic Review and Meta-Analysis.
Yan, A. F., Williams, M. Y., Shi, Z., Oyekan, R., Yoon, C., Bowen, R., & Chertow, G. M. (2024). Bias and Accuracy of Glomerular Filtration Rate Estimating Equations in the US: A Systematic Review and Meta-Analysis. JAMA Network Open, 7(3), e241127.

Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trial.
Zhang, Z., Heerspink, H. J., Chertow, G. M., Correa-Rotter, R., Gasparrini, A., Jongs, N., … Caplin, B. (2024). Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trial. The Lancet. Planetary Health, 8(4), e225–e233.

Effects of RBT-1 on preconditioning response biomarkers in patients undergoing coronary artery bypass graft or heart valve surgery: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.
Lamy, A., Chertow, G. M., Jessen, M., Collar, A., Brown, C. D., Mack, C. A., … Singh, B. (2024). Effects of RBT-1 on preconditioning response biomarkers in patients undergoing coronary artery bypass graft or heart valve surgery: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial. EClinicalMedicine, 68, 102364.

Safety and Tolerability of the APOL1 Inhibitor, Inaxaplin, following Single- and Multiple-Ascending Doses in Healthy Adults.
Egbuna, O., Audard, V., Manos, G., Tian, S., Hagos, F., & Chertow, G. M. (2024). Safety and Tolerability of the APOL1 Inhibitor, Inaxaplin, following Single- and Multiple-Ascending Doses in Healthy Adults. Glomerular Diseases, 4(1), 64–73.

Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials.
Fletcher, R. A., Herrington, W. G., Agarwal, R., Mayne, K. J., Arnott, C., Jardine, M. J., … Neuen, B. L. (2024). Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials. Clinical Journal of the American Society of Nephrology : CJASN.

The Use of Telemedicine by US Nephrologists for In-Center Hemodialysis Care During the Pandemic: AnAnalysis of National Medicare Claims.
Niu, J., Rosales, O., Oluyomi, A., Lew, S. Q., Winkelmayer, W. C., Chertow, G. M., & Erickson, K. F. (2024). The Use of Telemedicine by US Nephrologists for In-Center Hemodialysis Care During the Pandemic: AnAnalysis of National Medicare Claims. Kidney Medicine, 6(4), 100798.

Association of Changes in Vector Length with Changes in Left Ventricular Mass Among Patients on Maintenance Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial.
Elsayed, E., Farag, Y. M., Ravi, K. S., Chertow, G. M., & Mc Causland, F. R. (2024). Association of Changes in Vector Length with Changes in Left Ventricular Mass Among Patients on Maintenance Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial. Kidney360.

My Plate Awareness and Engagement and Perceived and Objective Diet Quality in US Adults with Chronic Kidney Disease.
Thule, J., Yu, X., Montez-Rath, M. E., & Chertow, G. M. (2024). My Plate Awareness and Engagement and Perceived and Objective Diet Quality in US Adults with Chronic Kidney Disease. Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation.

A Prospective Clinical Study to EvaluAte the AbiliTy of the CloudCath System to Detect Peritonitis During In-Home Peritoneal Dialysis (CATCH)
Mehrotra, R., Williamson, D. E., Betts, C. R., Greco, B. A., Yu, E., El-Badry, A., … Chertow, G. M. (2024). A Prospective Clinical Study to EvaluAte the AbiliTy of the CloudCath System to Detect Peritonitis During In-Home Peritoneal Dialysis (CATCH). KIDNEY INTERNATIONAL REPORTS, 9(4), 929–940.

A Prospective Clinical Study to EvaluAte the AbiliTy of the CloudCath System to Detect Peritonitis During In-Home Peritoneal Dialysis (CATCH).
Mehrotra, R., Williamson, D. E., Betts, C. R., Greco, B. A., Yu, E., El-Badry, A., … Chertow, G. M. (2024). A Prospective Clinical Study to EvaluAte the AbiliTy of the CloudCath System to Detect Peritonitis During In-Home Peritoneal Dialysis (CATCH). Kidney International Reports, 9(4), 929–940.

IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.
Chertow, G. M., Chang, A. M., Felker, G. M., Heise, M., Velkoska, E., Fellström, B., … Wolf, M. (2024). IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature Medicine.

Revisiting a "Paradigm" in Cardiovascular and Kidney Disease.
Chertow, G. M. (2024). Revisiting a "Paradigm" in Cardiovascular and Kidney Disease. Journal of the American College of Cardiology, 83(22), 2160–2162.

The Use of KDIGO AKI Definitions in AKI Research: PRO.
McCoy, I. E., & Chertow, G. M. (2024). The Use of KDIGO AKI Definitions in AKI Research: PRO. Kidney360.

The Medical Costs of Determining Eligibility and Waiting for a Kidney Transplantation.
Xu, K., Dor, A., Mohanty, S., Han, J., Parvathinathan, G., Braggs-Gresham, J. L., … Cheng, X. S. (2024). The Medical Costs of Determining Eligibility and Waiting for a Kidney Transplantation. Medical Care.

Patient Perspectives on Using Telemedicine During In-Center Hemodialysis: A Qualitative Study.
Haltom, T. M., Lew, S. Q., Winkelmayer, W. C., Chertow, G. M., Jaure, A., & Erickson, K. F. (2024). Patient Perspectives on Using Telemedicine During In-Center Hemodialysis: A Qualitative Study. Kidney Medicine, 6(7), 100848.

Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial.
Moloney, B. M., Chertow, G. M., & Mc Causland, F. R. (2024). Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial. American Journal of Nephrology, 1–8.

Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.
Chertow, G. M., Chang, A. M., Felker, G. M., Heise, M., Velkoska, E., Fellström, B., … Wolf, M. (2024). Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature Medicine.

Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients with Kidney Failure.
Hill Gallant, K. M., Sprague, S. M., Rosenbaum, D. P., Spiegel, D. M., Kozuka, K., Edelstein, S., & Chertow, G. M. (2024). Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients with Kidney Failure. Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation.

Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study.
Chertow, G. M., Correa-Rotter, R., Eckardt, K.-U. U., Kanda, E., Karasik, A., Li, G., … Retat, L. (2024). Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study. EClinicalMedicine, 72, 102614.

Plasmapheresis in ANCA-Associated Vasculitis with Active Kidney Involvement in the United States (2016-2020): A Cross-Sectional Study.
Tao, J., Yasui, O. W., Kamdar, N. S., Zheng, S., Popat, R. A., Rehkopf, D. H., & Chertow, G. M. (2024). Plasmapheresis in ANCA-Associated Vasculitis with Active Kidney Involvement in the United States (2016-2020): A Cross-Sectional Study. Kidney360.

Selonsertib in Patients with Diabetic Kidney Disease: A Phase 2b Randomized Active Run-In Clinical Trial.
Heerspink, H. J., Perkovic, V., Tuttle, K. R., Pergola, P. E., Mahaffey, K. W., Patel, U. D., … Chertow, G. M. (2024). Selonsertib in Patients with Diabetic Kidney Disease: A Phase 2b Randomized Active Run-In Clinical Trial. Journal of the American Society of Nephrology : JASN.

Tenapanor improves long-term control of high phosphate concentrations in the blood in patients receiving maintenance dialysis: a plain language summary of the NORMALIZE study.
Silva, A., Edelstein, S., Yang, Y., Rosenbaum, D., Battelli, L., & Chertow, G. M. (2024). Tenapanor improves long-term control of high phosphate concentrations in the blood in patients receiving maintenance dialysis: a plain language summary of the NORMALIZE study. Current Medical Research and Opinion, 1–12.

SGLT2 Inhibitor Use in Chronic Kidney Disease: Supporting Cardiovascular, Kidney, and Metabolic Health
Madero, M., Chertow, G. M., & Mark, P. B. (2024). SGLT2 Inhibitor Use in Chronic Kidney Disease: Supporting Cardiovascular, Kidney, and Metabolic Health. KIDNEY MEDICINE, 6(8).

The Legacy Effect of Intensive versus Standard Blood Pressure Control on the Incidence of Dialysis or Kidney Transplantation.
Pajewski, N. M., Beddhu, S., Bress, A. P., Chang, T. I., Chertow, G. M., Cheung, A. K., … Ix, J. H. (2024). The Legacy Effect of Intensive versus Standard Blood Pressure Control on the Incidence of Dialysis or Kidney Transplantation. Journal of the American Society of Nephrology : JASN.

Hyperkalemia and risk of chronic kidney disease progression: A propensity score matched analysis.
Agiro, A., Cook, E., Mu, F., Greatsinger, A., Chen, J., Zhao, A., … Chertow, G. M. (2024). Hyperkalemia and risk of chronic kidney disease progression: A propensity score matched analysis. Kidney360.

Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients with CKD.
Bakker, W. M., Gansevoort, R. T., Yang, C., Chertow, G. M., Heerspink, H. J., & Vart, P. (2024). Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients with CKD. Journal of the American Society of Nephrology : JASN.

Management of Patients With Kidney Disease in Need of Cardiovascular Catheterization: A Scientific Workshop Cosponsored by the National Kidney Foundation and the Society for Cardiovascular Angiography and Interventions.
Prasad, A., Palevsky, P. M., Bansal, S., Chertow, G. M., Kaufman, J., Kashani, K., … Weisbord, S. (2022). Management of Patients With Kidney Disease in Need of Cardiovascular Catheterization: A Scientific Workshop Cosponsored by the National Kidney Foundation and the Society for Cardiovascular Angiography and Interventions. Journal of the Society for Cardiovascular Angiography & Interventions, 1(6), 100445.

Effects of Dapagliflozin in Patients with Membranous Nephropathy.
Chertow, G. M., Heerspink, H. L., Mark, P. B., Dwyer, J. P., Nowicki, M., Wheeler, D. C., … Jongs, N. (2024). Effects of Dapagliflozin in Patients with Membranous Nephropathy. Glomerular Diseases, 4(1), 137–145.

Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists.
Rastogi, A., Collins, A., Kelepouris, E., Kotzker, W., Middleton, J. P., Rajpal, M., … Chertow, G. M. (2024). Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists. Journal of Primary Care & Community Health, 15, 21501319241259905.

CALCIMIMETIC PRESCRIPTIONS FOLLOWING THE TRANSITIONAL DRUG ADD-ON PAYMENT ADJUSTMENT IN FEE-FOR-SERVICE MEDICARE PATIENTS ON DIALYSIS
Caldwell, J., Cheng, X. S., Bendavid, E., Chertow, G. M., & Lin, E. (2024). CALCIMIMETIC PRESCRIPTIONS FOLLOWING THE TRANSITIONAL DRUG ADD-ON PAYMENT ADJUSTMENT IN FEE-FOR-SERVICE MEDICARE PATIENTS ON DIALYSIS. VALUE IN HEALTH. ELSEVIER SCIENCE INC.

Prospective Study on Kidney Dysfunction Markers and Risk for Mortality among South Asians
Jagannathan, R., Anand, S., Kondal, D., Han, J., Montez-Rath, M., Ali, M. K., … Prabhakaran, D. (2024). Prospective Study on Kidney Dysfunction Markers and Risk for Mortality among South Asians. KIDNEY INTERNATIONAL REPORTS, 9(8), 2537–2545.

Prospective Study on Kidney Dysfunction Markers and Risk for Mortality among South Asians.
Jagannathan, R., Anand, S., Kondal, D., Han, J., Montez-Rath, M., Ali, M. K., … Prabhakaran, D. (2024). Prospective Study on Kidney Dysfunction Markers and Risk for Mortality among South Asians. Kidney International Reports, 9(8), 2537–2545.

SERUM BICARBONATE CONCENTRATIONS AND CKD PROGRESSION IN PATIENTS WITH METABOLIC ACIDOSIS: EVIDENCE FROM VALOR-CKD
Singh, B., Tangri, N., Bushinsky, D., Chertow, G., Pergola, P., Kendrick, I., … Wesson, D. (2024). SERUM BICARBONATE CONCENTRATIONS AND CKD PROGRESSION IN PATIENTS WITH METABOLIC ACIDOSIS: EVIDENCE FROM VALOR-CKD. AMERICAN JOURNAL OF KIDNEY DISEASES. W B SAUNDERS CO-ELSEVIER INC.

Safety and efficacy of vadadustat vs darbepoetin alfa in patients on maintenance dialysis by prespecified subgroups of baseline ESA dose
Chertow, G., Jardine, A. G., Burke, S., Luo, W., Minga, T., Koury, M. J., & Eckardt, K.-U. (2024). Safety and efficacy of vadadustat vs darbepoetin alfa in patients on maintenance dialysis by prespecified subgroups of baseline ESA dose. NEPHROLOGY DIALYSIS TRANSPLANTATION. OXFORD UNIV PRESS.

In memoriam: George L. Bakris, MD, 1952-2024.
Chapman, A. B., Rafey, M. A., Chertow, G. M., & Weir, M. (2024). In memoriam: George L. Bakris, MD, 1952-2024. Kidney International.

Where Are Patients' Voices in Chronic Kidney Disease?
Rüssmann, D., Roy-Chaudhury, P., Chertow, G. M., Gee, P., Chauhan, C., Macari, S., … Rossignol, P. (2024). Where Are Patients' Voices in Chronic Kidney Disease? Clinical Journal of the American Society of Nephrology : CJASN.

Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension
Sinha, S., Nigwekar, S. U., Brandenburg, V., Gould, L. J., Serena, T. E., Moe, S. M., … Chertow, G. M. (2024). Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension. ECLINICALMEDICINE, 75.

Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension.
Sinha, S., Nigwekar, S. U., Brandenburg, V., Gould, L. J., Serena, T. E., Moe, S. M., … Chertow, G. M. (2024). Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension. EClinicalMedicine, 75, 102784.